>HW350178.1 JP 2013534413-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-tRNA SYNTHETASES
CTCGAGTAATGA
>HW350171.1 JP 2013534413-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-tRNA SYNTHETASES
TAATGACTCGAG
>HW349916.1 JP 2013534807-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF PHENYLALANYL-BETA-tRNA SYNTHETASES
CATATGGGATCC
>HW349915.1 JP 2013534807-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF PHENYLALANYL-BETA-tRNA SYNTHETASES
CTCGAGTAATGA
>HW349908.1 JP 2013534807-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF PHENYLALANYL-BETA-tRNA SYNTHETASES
TAATGACTCGAG
>HW349759.1 JP 2013534805-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ISOLEUCYL tRNA SYNTHETASES
CATATGGGATCC
>HW349758.1 JP 2013534805-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ISOLEUCYL tRNA SYNTHETASES
CTCGAGTAATGA
>HW349751.1 JP 2013534805-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ISOLEUCYL tRNA SYNTHETASES
TAATGACTCGAG
>HW363618.1 JP 2013535495-A/20: INJECTABLE PHARMACEUTICAL COMPOSITION FOR PREVENTING, STABILISING AND/OR INHIBITING PATHOLOGICAL NEOVASCULARIZATION-RELATED CONDITIONS
CGCCATGCTGCT
>HW355230.1 JP 2013534132-A/4: Process
GTTGACACTGTC
>HW355194.1 JP 2013534130-A/4192: ANTIBODY LIBRARIES
NNGGTACTTCGA
>HW355193.1 JP 2013534130-A/4191: ANTIBODY LIBRARIES
CTGGTACTTCGA
>HW355190.1 JP 2013534130-A/4188: ANTIBODY LIBRARIES
NNATACTTCCAG
>HW355189.1 JP 2013534130-A/4187: ANTIBODY LIBRARIES
GAATACTTCCAG
>HW354982.1 JP 2013534130-A/3980: ANTIBODY LIBRARIES
GGABHCACACAA
>HW354981.1 JP 2013534130-A/3979: ANTIBODY LIBRARIES
GGABHCACAGCT
>HW354980.1 JP 2013534130-A/3978: ANTIBODY LIBRARIES
GGABHCGGACTA
>HW354979.1 JP 2013534130-A/3977: ANTIBODY LIBRARIES
GGABHCGGATGG
>HW354978.1 JP 2013534130-A/3976: ANTIBODY LIBRARIES
AGGAGAVHGTAC
>HW354977.1 JP 2013534130-A/3975: ANTIBODY LIBRARIES
GGTAGAVHGTAC
>HW354976.1 JP 2013534130-A/3974: ANTIBODY LIBRARIES
CCABHCGGATAC
>HW354975.1 JP 2013534130-A/3973: ANTIBODY LIBRARIES
AGCBHCGGATAC
>HW354974.1 JP 2013534130-A/3972: ANTIBODY LIBRARIES
AGABHCGGATAC
>HW354973.1 JP 2013534130-A/3971: ANTIBODY LIBRARIES
GGABHCGGATAC
>HW354902.1 JP 2013534130-A/3900: ANTIBODY LIBRARIES
VHABTCGGAGGT
>HW354901.1 JP 2013534130-A/3899: ANTIBODY LIBRARIES
VNCTACTACTHT
>HW354900.1 JP 2013534130-A/3898: ANTIBODY LIBRARIES
VBCTGGTTCGGT
>HW354899.1 JP 2013534130-A/3897: ANTIBODY LIBRARIES
BHCVGCTACAGT
>HW354898.1 JP 2013534130-A/3896: ANTIBODY LIBRARIES
NHCTACTACTHT
>HW354897.1 JP 2013534130-A/3895: ANTIBODY LIBRARIES
NHCTACGGAKCT
>HW354896.1 JP 2013534130-A/3894: ANTIBODY LIBRARIES
VBCGVCTACAGT
>HW354895.1 JP 2013534130-A/3893: ANTIBODY LIBRARIES
GACAGCAGCDBG
>HW354894.1 JP 2013534130-A/3892: ANTIBODY LIBRARIES
VBTCDAGGAGTT
>HW354893.1 JP 2013534130-A/3891: ANTIBODY LIBRARIES
VHAGTASSAGCT
>HW354892.1 JP 2013534130-A/3890: ANTIBODY LIBRARIES
BHCTACAGCKMT
>HW354891.1 JP 2013534130-A/3889: ANTIBODY LIBRARIES
VBTBTCGGAGAG
>HW354890.1 JP 2013534130-A/3888: ANTIBODY LIBRARIES
VHGGGARKCGCT
>HW354889.1 JP 2013534130-A/3887: ANTIBODY LIBRARIES
VHACAACTAKKG
>HW354888.1 JP 2013534130-A/3886: ANTIBODY LIBRARIES
VBCKMCGGATAT
>HW354887.1 JP 2013534130-A/3885: ANTIBODY LIBRARIES
NHCTACTACGVT
>HW354886.1 JP 2013534130-A/3884: ANTIBODY LIBRARIES
GTAGCAGCAVHA
>HW354885.1 JP 2013534130-A/3883: ANTIBODY LIBRARIES
VBCAYATTCGGT
>HW354884.1 JP 2013534130-A/3882: ANTIBODY LIBRARIES
GCAGCAGCAVBT
>HW354883.1 JP 2013534130-A/3881: ANTIBODY LIBRARIES
VHAGTAACARMG
>HW354882.1 JP 2013534130-A/3880: ANTIBODY LIBRARIES
BHCGGATACKMT
>HW354881.1 JP 2013534130-A/3879: ANTIBODY LIBRARIES
NHCAGCGGABGG
>HW354880.1 JP 2013534130-A/3878: ANTIBODY LIBRARIES
BHCGGATSGTAT
>HW354879.1 JP 2013534130-A/3877: ANTIBODY LIBRARIES
BHCGGAAGCKMT
>HW354878.1 JP 2013534130-A/3876: ANTIBODY LIBRARIES
VHACAACTAGNT
>HW354877.1 JP 2013534130-A/3875: ANTIBODY LIBRARIES
BHCAGCTGGTHT
>HW354876.1 JP 2013534130-A/3874: ANTIBODY LIBRARIES
NHCTMCTACGGT
>HW354875.1 JP 2013534130-A/3873: ANTIBODY LIBRARIES
AGCAGCAGCDBG
>HW354874.1 JP 2013534130-A/3872: ANTIBODY LIBRARIES
VBCACAGTARMG
>HW354873.1 JP 2013534130-A/3871: ANTIBODY LIBRARIES
VHAGTAGCAGNT
>HW354872.1 JP 2013534130-A/3870: ANTIBODY LIBRARIES
CAGTGGCTABHT
>HW354871.1 JP 2013534130-A/3869: ANTIBODY LIBRARIES
VHATACAGCRST
>HW354870.1 JP 2013534130-A/3868: ANTIBODY LIBRARIES
VHGRYGGCAACT
>HW354869.1 JP 2013534130-A/3867: ANTIBODY LIBRARIES
NHCTACGGAGVT
>HW354868.1 JP 2013534130-A/3866: ANTIBODY LIBRARIES
VBCGACGGATHT
>HW354867.1 JP 2013534130-A/3865: ANTIBODY LIBRARIES
VHGGTARSAGGT
>HW354866.1 JP 2013534130-A/3864: ANTIBODY LIBRARIES
TACAGCAGCVBT
>HW354865.1 JP 2013534130-A/3863: ANTIBODY LIBRARIES
BHCGGAKMCTAT
>HW354864.1 JP 2013534130-A/3862: ANTIBODY LIBRARIES
DBGTTCGGAGNG
>HW354863.1 JP 2013534130-A/3861: ANTIBODY LIBRARIES
VHGGBAGCAACT
>HW354862.1 JP 2013534130-A/3860: ANTIBODY LIBRARIES
BHCACAGCCAKS
>HW354831.1 JP 2013534130-A/3829: ANTIBODY LIBRARIES
GCCAAGCCAGTG
>HW354830.1 JP 2013534130-A/3828: ANTIBODY LIBRARIES
GCCAGACCGGTG
>HW354825.1 JP 2013534130-A/3823: ANTIBODY LIBRARIES
GCCAAGCCTACT
>HW354824.1 JP 2013534130-A/3822: ANTIBODY LIBRARIES
GCCAGACCTACT
>HW354821.1 JP 2013534130-A/3819: ANTIBODY LIBRARIES
GCCAAGCCGGCT
>HW354820.1 JP 2013534130-A/3818: ANTIBODY LIBRARIES
GCCAGACCAGCT
>HW354817.1 JP 2013534130-A/3815: ANTIBODY LIBRARIES
GCCAAGCCACCT
>HW354816.1 JP 2013534130-A/3814: ANTIBODY LIBRARIES
GCCAGACCACCT
>HW354807.1 JP 2013534130-A/3805: ANTIBODY LIBRARIES
GCCAAGACCGGA
>HW354806.1 JP 2013534130-A/3804: ANTIBODY LIBRARIES
GCCAGAACTGGA
>HW354795.1 JP 2013534130-A/3793: ANTIBODY LIBRARIES
GCCAAGCCCGGA
>HW354794.1 JP 2013534130-A/3792: ANTIBODY LIBRARIES
GCCAGACCAGGA
>HW354765.1 JP 2013534130-A/3763: ANTIBODY LIBRARIES
GCCAAGGAATTG
>HW354764.1 JP 2013534130-A/3762: ANTIBODY LIBRARIES
GCCAGAGAGTTG
>HW354763.1 JP 2013534130-A/3761: ANTIBODY LIBRARIES
GCCAAGGAGCCT
>HW354762.1 JP 2013534130-A/3760: ANTIBODY LIBRARIES
GCCAGAGAGCCT
>HW354705.1 JP 2013534130-A/3703: ANTIBODY LIBRARIES
TATATGGATGTC
>HW354704.1 JP 2013534130-A/3702: ANTIBODY LIBRARIES
TATTTCCAGCAC
>HW354703.1 JP 2013534130-A/3701: ANTIBODY LIBRARIES
TACTTCGATTAC
>HW354702.1 JP 2013534130-A/3700: ANTIBODY LIBRARIES
TATTTCGACTTA
>HW354701.1 JP 2013534130-A/3699: ANTIBODY LIBRARIES
TGGTTCGATCCA
>HW354700.1 JP 2013534130-A/3698: ANTIBODY LIBRARIES
GTTTTCGATTAT
>HW354699.1 JP 2013534130-A/3697: ANTIBODY LIBRARIES
ACATTTGACTAC
>HW354698.1 JP 2013534130-A/3696: ANTIBODY LIBRARIES
AGTTTCGATTAC
>HW354697.1 JP 2013534130-A/3695: ANTIBODY LIBRARIES
AGGTTTGACTAT
>HW354696.1 JP 2013534130-A/3694: ANTIBODY LIBRARIES
CCCTTCGACTAT
>HW354695.1 JP 2013534130-A/3693: ANTIBODY LIBRARIES
AACTTTGATTAC
>HW354694.1 JP 2013534130-A/3692: ANTIBODY LIBRARIES
TTATTTGATTAT
>HW354693.1 JP 2013534130-A/3691: ANTIBODY LIBRARIES
ATATTCGATTAC
>HW354692.1 JP 2013534130-A/3690: ANTIBODY LIBRARIES
CACTTTGACTAT
>HW354691.1 JP 2013534130-A/3689: ANTIBODY LIBRARIES
GGCATGGATGTA
>HW354690.1 JP 2013534130-A/3688: ANTIBODY LIBRARIES
GGGTTCGACTAC
>HW354689.1 JP 2013534130-A/3687: ANTIBODY LIBRARIES
GGGTTTGACCCA
>HW354687.1 JP 2013534130-A/3685: ANTIBODY LIBRARIES
GATTTCGACTAT
>HW354679.1 JP 2013534130-A/3677: ANTIBODY LIBRARIES
TACTCAAGTGGT
>HW354663.1 JP 2013534130-A/3661: ANTIBODY LIBRARIES
AGAGATGGTTAC
>HW354659.1 JP 2013534130-A/3657: ANTIBODY LIBRARIES
ACAACTGTGACT
>HW354655.1 JP 2013534130-A/3653: ANTIBODY LIBRARIES
GATTACGGCGAT
>HW354627.1 JP 2013534130-A/3625: ANTIBODY LIBRARIES
GACTCATCCGGT
>HW354591.1 JP 2013534130-A/3589: ANTIBODY LIBRARIES
TGGTTTGGGGAG
>HW354563.1 JP 2013534130-A/3561: ANTIBODY LIBRARIES
GCAAAAGTCAGA
>HW354559.1 JP 2013534130-A/3557: ANTIBODY LIBRARIES
GCAAAAGACAAG
>HW354555.1 JP 2013534130-A/3553: ANTIBODY LIBRARIES
GCTAAAGCAGAG
>HW354547.1 JP 2013534130-A/3545: ANTIBODY LIBRARIES
GCCAAGGCAAGA
>HW354543.1 JP 2013534130-A/3541: ANTIBODY LIBRARIES
GCCAAGGTACCT
>HW354539.1 JP 2013534130-A/3537: ANTIBODY LIBRARIES
GCCAAGAGTCCT
>HW354535.1 JP 2013534130-A/3533: ANTIBODY LIBRARIES
GCCAAGCCGTTG
>HW354523.1 JP 2013534130-A/3521: ANTIBODY LIBRARIES
GCCAAGTTAGGA
>HW354503.1 JP 2013534130-A/3501: ANTIBODY LIBRARIES
GCCAAGGACGTG
>HW354499.1 JP 2013534130-A/3497: ANTIBODY LIBRARIES
GCCAAGGAAACT
>HW354495.1 JP 2013534130-A/3493: ANTIBODY LIBRARIES
GCCAAGGGGTTG
>HW354491.1 JP 2013534130-A/3489: ANTIBODY LIBRARIES
GCCAAGGGATCT
>HW354490.1 JP 2013534130-A/3488: ANTIBODY LIBRARIES
GCCAAGGATTCT
>HW354688.1 JP 2013534130-A/3686: ANTIBODY LIBRARIES
TTCTTCGATTAC
>HW354684.1 JP 2013534130-A/3682: ANTIBODY LIBRARIES
GCCGCAAGACCT
>HW354680.1 JP 2013534130-A/3678: ANTIBODY LIBRARIES
CAGTGGTTAGTT
>HW354672.1 JP 2013534130-A/3670: ANTIBODY LIBRARIES
CAGCAATTGGTT
>HW354664.1 JP 2013534130-A/3662: ANTIBODY LIBRARIES
GATACTGCTATG
>HW354660.1 JP 2013534130-A/3658: ANTIBODY LIBRARIES
ACAGTAACTACT
>HW354656.1 JP 2013534130-A/3654: ANTIBODY LIBRARIES
TACGGCGATTAT
>HW354644.1 JP 2013534130-A/3642: ANTIBODY LIBRARIES
GTGTTGAGGTAT
>HW354608.1 JP 2013534130-A/3606: ANTIBODY LIBRARIES
TACTACGATTCC
>HW354600.1 JP 2013534130-A/3598: ANTIBODY LIBRARIES
ATGGTAAGAGGT
>HW354592.1 JP 2013534130-A/3590: ANTIBODY LIBRARIES
AGTGGATCTTAT
>HW354568.1 JP 2013534130-A/3566: ANTIBODY LIBRARIES
GCCAAGCAAGGA
>HW354564.1 JP 2013534130-A/3562: ANTIBODY LIBRARIES
GCAAAGGCAAAG
>HW354560.1 JP 2013534130-A/3558: ANTIBODY LIBRARIES
GCCAAAGTATCT
>HW354552.1 JP 2013534130-A/3550: ANTIBODY LIBRARIES
GCAAAGAGCTTG
>HW354548.1 JP 2013534130-A/3546: ANTIBODY LIBRARIES
GCCAAGGCATCT
>HW354628.1 JP 2013534130-A/3626: ANTIBODY LIBRARIES
GGTTACTATTAC
>HW354540.1 JP 2013534130-A/3538: ANTIBODY LIBRARIES
GCCAAGCTACCT
>HW354528.1 JP 2013534130-A/3526: ANTIBODY LIBRARIES
GCCAAGCCTAGA
>HW354520.1 JP 2013534130-A/3518: ANTIBODY LIBRARIES
GCCAAGTCTGGA
>HW354516.1 JP 2013534130-A/3514: ANTIBODY LIBRARIES
GCCAAGAGAGGA
>HW354504.1 JP 2013534130-A/3502: ANTIBODY LIBRARIES
GCCAAGGGCGTG
>HW354500.1 JP 2013534130-A/3498: ANTIBODY LIBRARIES
GCCAAGGATACT
>HW354496.1 JP 2013534130-A/3494: ANTIBODY LIBRARIES
GCCAAGGAAGCT
>HW354492.1 JP 2013534130-A/3490: ANTIBODY LIBRARIES
GCCAAGGATCCT
>HW354685.1 JP 2013534130-A/3683: ANTIBODY LIBRARIES
GCCTTCGATATC
>HW354681.1 JP 2013534130-A/3679: ANTIBODY LIBRARIES
GAGTACTCATCC
>HW354677.1 JP 2013534130-A/3675: ANTIBODY LIBRARIES
AGTGGTTGGTAT
>HW354669.1 JP 2013534130-A/3667: ANTIBODY LIBRARIES
AGTAGCTCTTGG
>HW354665.1 JP 2013534130-A/3663: ANTIBODY LIBRARIES
TATTCATATGGT
>HW354645.1 JP 2013534130-A/3643: ANTIBODY LIBRARIES
TTGAGATATTTC
>HW354629.1 JP 2013534130-A/3627: ANTIBODY LIBRARIES
AGCGGCTACTAT
>HW354609.1 JP 2013534130-A/3607: ANTIBODY LIBRARIES
TATTATTATGAC
>HW354593.1 JP 2013534130-A/3591: ANTIBODY LIBRARIES
TATTATGGCAGT
>HW354569.1 JP 2013534130-A/3567: ANTIBODY LIBRARIES
GTTGGCGCAACT
>HW354565.1 JP 2013534130-A/3563: ANTIBODY LIBRARIES
GCAAAGGGCAAG
>HW354557.1 JP 2013534130-A/3555: ANTIBODY LIBRARIES
GCAAAAGGGGAC
>HW354553.1 JP 2013534130-A/3551: ANTIBODY LIBRARIES
GCTAAATTGCAC
>HW354545.1 JP 2013534130-A/3543: ANTIBODY LIBRARIES
GCCAAGGATCAG
>HW354541.1 JP 2013534130-A/3539: ANTIBODY LIBRARIES
GCCAAGGCTCCT
>HW354537.1 JP 2013534130-A/3535: ANTIBODY LIBRARIES
GCCAAGAGGCCT
>HW354525.1 JP 2013534130-A/3523: ANTIBODY LIBRARIES
GCCAAGGCTGGA
>HW354501.1 JP 2013534130-A/3499: ANTIBODY LIBRARIES
GCCAAGGGAACT
>HW354497.1 JP 2013534130-A/3495: ANTIBODY LIBRARIES
GCCAAGGACGCT
>HW354493.1 JP 2013534130-A/3491: ANTIBODY LIBRARIES
GCCAAGGGTCCT
>HW354686.1 JP 2013534130-A/3684: ANTIBODY LIBRARIES
GCCTTCGATTAC
>HW354678.1 JP 2013534130-A/3676: ANTIBODY LIBRARIES
AGTTCCGGTTGG
>HW354670.1 JP 2013534130-A/3668: ANTIBODY LIBRARIES
TACAGCAGCTCC
>HW354646.1 JP 2013534130-A/3644: ANTIBODY LIBRARIES
AGATACTTTGAT
>HW354594.1 JP 2013534130-A/3592: ANTIBODY LIBRARIES
TACTACTATGGC
>HW354562.1 JP 2013534130-A/3560: ANTIBODY LIBRARIES
GCCAAAGGACAG
>HW354558.1 JP 2013534130-A/3556: ANTIBODY LIBRARIES
GCAAAAAGGAGA
>HW354550.1 JP 2013534130-A/3548: ANTIBODY LIBRARIES
GCCAAGAGTAGA
>HW354546.1 JP 2013534130-A/3544: ANTIBODY LIBRARIES
GCTAAAGACCAC
>HW354542.1 JP 2013534130-A/3540: ANTIBODY LIBRARIES
GCCAAGACGCCT
>HW354530.1 JP 2013534130-A/3528: ANTIBODY LIBRARIES
GCCAAGCCTTCT
>HW354526.1 JP 2013534130-A/3524: ANTIBODY LIBRARIES
GCCAAGGTAGGA
>HW354502.1 JP 2013534130-A/3500: ANTIBODY LIBRARIES
GCCAAGGAAGTG
>HW354498.1 JP 2013534130-A/3496: ANTIBODY LIBRARIES
GCCAAGGGCGCT
>HW354494.1 JP 2013534130-A/3492: ANTIBODY LIBRARIES
GCCAAGGACTTG
>HW354397.1 JP 2013534130-A/3395: ANTIBODY LIBRARIES
GCCAGAGAGGGA
>HW354489.1 JP 2013534130-A/3487: ANTIBODY LIBRARIES
GCCAAGGAATCT
>HW354457.1 JP 2013534130-A/3455: ANTIBODY LIBRARIES
GCCAGAGTCCCT
>HW354453.1 JP 2013534130-A/3451: ANTIBODY LIBRARIES
GCCAGATCACCT
>HW354449.1 JP 2013534130-A/3447: ANTIBODY LIBRARIES
GCCAGACCGTTG
>HW354437.1 JP 2013534130-A/3435: ANTIBODY LIBRARIES
GCCAGATTGGGA
>HW354417.1 JP 2013534130-A/3415: ANTIBODY LIBRARIES
GCCAGAGATGTG
>HW354413.1 JP 2013534130-A/3411: ANTIBODY LIBRARIES
GCCAGAGAGACT
>HW354409.1 JP 2013534130-A/3407: ANTIBODY LIBRARIES
GCCAGAGGGTTG
>HW354405.1 JP 2013534130-A/3403: ANTIBODY LIBRARIES
GCCAGAGGTTCT
>HW354485.1 JP 2013534130-A/3483: ANTIBODY LIBRARIES
GCCAAGGGCGGA
>HW354477.1 JP 2013534130-A/3475: ANTIBODY LIBRARIES
GCCAGGGTCAGA
>HW354473.1 JP 2013534130-A/3471: ANTIBODY LIBRARIES
GCTAGAGATAAG
>HW354469.1 JP 2013534130-A/3467: ANTIBODY LIBRARIES
GCAAGAGCCGAG
>HW354461.1 JP 2013534130-A/3459: ANTIBODY LIBRARIES
GCAAGGGCTAGA
>HW354401.1 JP 2013534130-A/3399: ANTIBODY LIBRARIES
GCCAGAGACAGA
>HW354486.1 JP 2013534130-A/3484: ANTIBODY LIBRARIES
GCCAAGGAAAGA
>HW354482.1 JP 2013534130-A/3480: ANTIBODY LIBRARIES
GCCAGGCAGGGA
>HW354478.1 JP 2013534130-A/3476: ANTIBODY LIBRARIES
GCTAGGGCTAAG
>HW354474.1 JP 2013534130-A/3472: ANTIBODY LIBRARIES
GCTAGAGTATCT
>HW354466.1 JP 2013534130-A/3464: ANTIBODY LIBRARIES
GCTAGATCTTTG
>HW354462.1 JP 2013534130-A/3460: ANTIBODY LIBRARIES
GCTAGGGCATCT
>HW354454.1 JP 2013534130-A/3452: ANTIBODY LIBRARIES
GCCAGACTTCCT
>HW354442.1 JP 2013534130-A/3440: ANTIBODY LIBRARIES
GCCAGACCCAGA
>HW354434.1 JP 2013534130-A/3432: ANTIBODY LIBRARIES
GCCAGATCAGGA
>HW354430.1 JP 2013534130-A/3428: ANTIBODY LIBRARIES
GCCAGAAGAGGA
>HW354418.1 JP 2013534130-A/3416: ANTIBODY LIBRARIES
GCCAGAGGGGTG
>HW354414.1 JP 2013534130-A/3412: ANTIBODY LIBRARIES
GCCAGAGATACT
>HW354410.1 JP 2013534130-A/3408: ANTIBODY LIBRARIES
GCCAGAGAGGCT
>HW354406.1 JP 2013534130-A/3404: ANTIBODY LIBRARIES
GCCAGAGACCCT
>HW354402.1 JP 2013534130-A/3400: ANTIBODY LIBRARIES
GCCAGAGGCAGA
>HW354398.1 JP 2013534130-A/3396: ANTIBODY LIBRARIES
GCCAGAGACGGA
>HW354487.1 JP 2013534130-A/3485: ANTIBODY LIBRARIES
GCCAAGGACAGA
>HW354483.1 JP 2013534130-A/3481: ANTIBODY LIBRARIES
GCCAAGGAAGGA
>HW354479.1 JP 2013534130-A/3477: ANTIBODY LIBRARIES
GCCAGGGGTAAG
>HW354471.1 JP 2013534130-A/3469: ANTIBODY LIBRARIES
GCTAGAGGGGAC
>HW354467.1 JP 2013534130-A/3465: ANTIBODY LIBRARIES
GCTAGGTTGCAC
>HW354459.1 JP 2013534130-A/3457: ANTIBODY LIBRARIES
GCCAGGGACCAG
>HW354455.1 JP 2013534130-A/3453: ANTIBODY LIBRARIES
GCCAGAGCCCCT
>HW354451.1 JP 2013534130-A/3449: ANTIBODY LIBRARIES
GCCAGAAGGCCT
>HW354439.1 JP 2013534130-A/3437: ANTIBODY LIBRARIES
GCCAGAGCTGGA
>HW354415.1 JP 2013534130-A/3413: ANTIBODY LIBRARIES
GCCAGAGGCACT
>HW354411.1 JP 2013534130-A/3409: ANTIBODY LIBRARIES
GCCAGAGATGCT
>HW354407.1 JP 2013534130-A/3405: ANTIBODY LIBRARIES
GCCAGAGGGCCT
>HW354403.1 JP 2013534130-A/3401: ANTIBODY LIBRARIES
GCCAGAGAATCT
>HW354399.1 JP 2013534130-A/3397: ANTIBODY LIBRARIES
GCCAGAGGTGGA
>HW354488.1 JP 2013534130-A/3486: ANTIBODY LIBRARIES
GCCAAGGGCAGA
>HW354472.1 JP 2013534130-A/3470: ANTIBODY LIBRARIES
GCTAGGAGGAGA
>HW354464.1 JP 2013534130-A/3462: ANTIBODY LIBRARIES
GCTAGATCAAGA
>HW354484.1 JP 2013534130-A/3482: ANTIBODY LIBRARIES
GCCAAGGACGGA
>HW354476.1 JP 2013534130-A/3474: ANTIBODY LIBRARIES
GCTAGGGGCCAG
>HW354460.1 JP 2013534130-A/3458: ANTIBODY LIBRARIES
GCAAGAGACCAC
>HW354456.1 JP 2013534130-A/3454: ANTIBODY LIBRARIES
GCCAGAACTCCT
>HW354444.1 JP 2013534130-A/3442: ANTIBODY LIBRARIES
GCCAGACCATCT
>HW354440.1 JP 2013534130-A/3438: ANTIBODY LIBRARIES
GCCAGAGTGGGA
>HW354416.1 JP 2013534130-A/3414: ANTIBODY LIBRARIES
GCCAGAGAGGTG
>HW354412.1 JP 2013534130-A/3410: ANTIBODY LIBRARIES
GCCAGAGGTGCT
>HW354408.1 JP 2013534130-A/3406: ANTIBODY LIBRARIES
GCCAGAGACTTG
>HW354404.1 JP 2013534130-A/3402: ANTIBODY LIBRARIES
GCCAGAGACTCT
>HW354400.1 JP 2013534130-A/3398: ANTIBODY LIBRARIES
GCCAGAGAGAGA
>JC078687.1 Sequence 2154 from Patent EP2663334
TTTGACGACTGG
>JC078685.1 Sequence 2152 from Patent EP2663334
TTGGACGTCTGG
>JC078671.1 Sequence 2138 from Patent EP2663334
CGGGGGACAAAA
>JC078665.1 Sequence 2132 from Patent EP2663334
TGGGTACAGTGG
>JC078659.1 Sequence 2126 from Patent EP2663334
AGTGCGACCCAC
>JC078645.1 Sequence 2112 from Patent EP2663334
TGACTACGGTGA
>JC078639.1 Sequence 2106 from Patent EP2663334
GGTGACACTGGA
>JC078637.1 Sequence 2104 from Patent EP2663334
TGACTACGGTGA
>JC078634.1 Sequence 2101 from Patent EP2663334
TAGTCCTAGGTG
>JC078629.1 Sequence 2096 from Patent EP2663334
ACTGGTTATTAT
>JC078621.1 Sequence 2088 from Patent EP2663334
TGGGGGTCGGGC
>JC078620.1 Sequence 2087 from Patent EP2663334
CCAGTGCTGGCG
>JC078618.1 Sequence 2085 from Patent EP2663334
CCAGTGCCGGCG
>JC078615.1 Sequence 2082 from Patent EP2663334
CAAGGGGACCCT
>JC087885.1 Sequence 70 from Patent WO2013156443
AGGCGGAGACGC
>JC087884.1 Sequence 69 from Patent WO2013156443
AGGAGACGGCGC
>JC087855.1 Sequence 40 from Patent WO2013156443
TTCTTTTTCTTC
>JC087854.1 Sequence 39 from Patent WO2013156443
TTCTTCTTTTTC
>JC087853.1 Sequence 38 from Patent WO2013156443
TTCTTCTTCTTT
>JC087839.1 Sequence 24 from Patent WO2013156443
GAAGAGGAAGAA
>JC087838.1 Sequence 23 from Patent WO2013156443
GAAGAAGAGGAA
>JC087837.1 Sequence 22 from Patent WO2013156443
GAAGAAGAAGAG
>JC086660.1 Sequence 10127 from Patent EP2663334
TTTGACTACTGG
>JC086647.1 Sequence 10114 from Patent EP2663334
TTTGACTACTGG
>JC086637.1 Sequence 10104 from Patent EP2663334
TTTGACTACTGG
>JC086633.1 Sequence 10100 from Patent EP2663334
TTTGACTACTGG
>JC086627.1 Sequence 10094 from Patent EP2663334
TTTAACTACTGG
>JC086619.1 Sequence 10086 from Patent EP2663334
TTTGATTATTGG
>JC086612.1 Sequence 10079 from Patent EP2663334
GCCCACCGGGGC
>JC086607.1 Sequence 10074 from Patent EP2663334
GGTTCGGGGAGT
>JC086600.1 Sequence 10067 from Patent EP2663334
GGTGATTATGCC
>JC086598.1 Sequence 10065 from Patent EP2663334
CTTCGGTGACTA
>JC086589.1 Sequence 10056 from Patent EP2663334
ATGGTCCGTGGA
>JC086579.1 Sequence 10046 from Patent EP2663334
AATCCGGACGTA
>JC086578.1 Sequence 10045 from Patent EP2663334
CCCGGACGGTCG
>JC086564.1 Sequence 10031 from Patent EP2663334
CCCATATCCGAC
>JC084660.1 Sequence 8127 from Patent EP2663334
TGGGGCCAGGGA
>JC084155.1 Sequence 7622 from Patent EP2663334
TTTGACTACTGG
>JC084146.1 Sequence 7613 from Patent EP2663334
TTTGACTACTGG
>JC084134.1 Sequence 7601 from Patent EP2663334
TTTGACTACTGG
>JC084126.1 Sequence 7593 from Patent EP2663334
TTTGACTACTGG
>JC084123.1 Sequence 7590 from Patent EP2663334
TTTCACTACTGG
>JC084106.1 Sequence 7573 from Patent EP2663334
TTTGACTACTGG
>JC084095.1 Sequence 7562 from Patent EP2663334
TTTGACACCTGG
>JC084092.1 Sequence 7559 from Patent EP2663334
TTTGATCTTTGG
>JC084091.1 Sequence 7558 from Patent EP2663334
TTCGATCTCTGG
>JC084089.1 Sequence 7556 from Patent EP2663334
TTTGACTCCTGG
>JC084058.1 Sequence 7525 from Patent EP2663334
TTTGACTCCTGG
>JC084049.1 Sequence 7516 from Patent EP2663334
ATGGACGTCTGG
>JC084031.1 Sequence 7498 from Patent EP2663334
TTTGACTACTGG
>JC084029.1 Sequence 7496 from Patent EP2663334
TTTGACTCCTGG
>JC084010.1 Sequence 7477 from Patent EP2663334
TTTGAATTCTGG
>JC084004.1 Sequence 7471 from Patent EP2663334
ATGGACGTCTGG
>JC083985.1 Sequence 7452 from Patent EP2663334
AACCCAGGTGGA
>JC083972.1 Sequence 7439 from Patent EP2663334
GCTCAGCTATGT
>JC083968.1 Sequence 7435 from Patent EP2663334
CGAGACACGGGC
>JC083951.1 Sequence 7418 from Patent EP2663334
TAATTACTATTA
>JC083927.1 Sequence 7394 from Patent EP2663334
CGCCGCCCGCAG
>JC083921.1 Sequence 7388 from Patent EP2663334
TATTTGTACAGG
>JC083919.1 Sequence 7386 from Patent EP2663334
GTGGGACCTACT
>JC083917.1 Sequence 7384 from Patent EP2663334
GTGGGAGCTACT
>JC083912.1 Sequence 7379 from Patent EP2663334
TATTTGTACAGG
>JC083910.1 Sequence 7377 from Patent EP2663334
AGGGAGGGATAC
>JC083909.1 Sequence 7376 from Patent EP2663334
TATTTGTACAGG
>JC083908.1 Sequence 7375 from Patent EP2663334
GGTGGGAACCCC
>JC083898.1 Sequence 7365 from Patent EP2663334
TATTTGTACAGG
>JC083895.1 Sequence 7362 from Patent EP2663334
TATTTGTACAGG
>JC083894.1 Sequence 7361 from Patent EP2663334
GGGACCCCTTAT
>JC083888.1 Sequence 7355 from Patent EP2663334
AAGTGGGACTAC
>JC083879.1 Sequence 7346 from Patent EP2663334
ATTGATGGTGGA
>JC083869.1 Sequence 7336 from Patent EP2663334
GTGGGAGCTACT
>JC083865.1 Sequence 7332 from Patent EP2663334
GGTGGGAACCCC
>JC083843.1 Sequence 7310 from Patent EP2663334
TAGCCGTGGCTG
>JC083840.1 Sequence 7307 from Patent EP2663334
TACAAGCACGAC
>JC083837.1 Sequence 7304 from Patent EP2663334
AGCACCTCGTCC
>JC083835.1 Sequence 7302 from Patent EP2663334
TACAGTGACTAC
>JC083832.1 Sequence 7299 from Patent EP2663334
ATTACTACTTTT
>JC083829.1 Sequence 7296 from Patent EP2663334
TATAGTGCCTAC
>JC083826.1 Sequence 7293 from Patent EP2663334
TACGGTGACTAC
>JC083825.1 Sequence 7292 from Patent EP2663334
GTATTTCCAAGA
>JC083816.1 Sequence 7283 from Patent EP2663334
GGCCTCAATTAC
>JC083815.1 Sequence 7282 from Patent EP2663334
GTTTTTGGAGTT
>JC083805.1 Sequence 7272 from Patent EP2663334
TTCGGGGGACTT
>JC083803.1 Sequence 7270 from Patent EP2663334
GGAAGCTACAAC
>JC083795.1 Sequence 7262 from Patent EP2663334
TGACTATGGTGA
>JC083767.1 Sequence 7234 from Patent EP2663334
ACTAATGGTCTA
>JC083764.1 Sequence 7231 from Patent EP2663334
GACTATAATCCC
>JC083755.1 Sequence 7222 from Patent EP2663334
GTGGCGGTGGTA
>JC083753.1 Sequence 7220 from Patent EP2663334
GGGGAACAATCG
>JC083746.1 Sequence 7213 from Patent EP2663334
GGGGAACAATCG
>JC083744.1 Sequence 7211 from Patent EP2663334
GTATTACTATGA
>JC083738.1 Sequence 7205 from Patent EP2663334
CCTCGACCTTAA
>JC083731.1 Sequence 7198 from Patent EP2663334
CCGTAACGACAT
>JC083725.1 Sequence 7192 from Patent EP2663334
CCGTAACGACAT
>JC083723.1 Sequence 7190 from Patent EP2663334
GGCCGCAGGGGA
>JC083714.1 Sequence 7181 from Patent EP2663334
CGGCGTGGCGGG
>JC083710.1 Sequence 7177 from Patent EP2663334
CGTTCGGCAGAC
>JC083709.1 Sequence 7176 from Patent EP2663334
CAACCCGGTCGC
>JC083693.1 Sequence 7160 from Patent EP2663334
TTGGGGAACCGC
>JC051080.1 Sequence 12 from Patent WO2013154799
CCAGTGATATGC
>JC051079.1 Sequence 11 from Patent WO2013154799
GCATATCACTGG
>JC051078.1 Sequence 10 from Patent WO2013154799
GCATATCACTGG
>JC051077.1 Sequence 9 from Patent WO2013154799
AGCAAACAACGC
>JC051076.1 Sequence 8 from Patent WO2013154799
AGCAAATAACGC
>JC051075.1 Sequence 7 from Patent WO2013154799
AGCAAAGAACGC
>JC051074.1 Sequence 6 from Patent WO2013154799
AGCAAAAAACGC
>JC051073.1 Sequence 5 from Patent WO2013154799
GCGTTTTTTGCT
>JC051056.1 Sequence 7 from Patent WO2013154798
AGCAAABAACGC
>JC051055.1 Sequence 6 from Patent WO2013154798
AGCAAAAAACGC
>JC051054.1 Sequence 5 from Patent WO2013154798
GCGTTTTTTGCT
>JC083405.1 Sequence 6872 from Patent EP2663334
TGTGCAAAAGAT
>JC048812.1 Sequence 66 from Patent EP2653559
GTCGTATCCAGT
>JC082608.1 Sequence 6075 from Patent EP2663334
GGTAGTACCATA
>JC082405.1 Sequence 5872 from Patent EP2663334
TGGGTGGCAGTA
>JC060394.1 Sequence 70 from Patent EP2650368
GGGTTTTTTGGG
>JC060383.1 Sequence 59 from Patent EP2650368
GGTTTTTTTTGG
>JC082060.1 Sequence 5527 from Patent EP2663334
TGTGCAGNCTCT
>JC038413.1 Sequence 249 from Patent EP2643016
GCCTATGACTTG
>JC038057.1 Sequence 6 from Patent WO2013187958
CGTGGGTTGCAA
>JC036931.1 Sequence 1 from Patent WO2013165588
GATGATGATGAT
>JC033994.1 Sequence 2 from Patent EP2598636
ATGGCGTAAATG
>JC030935.1 Sequence 48 from Patent EP2638178
GCAGTCACCCCG
>JC030922.1 Sequence 35 from Patent EP2638178
ACAGACCGCCGG
>JC030919.1 Sequence 32 from Patent EP2638178
CAGCGGGTTGTT
>JC030898.1 Sequence 11 from Patent EP2638178
ACAGACCGCCGG
>JC030895.1 Sequence 8 from Patent EP2638178
CAGCGGGTTGTT
>JC048372.1 Sequence 113 from Patent EP2660318
TGGGGCCACTAG
>JC048371.1 Sequence 112 from Patent EP2660318
GGAACTGGATGG
>JC048369.1 Sequence 110 from Patent EP2660318
ATCAAGCTTATC
>JC029164.1 Sequence 6 from Patent WO2013185042
TAGCCGGTGACC
>JC025665.1 Sequence 117 from Patent EP2661487
TCRNNNNNNACG
>JC008208.1 Sequence 71 from Patent EP2647647
CGACCACGACCA
>JC008203.1 Sequence 66 from Patent EP2647647
CGACCACGACCA
>JC005471.1 Sequence 79 from Patent EP2646553
CAAGGCACTGCA
>JC005467.1 Sequence 75 from Patent EP2646553
TGGGCTTGACTT
>JC005463.1 Sequence 71 from Patent EP2646553
TTCCTTGATGTA
>JC005457.1 Sequence 65 from Patent EP2646553
CTGGCTGTACAT
>JC005452.1 Sequence 60 from Patent EP2646553
CAAGTTTCTTCA
>JC005448.1 Sequence 56 from Patent EP2646553
GACACCCAGAAG
>JC005445.1 Sequence 53 from Patent EP2646553
TGACACAAGTGG
>JC005442.1 Sequence 50 from Patent EP2646553
TGTGAAGAGAGT
>JC019851.1 Sequence 98 from Patent EP2644700
ATTCACTTTCAT
>JC019850.1 Sequence 97 from Patent EP2644700
TTCACTTTCATA
>JC019849.1 Sequence 96 from Patent EP2644700
TCACTTTCATAA
>JC019847.1 Sequence 94 from Patent EP2644700
CACTTTCATAAT
>JC019845.1 Sequence 92 from Patent EP2644700
ACTTTCATAATG
>JC019843.1 Sequence 90 from Patent EP2644700
CTTTCATAATGC
>JC019841.1 Sequence 88 from Patent EP2644700
TTTCATAATGCT
>JC019839.1 Sequence 86 from Patent EP2644700
TTCATAATGCTG
>JC019837.1 Sequence 84 from Patent EP2644700
TCATAATGCTGG
>JC019829.1 Sequence 76 from Patent EP2644700
CCTTAATTTAAG
>JC019828.1 Sequence 75 from Patent EP2644700
CTTAATTTAAGG
>JC019827.1 Sequence 74 from Patent EP2644700
TTAATTTAAGGA
>JC019825.1 Sequence 72 from Patent EP2644700
TAATTTAAGGAA
>JC019823.1 Sequence 70 from Patent EP2644700
AATTTAAGGAAT
>JC019821.1 Sequence 68 from Patent EP2644700
ATTTAAGGAATG
>JC019819.1 Sequence 66 from Patent EP2644700
TTTAAGGAATGT
>JC019816.1 Sequence 63 from Patent EP2644700
TTAAGGAATGTG
>JC019813.1 Sequence 60 from Patent EP2644700
TAAGGAATGTGA
>JC019810.1 Sequence 57 from Patent EP2644700
AAGGAATGTGAG
>JC019801.1 Sequence 48 from Patent EP2644700
TCTTTTTGATTT
>JC019800.1 Sequence 47 from Patent EP2644700
CTTTTTGATTTT
>JC019798.1 Sequence 45 from Patent EP2644700
TTTTTGATTTTG
>JC019797.1 Sequence 44 from Patent EP2644700
TTTTGATTTTGT
>JC019795.1 Sequence 42 from Patent EP2644700
TTTGATTTTGTC
>JC019793.1 Sequence 40 from Patent EP2644700
TTGATTTTGTCT
>JC019792.1 Sequence 39 from Patent EP2644700
TGATTTTGTCTA
>JC019788.1 Sequence 35 from Patent EP2644700
GATTTTGTCTAA
>JC019786.1 Sequence 33 from Patent EP2644700
ATTTTGTCTAAA
>JC019784.1 Sequence 31 from Patent EP2644700
TTTTGTCTAAAA
>JC019774.1 Sequence 21 from Patent EP2644700
ATATAGATATAG
>JC019773.1 Sequence 20 from Patent EP2644700
TATAGATATAGA
>JC019772.1 Sequence 19 from Patent EP2644700
ATAGATATAGAT
>JC019770.1 Sequence 17 from Patent EP2644700
TAGATATAGATA
>JC019768.1 Sequence 15 from Patent EP2644700
AGATATAGATAG
>JC019766.1 Sequence 13 from Patent EP2644700
GATATAGATAGC
>JC019764.1 Sequence 11 from Patent EP2644700
ATATAGATAGCT
>JC019762.1 Sequence 9 from Patent EP2644700
TATAGATAGCTA
>JC019760.1 Sequence 7 from Patent EP2644700
ATAGATAGCTAT
>JC019751.1 Sequence 6 from Patent EP2677039
AGTGATGGCATG
>JC019750.1 Sequence 5 from Patent EP2677039
ACCAAATCCGTT
>JC002472.1 Sequence 36 from Patent EP2592155
TAAGAGAAGCAA
>JC002393.1 Sequence 325 from Patent EP2592093
GGGAAAGGGAAA
>JC019074.1 Sequence 64 from Patent EP2653549
TCCGGGGCTCAC
>JC019073.1 Sequence 63 from Patent EP2653549
CCCGGGGCTCAC
>JC018693.1 Sequence 7 from Patent EP2653562
GGGCGGGTGCCG
>JC013567.1 Sequence 9 from Patent EP2673380
GACNNNNNNGTC
>JC013562.1 Sequence 4 from Patent EP2673380
CGANNNNNNTGC
>JB973269.1 Sequence 123 from Patent EP2683387
GGACAGGACTGA
>JB973268.1 Sequence 122 from Patent EP2683387
CAGACTTTGTTG
>JB973266.1 Sequence 120 from Patent EP2683387
GTGGAAGATATA
>JB973265.1 Sequence 119 from Patent EP2683387
TTGAATCATGTT
>JB973264.1 Sequence 118 from Patent EP2683387
GGAAAGAATGTC
>JB973263.1 Sequence 117 from Patent EP2683387
GTGGAAGATATA
>JB973262.1 Sequence 116 from Patent EP2683387
TATTGTAATGAC
>JB973258.1 Sequence 112 from Patent EP2683387
TTAAACCACAGC
>JB973249.1 Sequence 103 from Patent EP2683387
GTCGTGATTAGT
>JB973248.1 Sequence 102 from Patent EP2683387
AAAAATTCTCTT
>JB973245.1 Sequence 99 from Patent EP2683387
CGCAAGCTTGCT
>JB973244.1 Sequence 98 from Patent EP2683387
GTCCGAYTGACA
>JB973243.1 Sequence 97 from Patent EP2683387
TTAACCCGTAAA
>JB973239.1 Sequence 93 from Patent EP2683387
CTGGTGGAAAAG
>JB973233.1 Sequence 87 from Patent EP2683387
TGCATAACCTAA
>JB973232.1 Sequence 86 from Patent EP2683387
TCTCTCMACTTT
>JB973231.1 Sequence 85 from Patent EP2683387
GATTACCATCAA
>JB973230.1 Sequence 84 from Patent EP2683387
GCTGGAATTACA
>JB973227.1 Sequence 81 from Patent EP2683387
TATTTTCGCATA
>JB973220.1 Sequence 74 from Patent EP2683387
GCGCGCCGGCCG
>JB973213.1 Sequence 67 from Patent EP2683387
GATTTGGAAAGG
>JB973211.1 Sequence 65 from Patent EP2683387
TGGCGTCGTGAT
>JB973203.1 Sequence 57 from Patent EP2683387
GCCGGCCGGCTC
>JB973202.1 Sequence 56 from Patent EP2683387
GCGCCGGCCGGC
>JB973199.1 Sequence 53 from Patent EP2683387
GCGCGCCGGCCG
>JB973196.1 Sequence 50 from Patent EP2683387
GTCTTRCTCGAG
>JB973192.1 Sequence 46 from Patent EP2683387
GTTATGGCGACC
>JB973190.1 Sequence 44 from Patent EP2683387
AACAATGCAGAC
>JB973188.1 Sequence 42 from Patent EP2683387
GGAAAGAATGTC
>JB973187.1 Sequence 41 from Patent EP2683387
GTGGAAGATATA
>JB973186.1 Sequence 40 from Patent EP2683387
GTCGTGATTAGT
>JB973174.1 Sequence 28 from Patent EP2683387
GAAACATTGAAC
>JB973164.1 Sequence 18 from Patent EP2683387
CGTTATGGCGAC
>JB973163.1 Sequence 17 from Patent EP2683387
AGAATTTTATCT
>JB973160.1 Sequence 14 from Patent EP2683387
TATTGTAATGAC
>JB973155.1 Sequence 9 from Patent EP2683387
GTCGTGATTAGT
>JB987743.1 Sequence 5 from Patent EP2602321
CGTGGAGGCGTG
>JB987742.1 Sequence 4 from Patent EP2602321
GTGCGGAGGTGC
>JB987740.1 Sequence 2 from Patent EP2602321
CGTGGAGGCGTG
>JB987614.1 Sequence 25 from Patent EP2602323
GTTCTGGTAGTT
>JB981670.1 Sequence 21 from Patent EP2682467
CGCCATGCTGCT
>JB980000.1 Sequence 21 from Patent WO2014006110
CGCCATGCTGCT
>JB974458.1 Sequence 16 from Patent EP2678043
AGCTAGCTAGCA
>JB985841.1 Sequence 19 from Patent WO2014012090
GACGACTAGGAT
>JB981020.1 Sequence 11 from Patent WO2014006063
GGGSGGGSGGGS
>JB979094.1 Sequence 127 from Patent WO2014001422
GTCGTCGTCGTC
>JB979011.1 Sequence 44 from Patent WO2014001422
GTCGTCGTCGTC
>JB974579.1 Sequence 42 from Patent EP2678433
GCGGCCGCCATG
>HW317216.1 JP 2013177337-A/3: Anti-beta-D-glucuronidase antibody and use thereof
GCTGTCCTGATC
>HW317215.1 JP 2013177337-A/2: Anti-beta-D-glucuronidase antibody and use thereof
TCCAKAGTTCCA
>HW317207.1 JP 2013177335-A/3: Anti-beta-D-glucuronidase antibody and use thereof
GCTGTCCTGATC
>HW317206.1 JP 2013177335-A/2: Anti-beta-D-glucuronidase antibody and use thereof
TCCAKAGTTCCA
>HW326493.1 JP 2013530938-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF P38 MULTI-tRNA SYNTHETASE COMPLEX
CATATGGGATCC
>HW326492.1 JP 2013530938-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF P38 MULTI-tRNA SYNTHETASE COMPLEX
CTCGAGTAATGA
>HW326485.1 JP 2013530938-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF P38 MULTI-tRNA SYNTHETASE COMPLEX
TAATGACTCGAG
>HW332971.1 JP 2013531981-A/383: Native Ligation
AAAAGTGTTTCT
>HW332970.1 JP 2013531981-A/382: Native Ligation
CATTGTTCAATA
>HW332968.1 JP 2013531981-A/380: Native Ligation
ATTGTTCAATAT
>HW332966.1 JP 2013531981-A/378: Native Ligation
TTGTTCAATATC
>HW332965.1 JP 2013531981-A/377: Native Ligation
AAATCATCCATT
>HW332964.1 JP 2013531981-A/376: Native Ligation
TCTGAAAATGTT
>HW332962.1 JP 2013531981-A/374: Native Ligation
CTGAAAATGTTT
>HW332961.1 JP 2013531981-A/373: Native Ligation
TGAAAATGTTTC
>HW332960.1 JP 2013531981-A/372: Native Ligation
AAAATGTTTCCT
>HW321144.1 WO 2013129634-A/17: Antibody to lipoarabinomannan and immunoassay of mycobacteriosis with the antibody
ACCTGCGGCCGC
>HW329299.1 JP 2013531974-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC,DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF VALYL TRNA SYNTHETASES
CATATGGGATCC
>HW329298.1 JP 2013531974-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC,DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF VALYL TRNA SYNTHETASES
CTCGAGTAATGA
>HW329291.1 JP 2013531974-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC,DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF VALYL TRNA SYNTHETASES
TAATGACTCGAG
>HW329147.1 JP 2013532141-A/17: REGULATION OF METABOLISM BY miR-378
TGGAGTCAGGAG
>HW329140.1 JP 2013532141-A/10: REGULATION OF METABOLISM BY miR-378
TCCAAGTCCAGT
>HW319937.1 JP 2013174607-A/1: Method for detection of Influenza A Virus subtype H5
AGCAAAAGCAGG
>HW319702.1 JP 2013176378-A/51: Detection of Nucleic Acids
AACTATACAACT
>HW319632.1 JP 2013176375-A/43: Virus-Like Particles as Vaccines for Paramyxovirus
GACGACGACAAG
>HW328646.1 JP 2013531478-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMYL-PROLYL-tRNA SYNTHETASES
CATATGGGATCC
>HW328645.1 JP 2013531478-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMYL-PROLYL-tRNA SYNTHETASES
CTCGAGTAATGA
>HW328638.1 JP 2013531478-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMYL-PROLYL-tRNA SYNTHETASES
TAATGACTCGAG
>HW328574.1 JP 2013532957-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES
CATATGGGATCC
>HW328573.1 JP 2013532957-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES
CTCGAGTAATGA
>HW328566.1 JP 2013532957-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES
TAATGACTCGAG
>HW328527.1 JP 2013533733-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF PHENYLALANYL-ALPHA-tRNA SYNTHETASES
CATATGGGATCC
>HW328526.1 JP 2013533733-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF PHENYLALANYL-ALPHA-tRNA SYNTHETASES
CTCGAGTAATGA
>HW328519.1 JP 2013533733-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF PHENYLALANYL-ALPHA-tRNA SYNTHETASES
TAATGACTCGAG
>HW319588.1 JP 2013179942-A/32: Collections of repeat proteins comprising repeat modules
GAAGACNNNNNN
>HW328402.1 JP 2013533209-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF SERYL-tRNA SYNTHETASES
CATATGGGATCC
>HW328401.1 JP 2013533209-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF SERYL-tRNA SYNTHETASES
CTCGAGTAATGA
>HW328394.1 JP 2013533209-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF SERYL-tRNA SYNTHETASES
TAATGACTCGAG
>HW328323.1 JP 2013533731-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ASPARAGINYL tRNA SYNTHETASE
CATATGGGATCC
>HW328322.1 JP 2013533731-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ASPARAGINYL tRNA SYNTHETASE
CTCGAGTAATGA
>HW328315.1 JP 2013533731-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ASPARAGINYL tRNA SYNTHETASE
TAATGACTCGAG
>HW319148.1 JP 2013189433-A/3: Cancer diagnosis or treatment using an anti-Desmoglein3 antibody
TGGGGTGACTCT
>HW328275.1 JP 2013531973-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF THREONYL tRNA SYNTHETASES
CATATGGGATCC
>HW328274.1 JP 2013531973-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF THREONYL tRNA SYNTHETASES
CTCGAGTAATGA
>HW328267.1 JP 2013531973-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF THREONYL tRNA SYNTHETASES
TAATGACTCGAG
>HW328223.1 JP 2013532956-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF CYSTEINYL-tRNA SYNTHETASE
CATATGGGATCC
>HW328222.1 JP 2013532956-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF CYSTEINYL-tRNA SYNTHETASE
CTCGAGTAATGA
>HW328215.1 JP 2013532956-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF CYSTEINYL-tRNA SYNTHETASE
TAATGACTCGAG
>HW318266.1 JP 2013184935-A/7: Asymmetric synthesis method and DNA-based hybrid catalyst used for the method
ACACACACACAC
>HW318265.1 JP 2013184935-A/6: Asymmetric synthesis method and DNA-based hybrid catalyst used for the method
GTGTGTGTGTGT
>HW318264.1 JP 2013184935-A/5: Asymmetric synthesis method and DNA-based hybrid catalyst used for the method
TGTGTGCACACA
>HW318262.1 JP 2013184935-A/3: Asymmetric synthesis method and DNA-based hybrid catalyst used for the method
AAAAAATTTTTT
>HW318261.1 JP 2013184935-A/2: Asymmetric synthesis method and DNA-based hybrid catalyst used for the method
TCAGGGCCCTGA
>HW318260.1 JP 2013184935-A/1: Asymmetric synthesis method and DNA-based hybrid catalyst used for the method
CGCGCGCGCGCG
>HW318206.1 JP 2013177336-A/3: Anti-beta-D-glucuronidase antibody and use thereof
GCTGTCCTGATC
>HW318205.1 JP 2013177336-A/2: Anti-beta-D-glucuronidase antibody and use thereof
TCCAKAGTTCCA
>HJ695348.1 Sequence 20 from patent US 8592646
CCACCAACCCCC
>HJ694785.1 Sequence 116 from patent US 8592566
TGCCGATCGGCA
>HJ694784.1 Sequence 115 from patent US 8592566
AACGACGTCGTT
>HJ694783.1 Sequence 114 from patent US 8592566
GACGACGTCGTC
>HJ694782.1 Sequence 113 from patent US 8592566
TGCATCGATGCA
>HJ694781.1 Sequence 112 from patent US 8592566
TGACGATCGTCA
>HJ694780.1 Sequence 111 from patent US 8592566
TGGCGATCGCCA
>HJ694779.1 Sequence 110 from patent US 8592566
TTCCGATCGGAA
>HJ694778.1 Sequence 109 from patent US 8592566
TCCCGATCGGGA
>HJ692649.1 Sequence 17 from patent US 8592158
CCGCCGCCGCCG
>HJ691939.1 Sequence 42 from patent US 8575432
TATGTTTGAACT
>HJ690801.1 Sequence 307 from patent US 8575325
CGCCACAAGGTC
>HJ690800.1 Sequence 306 from patent US 8575325
CGCCACGAGGTC
>HJ690799.1 Sequence 305 from patent US 8575325
CGCCATCAGGTC
>HJ690798.1 Sequence 304 from patent US 8575325
CGCCACGAGGTC
>HJ690797.1 Sequence 303 from patent US 8575325
CGCCACTAGGTC
>HJ690796.1 Sequence 302 from patent US 8575325
CGCCACTAGGTC
>HJ690795.1 Sequence 301 from patent US 8575325
CGCCACCAGGTC
>HJ690794.1 Sequence 300 from patent US 8575325
GACCTGTTGGCG
>HJ690793.1 Sequence 299 from patent US 8575325
GACCTGCTGGCG
>HJ690792.1 Sequence 298 from patent US 8575325
GACCTGATGGCG
>HJ690791.1 Sequence 297 from patent US 8575325
GACCTCGTGGCG
>HJ690790.1 Sequence 296 from patent US 8575325
GACCTTGTGGCG
>HJ690789.1 Sequence 295 from patent US 8575325
GACCTAGTGGCG
>HJ690788.1 Sequence 294 from patent US 8575325
GACCTGGTGGCG
>HJ690505.1 Sequence 11 from patent US 8575325
ACCCGGTTCATT
>HJ686062.1 Sequence 68 from patent US 8574846
CTATGCGAATTC
>HJ685706.1 Sequence 37 from patent US 8574832
CATAGGNNNNNN
>HJ685705.1 Sequence 36 from patent US 8574832
GTATCCNNNNNN
>HJ685698.1 Sequence 28 from patent US 8574832
CATAGGNNNNNN
>HJ685697.1 Sequence 27 from patent US 8574832
GTATCCNNNNNN
>HJ685545.1 Sequence 59 from patent US 8574599
TCAGCGTGCGCC
>HJ685356.1 Sequence 103 from patent US 8574591
CATGACGGTGAC
>HJ685012.1 Sequence 60 from patent US 8574564
CGGCGGCCGCCG
>HJ685010.1 Sequence 57 from patent US 8574564
CGGCGCGCGCCG
>HJ685009.1 Sequence 55 from patent US 8574564
CCGGCGCGCCGG
>HJ685008.1 Sequence 54 from patent US 8574564
CGACGGCCGTCG
>HJ685007.1 Sequence 53 from patent US 8574564
CGGCGCGCGCCG
>HJ685005.1 Sequence 51 from patent US 8574564
AACAACGTTGTT
>HJ685001.1 Sequence 45 from patent US 8574564
CGACGATCGTCG
>HJ580540.1 Sequence 1 from patent US 8614079
CTTTCCAGCACA
>HJ560390.1 Sequence 84 from patent US 8598328
TAGCGACATTCA
>HJ557582.1 Sequence 899 from patent US 8598089
AAGGCTCCAGCC
>HJ557581.1 Sequence 898 from patent US 8598089
CGGTGGCTGGAG
>HJ555882.1 Sequence 38 from patent US 8597912
CGTCTGGACAAG
>HJ555872.1 Sequence 24 from patent US 8597912
GTGGCGGCCCTG
>HJ555870.1 Sequence 22 from patent US 8597912
GATCCAGACAAG
>HJ555869.1 Sequence 21 from patent US 8597912
CAGGGTGGCTGG
>HJ551822.1 Sequence 155 from patent US 8597665
TCGAACGTTCGA
>HJ551814.1 Sequence 147 from patent US 8597665
TCGATTCGAGCG
>HJ551778.1 Sequence 111 from patent US 8597665
TCGTAACGTTCG
>HJ551776.1 Sequence 109 from patent US 8597665
TCGGAACGTTCG
>HJ551771.1 Sequence 104 from patent US 8597665
CTGAACGTTCAG
>HJ551642.1 Sequence 169 from patent US 8597657
GGAGACAATACC
>HJ551641.1 Sequence 168 from patent US 8597657
GGATCCGCGCGA
>HJ551640.1 Sequence 167 from patent US 8597657
TCCACCGCGGTG
>HJ551639.1 Sequence 166 from patent US 8597657
GCGGCCGCTCTA
>HJ551638.1 Sequence 165 from patent US 8597657
GGAGACAATACC
>HJ551637.1 Sequence 164 from patent US 8597657
GGATCCCCGGGA
>HJ551636.1 Sequence 163 from patent US 8597657
TCCACCGCGGTG
>HJ551635.1 Sequence 162 from patent US 8597657
GCGGCCGCTCTA
>HJ551634.1 Sequence 161 from patent US 8597657
ACCGGATCCGCG
>HJ551633.1 Sequence 160 from patent US 8597657
GGATTAGTCCAA
>HJ551632.1 Sequence 159 from patent US 8597657
TCCACCGCGGTG
>HJ551631.1 Sequence 158 from patent US 8597657
GCGGCCGCTCTA
>HJ519836.1 Sequence 1 from patent US 8589085
ACACACACACAC
>HJ510629.1 Sequence 26 from patent US 8586717
GGGGTTTTGGGG
>HJ510003.1 Sequence 1574 from patent US 8586554
GTAAGCAAGGCT
>HJ509993.1 Sequence 1560 from patent US 8586554
TACCGAACACCT
>HJ509990.1 Sequence 1554 from patent US 8586554
TAGCCACCAACT
>HJ509979.1 Sequence 1543 from patent US 8586554
CAGCCTGGGCAC
>HJ509959.1 Sequence 1522 from patent US 8586554
TGAGGCATTATC
>HJ509958.1 Sequence 1521 from patent US 8586554
GGGCATATCAAA
>HJ509957.1 Sequence 1520 from patent US 8586554
CTTTCAGTCATA
>HJ509956.1 Sequence 1519 from patent US 8586554
GTGTACAGATTT
>HJ509954.1 Sequence 1517 from patent US 8586554
AATGCCTTATTA
>HJ509953.1 Sequence 1516 from patent US 8586554
TAAATATAGGTC
>HJ509952.1 Sequence 1515 from patent US 8586554
GTAAATCCTAAG
>HJ509951.1 Sequence 1514 from patent US 8586554
AGAATGAGACTT
>HJ509950.1 Sequence 1513 from patent US 8586554
ACCCTCATTCAG
>HJ509949.1 Sequence 1512 from patent US 8586554
AGTTGAAATTTC
>HJ509948.1 Sequence 1511 from patent US 8586554
CACATTAACAGT
>HJ509946.1 Sequence 1509 from patent US 8586554
TGCTTGGAAGGA
>HJ509944.1 Sequence 1507 from patent US 8586554
ATCAACAGCTGC
>HJ509943.1 Sequence 1506 from patent US 8586554
TTCCAATGACTA
>HJ509942.1 Sequence 1505 from patent US 8586554
ATTTGATGCTGC
>HJ509941.1 Sequence 1504 from patent US 8586554
GGGAATCAGAGC
>HJ509940.1 Sequence 1503 from patent US 8586554
AGGACTTGGGAT
>HJ509939.1 Sequence 1502 from patent US 8586554
AAGGCTTAAAGT
>HJ509938.1 Sequence 1501 from patent US 8586554
GTGGCAACCACA
>HJ509936.1 Sequence 1499 from patent US 8586554
GGGACTTCACAC
>HJ509935.1 Sequence 1498 from patent US 8586554
ACCACAGCTAGT
>HJ509930.1 Sequence 1493 from patent US 8586554
AACACTGCACAT
>HJ509929.1 Sequence 1492 from patent US 8586554
GACAATTTCTAC
>HJ509928.1 Sequence 1491 from patent US 8586554
GTTAATGACATT
>HJ509927.1 Sequence 1490 from patent US 8586554
TGTGTAAGGTCA
>HJ509926.1 Sequence 1489 from patent US 8586554
TTAGCACTGGCC
>HJ509925.1 Sequence 1488 from patent US 8586554
CACTGGCCTTGA
>HJ509922.1 Sequence 1485 from patent US 8586554
TTAGCCAACTGC
>HJ509920.1 Sequence 1483 from patent US 8586554
AGCCAACTGCAA
>HJ509919.1 Sequence 1482 from patent US 8586554
GCAAACTTATCT
>HJ509917.1 Sequence 1480 from patent US 8586554
TTATAAAACTGG
>HJ509915.1 Sequence 1478 from patent US 8586554
AAAGTGCCATCT
>HJ509914.1 Sequence 1477 from patent US 8586554
TCCTAATTGAAT
>HJ509913.1 Sequence 1476 from patent US 8586554
ATTTTAAATGTC
>HJ509911.1 Sequence 1474 from patent US 8586554
ATATACATGACA
>HJ509909.1 Sequence 1472 from patent US 8586554
ACAGCTACACAA
>HJ509907.1 Sequence 1470 from patent US 8586554
AGCTACACAACC
>HJ509905.1 Sequence 1468 from patent US 8586554
AGATTGGTCAGG
>HJ509903.1 Sequence 1466 from patent US 8586554
GTTCCTATAACT
>HJ509901.1 Sequence 1464 from patent US 8586554
CTGACACAATGT
>HJ509895.1 Sequence 1458 from patent US 8586554
CTTCATCAAAAG
>HJ509888.1 Sequence 1451 from patent US 8586554
ATAATGATCAGG
>HJ509885.1 Sequence 1448 from patent US 8586554
TCAGGTTCATTG
>HJ509884.1 Sequence 1447 from patent US 8586554
CATTGTCACTAA
>HJ509881.1 Sequence 1444 from patent US 8586554
GAAGTTGAACTG
>HJ509880.1 Sequence 1443 from patent US 8586554
GTTGAACTGCTA
>HJ509871.1 Sequence 1434 from patent US 8586554
TAGCCTCTGGAT
>HJ509858.1 Sequence 1421 from patent US 8586554
CTTAAAATTTGG
>HJ509855.1 Sequence 1418 from patent US 8586554
AGTATCGGTTGG
>HJ509850.1 Sequence 1413 from patent US 8586554
CACGCTCTATAC
>HJ509847.1 Sequence 1410 from patent US 8586554
AGACTTCCATTT
>HJ509844.1 Sequence 1407 from patent US 8586554
GGTTTCCTCTGG
>HJ509841.1 Sequence 1404 from patent US 8586554
GGTCCTGGTATG
>HJ509840.1 Sequence 1403 from patent US 8586554
CCTGGTATGAAG
>HJ509838.1 Sequence 1401 from patent US 8586554
TATTTACCCAAA
>HJ509835.1 Sequence 1398 from patent US 8586554
TTACCCAAAAGT
>HJ509831.1 Sequence 1394 from patent US 8586554
TGGAAGAACTCT
>HJ509829.1 Sequence 1392 from patent US 8586554
GAAGAACTCTAC
>HJ509825.1 Sequence 1388 from patent US 8586554
GGGAACTCAAAG
>HJ509823.1 Sequence 1386 from patent US 8586554
GGAACTCAAAGT
>HJ509821.1 Sequence 1384 from patent US 8586554
TCAAAGTACATG
>HJ509816.1 Sequence 1379 from patent US 8586554
AGACCACAAACT
>HJ509813.1 Sequence 1376 from patent US 8586554
ACTGAACATTGG
>HJ509810.1 Sequence 1373 from patent US 8586554
GAATAGTTTCAA
>HJ509809.1 Sequence 1372 from patent US 8586554
AGTTTCAAACAT
>HJ509806.1 Sequence 1369 from patent US 8586554
CATCTTGTGAAA
>HJ509804.1 Sequence 1367 from patent US 8586554
CAGGTAGCTATA
>HJ509792.1 Sequence 1355 from patent US 8586554
TCATTACACCAG
>HJ509790.1 Sequence 1353 from patent US 8586554
CATTACACCAGT
>HJ509789.1 Sequence 1352 from patent US 8586554
CCAGCTTTACAG
>HJ509787.1 Sequence 1350 from patent US 8586554
GCTGCAACATGA
>HJ509781.1 Sequence 1344 from patent US 8586554
ATAAGTTCTAGC
>HJ509778.1 Sequence 1341 from patent US 8586554
TGGTCTTCAAAA
>HJ509776.1 Sequence 1339 from patent US 8586554
TAAATTTGGCGG
>HJ509771.1 Sequence 1334 from patent US 8586554
ATCTTGTAATGG
>HJ509768.1 Sequence 1331 from patent US 8586554
TTTGAATCCAAA
>HJ509765.1 Sequence 1328 from patent US 8586554
CAATATTGTTCC
>HJ509760.1 Sequence 1323 from patent US 8586554
CTGCAGGAAATC
>HJ509758.1 Sequence 1321 from patent US 8586554
ATCCCATAGCAA
>HJ509757.1 Sequence 1320 from patent US 8586554
CCATAGCAATAA
>HJ509755.1 Sequence 1318 from patent US 8586554
CTATTCCCACTG
>HJ509751.1 Sequence 1314 from patent US 8586554
CTAACTTTTAGA
>HJ509749.1 Sequence 1312 from patent US 8586554
TAAAATTCTTGG
>HJ509747.1 Sequence 1310 from patent US 8586554
GACTCAGTAAAT
>HJ509745.1 Sequence 1308 from patent US 8586554
TTATGCAAATCA
>HJ509743.1 Sequence 1306 from patent US 8586554
CCTAGGTTGAAT
>HJ509741.1 Sequence 1304 from patent US 8586554
TCGCATCCGTCT
>HJ509739.1 Sequence 1302 from patent US 8586554
GCAGAAATGGAT
>HJ509737.1 Sequence 1300 from patent US 8586554
AGGTCAAGTCTA
>HJ509736.1 Sequence 1299 from patent US 8586554
CAAGTCTAAGTC
>HJ509734.1 Sequence 1297 from patent US 8586554
GAATCCATCCTC
>HJ509729.1 Sequence 1292 from patent US 8586554
GTTTCTGCTAAC
>HJ509725.1 Sequence 1288 from patent US 8586554
TGATGATGGCTG
>HJ509723.1 Sequence 1286 from patent US 8586554
TGTCTGGGAGCC
>HJ509721.1 Sequence 1284 from patent US 8586554
TGGCTGAAGAAA
>HJ509719.1 Sequence 1282 from patent US 8586554
GAGAGATGGCAG
>HJ509717.1 Sequence 1280 from patent US 8586554
GATGGCAGAAGC
>HJ509715.1 Sequence 1278 from patent US 8586554
GAAATGGCTCTG
>HJ509712.1 Sequence 1275 from patent US 8586554
GATGCCCCTCGC
>HJ509709.1 Sequence 1272 from patent US 8586554
CCGGGTAATGGC
>HJ509707.1 Sequence 1270 from patent US 8586554
CTGGATGGTTGC
>HJ509706.1 Sequence 1269 from patent US 8586554
AGAGGCCTGGCA
>HJ509705.1 Sequence 1268 from patent US 8586554
ATGGTGACAGGC
>HJ509704.1 Sequence 1267 from patent US 8586554
GTGACAGGCGAC
>HJ509702.1 Sequence 1265 from patent US 8586554
CAGCGGCTCAAC
>HJ509699.1 Sequence 1262 from patent US 8586554
CCGAGAGGAGAG
>HJ509697.1 Sequence 1260 from patent US 8586554
AAGAGTCCCGCC
>HJ509695.1 Sequence 1258 from patent US 8586554
TGCAACAGCCCA
>HJ509694.1 Sequence 1256 from patent US 8586554
TTTGAAAGACAC
>HJ509693.1 Sequence 1255 from patent US 8586554
GGTGTCAGAATA
>HJ509692.1 Sequence 1254 from patent US 8586554
CTGATGAGGTAT
>HJ509691.1 Sequence 1253 from patent US 8586554
TTCAGGCTAATC
>HJ509690.1 Sequence 1252 from patent US 8586554
GTCAAATTCTAT
>HJ509689.1 Sequence 1251 from patent US 8586554
TATAAATGCTTC
>HJ509688.1 Sequence 1250 from patent US 8586554
TCCTATGCAATC
>HJ509687.1 Sequence 1249 from patent US 8586554
TGGCAGACCACA
>HJ509686.1 Sequence 1248 from patent US 8586554
GCACCAATATGC
>HJ509684.1 Sequence 1246 from patent US 8586554
ATAATGGCTGGA
>HJ509683.1 Sequence 1245 from patent US 8586554
ATGTCAAGGTCA
>HJ509682.1 Sequence 1244 from patent US 8586554
CAAGATCTTCAC
>HJ509681.1 Sequence 1243 from patent US 8586554
AAGATCTTCACA
>HJ509680.1 Sequence 1242 from patent US 8586554
TAAATTGTATGC
>HJ509679.1 Sequence 1241 from patent US 8586554
GAAGCCCTAATC
>HJ509678.1 Sequence 1240 from patent US 8586554
CCACTGAACATT
>HJ509677.1 Sequence 1239 from patent US 8586554
ATAAAGCATCTG
>HJ509676.1 Sequence 1238 from patent US 8586554
GGATTGCAAGTT
>HJ509675.1 Sequence 1237 from patent US 8586554
AATATTCATGTA
>HJ509674.1 Sequence 1236 from patent US 8586554
GTGCAACTCTGC
>HJ509672.1 Sequence 1234 from patent US 8586554
GCAAAACTCATT
>HJ509671.1 Sequence 1233 from patent US 8586554
AAATCATTGTCA
>HJ509670.1 Sequence 1232 from patent US 8586554
GCATCATCAATC
>HJ509669.1 Sequence 1231 from patent US 8586554
TGGCAGCCAGCA
>HJ509667.1 Sequence 1229 from patent US 8586554
CCACAGTAGGTA
>HJ509666.1 Sequence 1228 from patent US 8586554
ACTGATGTAGGG
>HJ509665.1 Sequence 1227 from patent US 8586554
AGAGTATCTGAA
>HJ509663.1 Sequence 1225 from patent US 8586554
AGATGGAGCAGT
>HJ509662.1 Sequence 1224 from patent US 8586554
TTACAACTGAGA
>HJ509661.1 Sequence 1223 from patent US 8586554
TCATTGTCAAAT
>HJ509660.1 Sequence 1222 from patent US 8586554
TTTGATGATGGC
>HJ509659.1 Sequence 1221 from patent US 8586554
GTTGAAAGCCTC
>HJ509658.1 Sequence 1220 from patent US 8586554
CCTTTAGCTGGC
>HJ509657.1 Sequence 1219 from patent US 8586554
CACCAATAAGTT
>HJ509656.1 Sequence 1218 from patent US 8586554
ACCAATATGCTC
>HJ509655.1 Sequence 1217 from patent US 8586554
TGCCTTTAAAAA
>HJ509654.1 Sequence 1216 from patent US 8586554
GTTTAGCATGCT
>HJ509653.1 Sequence 1215 from patent US 8586554
CAAAGAATGGTG
>HJ509652.1 Sequence 1214 from patent US 8586554
TGGGTTATGGTC
>HJ509651.1 Sequence 1213 from patent US 8586554
TGGTCCAGAGCC
>HJ509649.1 Sequence 1211 from patent US 8586554
GTGTCAAAACCC
>HJ509648.1 Sequence 1210 from patent US 8586554
TGTCAAAACCCT
>HJ509647.1 Sequence 1209 from patent US 8586554
AACCCTGCAGAA
>HJ509646.1 Sequence 1208 from patent US 8586554
TTCACTTAGCCA
>HJ509645.1 Sequence 1207 from patent US 8586554
CAGCTGGTGACA
>HJ509644.1 Sequence 1206 from patent US 8586554
AGGTATATACAT
>HJ509643.1 Sequence 1205 from patent US 8586554
GTCCTATTGCCA
>HJ509642.1 Sequence 1204 from patent US 8586554
TGTCAAAACCAC
>HJ509641.1 Sequence 1203 from patent US 8586554
GTCAGGAGAAGA
>HJ509640.1 Sequence 1202 from patent US 8586554
AATATTGTTCCT
>HJ509639.1 Sequence 1201 from patent US 8586554
CAATCTGACACA
>HJ509638.1 Sequence 1200 from patent US 8586554
TGTCATAATGTC
>HJ509637.1 Sequence 1199 from patent US 8586554
GTGCCTTTAAAA
>HJ509636.1 Sequence 1198 from patent US 8586554
ATCCTCTTGATA
>HJ509635.1 Sequence 1197 from patent US 8586554
GTCTTCAAAAGG
>HJ509634.1 Sequence 1196 from patent US 8586554
CTTCAAAAGGAT
>HJ509632.1 Sequence 1194 from patent US 8586554
GTCATAATGTCT
>HJ509631.1 Sequence 1193 from patent US 8586554
TCTGGAGTCACA
>HJ509630.1 Sequence 1192 from patent US 8586554
AGTAGTTGTACT
>HJ509624.1 Sequence 1186 from patent US 8586554
TGGACTTGGCGG
>HJ509621.1 Sequence 1183 from patent US 8586554
GATTTCCTGATC
>HJ509619.1 Sequence 1181 from patent US 8586554
TTGAGCATCTTG
>HJ509618.1 Sequence 1180 from patent US 8586554
CACACAGGCAAT
>HJ509617.1 Sequence 1179 from patent US 8586554
TAATCCAGGTGA
>HJ509616.1 Sequence 1178 from patent US 8586554
TATGCACAAATC
>HJ509615.1 Sequence 1177 from patent US 8586554
CTTTGTCAAGAT
>HJ509614.1 Sequence 1176 from patent US 8586554
TCATCAAAAGGT
>HJ509613.1 Sequence 1175 from patent US 8586554
ATCTTGTGAAAC
>HJ509612.1 Sequence 1174 from patent US 8586554
TCTGCAGTTAAA
>HJ509611.1 Sequence 1173 from patent US 8586554
GTCAGAATATCT
>HJ509610.1 Sequence 1172 from patent US 8586554
CATAGATTGTAT
>HJ509609.1 Sequence 1171 from patent US 8586554
CACCTTCAAGTC
>HJ509608.1 Sequence 1170 from patent US 8586554
TTCTGCAGGATG
>HJ509607.1 Sequence 1169 from patent US 8586554
TGGATAAATATC
>HJ509605.1 Sequence 1167 from patent US 8586554
ACAGGTCAAGTC
>HJ509603.1 Sequence 1165 from patent US 8586554
TTTCTGCAGGAA
>HJ509602.1 Sequence 1164 from patent US 8586554
TGGCCCTGGACC
>HJ509599.1 Sequence 1161 from patent US 8586554
CATGGCTGCAGC
>HJ509598.1 Sequence 1160 from patent US 8586554
ATGGCTGCTGCG
>HJ509597.1 Sequence 1159 from patent US 8586554
AGAGAGCAACTC
>HJ509596.1 Sequence 1158 from patent US 8586554
TGCTCACAGGCG
>HJ509595.1 Sequence 1157 from patent US 8586554
CCTGAAACTGCA
>HJ509594.1 Sequence 1156 from patent US 8586554
GTTAGAACAGAC
>HJ509593.1 Sequence 1155 from patent US 8586554
GGACCGCAGCCG
>HJ509592.1 Sequence 1154 from patent US 8586554
TGGCCTCACAGC
>HJ509591.1 Sequence 1153 from patent US 8586554
AGAGAGCTGAGC
>HJ509590.1 Sequence 1152 from patent US 8586554
ACAAAGAGTCCC
>HJ509589.1 Sequence 1151 from patent US 8586554
TCTGACTGGGAA
>HJ509588.1 Sequence 1150 from patent US 8586554
TGCTGCACATCC
>HJ509587.1 Sequence 1149 from patent US 8586554
TCTGGATCAGAG
>HJ509586.1 Sequence 1148 from patent US 8586554
GTTTAGTGCACA
>HJ509585.1 Sequence 1147 from patent US 8586554
GCACAAATTTTC
>HJ509584.1 Sequence 1146 from patent US 8586554
TTCTTAAAGGTG
>HJ509582.1 Sequence 1144 from patent US 8586554
GTGAAACATTTT
>HJ509581.1 Sequence 1143 from patent US 8586554
GAAGCTGCTGGT
>HJ509580.1 Sequence 1142 from patent US 8586554
CAGTTTATTCAA
>HJ509579.1 Sequence 1141 from patent US 8586554
ACAATTATGGCA
>HJ509578.1 Sequence 1140 from patent US 8586554
GTATTCAAGTAA
>HJ509577.1 Sequence 1139 from patent US 8586554
GAAATTGAGGAA
>HJ509576.1 Sequence 1138 from patent US 8586554
TGAAGTTAATTC
>HJ509568.1 Sequence 1130 from patent US 8586554
AAAGTCAGGCCA
>HJ509567.1 Sequence 1129 from patent US 8586554
TGCGAGTTGTTG
>HJ509566.1 Sequence 1128 from patent US 8586554
CAGTGGACCACA
>HJ509560.1 Sequence 1122 from patent US 8586554
GGGTCTTTCCTC
>HJ509559.1 Sequence 1121 from patent US 8586554
CTTGTCCATCAG
>HJ509558.1 Sequence 1120 from patent US 8586554
TGACTCTCGGAC
>HJ509557.1 Sequence 1119 from patent US 8586554
CTCGGACTTTGA
>HJ509556.1 Sequence 1118 from patent US 8586554
AATGCAGGATCT
>HJ509555.1 Sequence 1117 from patent US 8586554
GATCTCTCGAGT
>HJ509554.1 Sequence 1116 from patent US 8586554
CCAACTCCAACT
>HJ509553.1 Sequence 1115 from patent US 8586554
GTTGTTCCCTCT
>HJ509551.1 Sequence 1113 from patent US 8586554
CTCACCTTCATG
>HJ509550.1 Sequence 1112 from patent US 8586554
AGTTGTTGTTCC
>HJ509549.1 Sequence 1111 from patent US 8586554
GTTGTTGTTCCC
>HJ509548.1 Sequence 1110 from patent US 8586554
GCGCTAGGCCGC
>HJ509547.1 Sequence 1109 from patent US 8586554
CGAGTTGTTGTT
>HJ509546.1 Sequence 1108 from patent US 8586554
GAGTTGTTGTTC
>HJ509545.1 Sequence 1107 from patent US 8586554
TTGTTGTTCCCT
>HJ509536.1 Sequence 1098 from patent US 8586554
CAGCCTACCAGT
>HJ509516.1 Sequence 1078 from patent US 8586554
GTGCGCTCCCAT
>HJ509515.1 Sequence 1077 from patent US 8586554
GTTGAGCATGAC
>HJ509513.1 Sequence 1074 from patent US 8586554
TTTATAAAACTG
>HJ509512.1 Sequence 1073 from patent US 8586554
TAAAAACAACAA
>HJ509510.1 Sequence 1071 from patent US 8586554
GCTGACATCTCG
>HJ509509.1 Sequence 1070 from patent US 8586554
GGGCTTCTTCCA
>HJ509508.1 Sequence 1069 from patent US 8586554
TGGGTGGCCGGG
>HJ509506.1 Sequence 1067 from patent US 8586554
ACAGCCAGGTAG
>HJ509502.1 Sequence 1063 from patent US 8586554
CCCTGAAGGTTC
>HJ509501.1 Sequence 1062 from patent US 8586554
TGTGAGGCTCCA
>HJ509500.1 Sequence 1061 from patent US 8586554
GCGCGAGCCCGA
>HJ509498.1 Sequence 1059 from patent US 8586554
CAGGCCATGTGG
>HJ509497.1 Sequence 1058 from patent US 8586554
TTGACCAGGAAG
>HJ509494.1 Sequence 1055 from patent US 8586554
CACCCACTGGTG
>HJ509489.1 Sequence 1050 from patent US 8586554
CCCTCTACACCA
>HJ509486.1 Sequence 1047 from patent US 8586554
CTTCCACTGATC
>HJ509483.1 Sequence 1044 from patent US 8586554
CCTTCCACTGAT
>HJ509482.1 Sequence 1043 from patent US 8586554
AGGAAGGGCTTC
>HJ509481.1 Sequence 1042 from patent US 8586554
AGGGCTTCCAGT
>HJ509480.1 Sequence 1041 from patent US 8586554
AACTTCAGTGTC
>HJ509479.1 Sequence 1040 from patent US 8586554
AAGGGCCCTGGG
>HJ509475.1 Sequence 1036 from patent US 8586554
AGCTCCTTCCAC
>HJ509468.1 Sequence 1029 from patent US 8586554
TTCCACTGATCC
>HJ509465.1 Sequence 1026 from patent US 8586554
TCCACTGATCCT
>HJ509462.1 Sequence 1023 from patent US 8586554
CGTTTGGGTGGC
>HJ509460.1 Sequence 1021 from patent US 8586554
CTCCTTCCACTG
>HJ509457.1 Sequence 1018 from patent US 8586554
CTGCAACATGAT
>HJ509455.1 Sequence 1016 from patent US 8586554
GGAGAAGCGCAG
>HJ509453.1 Sequence 1014 from patent US 8586554
TTGTCGATCTGC
>HJ509452.1 Sequence 1013 from patent US 8586554
GCCAGACAGAAG
>HJ509451.1 Sequence 1012 from patent US 8586554
TTGTTCTTAGGA
>HJ509447.1 Sequence 1008 from patent US 8586554
TCGGACTTTGAA
>HJ509445.1 Sequence 1006 from patent US 8586554
GCTCCTTCCACT
>HJ509444.1 Sequence 1005 from patent US 8586554
ACACCATCTCCC
>HJ509443.1 Sequence 1004 from patent US 8586554
GTTCCCTCTACA
>HJ509441.1 Sequence 1002 from patent US 8586554
CGGTTTTTGTTC
>HJ509440.1 Sequence 1001 from patent US 8586554
TCCTTCCACTGA
>HJ509439.1 Sequence 1000 from patent US 8586554
CCCCAGCAGCGG
>HJ509437.1 Sequence 998 from patent US 8586554
TAATATGACTTG
>HJ509436.1 Sequence 997 from patent US 8586554
TTGATATAGTCA
>HJ509435.1 Sequence 996 from patent US 8586554
ATCTTCAGAGAT
>HJ509433.1 Sequence 994 from patent US 8586554
TATAGCTCCTCT
>HJ509432.1 Sequence 993 from patent US 8586554
CTACACCAGGTC
>HJ509431.1 Sequence 992 from patent US 8586554
CGGGTACTATGG
>HJ509429.1 Sequence 990 from patent US 8586554
TCCCAAACAAAT
>HJ509427.1 Sequence 988 from patent US 8586554
GTATGCACTGCT
>HJ509426.1 Sequence 987 from patent US 8586554
CAGAGAAGGTCT
>HJ509425.1 Sequence 986 from patent US 8586554
TTCTGCTCCCAC
>HJ509424.1 Sequence 985 from patent US 8586554
CTCCCACACCAT
>HJ509423.1 Sequence 984 from patent US 8586554
TCATTCCCCACT
>HJ509421.1 Sequence 982 from patent US 8586554
CCTCTACACCAG
>HJ509417.1 Sequence 978 from patent US 8586554
CCATTTTTATCA
>HJ509416.1 Sequence 977 from patent US 8586554
TAGTCATTATCT
>HJ509414.1 Sequence 975 from patent US 8586554
GGCTGACATTCA
>HJ509412.1 Sequence 973 from patent US 8586554
TACACCAGGTCA
>HJ509410.1 Sequence 971 from patent US 8586554
TGGCTTCATGTC
>HJ509408.1 Sequence 969 from patent US 8586554
CTCTACACCAGG
>HJ509407.1 Sequence 968 from patent US 8586554
GTTCTTAGGAAG
>HJ509405.1 Sequence 966 from patent US 8586554
GAGGTGGGAAAA
>HJ509404.1 Sequence 965 from patent US 8586554
ATGTCATTAAAC
>HJ509403.1 Sequence 964 from patent US 8586554
ACCCAGTCAGGG
>HJ509402.1 Sequence 963 from patent US 8586554
AGGTAGGAGAAG
>HJ509400.1 Sequence 961 from patent US 8586554
TCTACACCAGGT
>HJ509395.1 Sequence 956 from patent US 8586554
TCCCTCTACACC
>HJ509394.1 Sequence 955 from patent US 8586554
TTCCCTCTACAC
>HJ509390.1 Sequence 951 from patent US 8586554
CAAGTAGGATGT
>HJ509389.1 Sequence 950 from patent US 8586554
CGACACGGGAAC
>HJ509388.1 Sequence 949 from patent US 8586554
TTAACGAGCCTT
>HJ509373.1 Sequence 934 from patent US 8586554
TTTCCTCTTGTC
>HJ509368.1 Sequence 929 from patent US 8586554
TTGTTCCCTCTA
>HJ509367.1 Sequence 928 from patent US 8586554
CCCGCCACCACC
>HJ509361.1 Sequence 922 from patent US 8586554
GCTTACGATTGT
>HJ509360.1 Sequence 921 from patent US 8586554
CCATGGCGGGAC
>HJ509359.1 Sequence 920 from patent US 8586554
GTAAGAGGCAGG
>HJ509354.1 Sequence 915 from patent US 8586554
CCGTTGGACCCC
>HJ509348.1 Sequence 909 from patent US 8586554
TCAGCCAGACAG
>HJ509347.1 Sequence 908 from patent US 8586554
ATGTCAACCGGC
>HJ509346.1 Sequence 907 from patent US 8586554
CAAAAGGATCCC
>HJ509345.1 Sequence 906 from patent US 8586554
TGGATGATTGGC
>HJ509340.1 Sequence 901 from patent US 8586554
TGTTCCCTCTAC
>HJ509337.1 Sequence 898 from patent US 8586554
CTGGTAAATAGC
>HJ509331.1 Sequence 892 from patent US 8586554
GACTCCAAAGTC
>HJ509330.1 Sequence 891 from patent US 8586554
TTCTTGATGTCC
>HJ509328.1 Sequence 889 from patent US 8586554
CCGACTGTGGTC
>HJ509327.1 Sequence 888 from patent US 8586554
GACTGTGGTCAA
>HJ509326.1 Sequence 887 from patent US 8586554
TTTAATCCGACT
>HJ509325.1 Sequence 886 from patent US 8586554
TTGTCGATCTCC
>HJ509324.1 Sequence 885 from patent US 8586554
TTCCCAGCCTTG
>HJ509323.1 Sequence 884 from patent US 8586554
TTAATCCGACTG
>HJ509322.1 Sequence 883 from patent US 8586554
TGTGGTCAAAAG
>HJ509321.1 Sequence 882 from patent US 8586554
TGTCGATCTCCT
>HJ509320.1 Sequence 881 from patent US 8586554
TGGTCAAAAGGG
>HJ509319.1 Sequence 880 from patent US 8586554
TGCACTGACGAG
>HJ509318.1 Sequence 879 from patent US 8586554
TGCAATTTAATC
>HJ509317.1 Sequence 878 from patent US 8586554
TGATCCTGCACT
>HJ509316.1 Sequence 877 from patent US 8586554
TCGATCTCCTCG
>HJ509315.1 Sequence 876 from patent US 8586554
TCCTGCACTGAC
>HJ509314.1 Sequence 875 from patent US 8586554
TCCGACTGTGGT
>HJ509313.1 Sequence 874 from patent US 8586554
TCCCAGCCTTGT
>HJ509310.1 Sequence 871 from patent US 8586554
TAATCCGACTGT
>HJ509309.1 Sequence 870 from patent US 8586554
GTTCCCAGCCTT
>HJ509308.1 Sequence 869 from patent US 8586554
GTGGTCAAAAGG
>HJ509307.1 Sequence 868 from patent US 8586554
GTCGATCTCCTC
>HJ509305.1 Sequence 866 from patent US 8586554
GGTCAAAAGGGC
>HJ509304.1 Sequence 865 from patent US 8586554
GCCTTGTCGATC
>HJ509303.1 Sequence 864 from patent US 8586554
GCCGCCCAGTTC
>HJ509302.1 Sequence 863 from patent US 8586554
GCCCAGTTCCCA
>HJ509301.1 Sequence 862 from patent US 8586554
GCACTGACGAGT
>HJ509300.1 Sequence 861 from patent US 8586554
GCAATTTAATCC
>HJ509299.1 Sequence 860 from patent US 8586554
GATCCTGCACTG
>HJ509298.1 Sequence 859 from patent US 8586554
CTTGTCGATCTC
>HJ509297.1 Sequence 858 from patent US 8586554
CTGTGGTCAAAA
>HJ509296.1 Sequence 857 from patent US 8586554
CTGCACTGACGA
>HJ509295.1 Sequence 856 from patent US 8586554
CTGATCCTGCAC
>HJ509294.1 Sequence 855 from patent US 8586554
CGCCCAGTTCCC
>HJ509293.1 Sequence 854 from patent US 8586554
CGACTGTGGTCA
>HJ509292.1 Sequence 853 from patent US 8586554
CCTTGTCGATCT
>HJ509290.1 Sequence 851 from patent US 8586554
CCTGCACTGACG
>HJ509289.1 Sequence 850 from patent US 8586554
CCGCCCAGTTCC
>HJ509288.1 Sequence 849 from patent US 8586554
CCCAGTTCCCAG
>HJ509287.1 Sequence 848 from patent US 8586554
CCCAGCCTTGTC
>HJ509286.1 Sequence 847 from patent US 8586554
CCAGTTCCCAGC
>HJ509285.1 Sequence 846 from patent US 8586554
CCAGCCTTGTCG
>HJ509284.1 Sequence 845 from patent US 8586554
CCACTGATCCTG
>HJ509283.1 Sequence 844 from patent US 8586554
CAGTTCCCAGCC
>HJ509282.1 Sequence 843 from patent US 8586554
CAGCCTTGTCGA
>HJ509281.1 Sequence 842 from patent US 8586554
CACTGATCCTGC
>HJ509280.1 Sequence 841 from patent US 8586554
CACTGACGAGTC
>HJ509279.1 Sequence 840 from patent US 8586554
CAATTTAATCCG
>HJ509278.1 Sequence 839 from patent US 8586554
ATTTAATCCGAC
>HJ509277.1 Sequence 838 from patent US 8586554
ATCCTGCACTGA
>HJ509276.1 Sequence 837 from patent US 8586554
ATCCGACTGTGG
>HJ509275.1 Sequence 836 from patent US 8586554
AGTTCCCAGCCT
>HJ509274.1 Sequence 835 from patent US 8586554
AGCCTTGTCGAT
>HJ509273.1 Sequence 834 from patent US 8586554
AGCCGCCCAGTT
>HJ509272.1 Sequence 833 from patent US 8586554
ACTGTGGTCAAA
>HJ509271.1 Sequence 832 from patent US 8586554
ACTGATCCTGCA
>HJ509269.1 Sequence 830 from patent US 8586554
AATTTAATCCGA
>HJ509268.1 Sequence 829 from patent US 8586554
AATCCGACTGTG
>HJ509217.1 Sequence 777 from patent US 8586554
GTTCACCTCCAG
>HJ509216.1 Sequence 776 from patent US 8586554
AGCTTCACCAGG
>HJ509215.1 Sequence 775 from patent US 8586554
GCCTCCATGTAC
>HJ509206.1 Sequence 766 from patent US 8586554
GGTACAGGTCGA
>HJ509201.1 Sequence 761 from patent US 8586554
CTTGGAGTAGGG
>HJ509193.1 Sequence 753 from patent US 8586554
GGACCCATCGGC
>HJ509181.1 Sequence 741 from patent US 8586554
CAGGGTGACTGC
>HJ509180.1 Sequence 740 from patent US 8586554
CCAGGCATGGAG
>HJ509177.1 Sequence 737 from patent US 8586554
CCACTCCCATTC
>HJ509176.1 Sequence 736 from patent US 8586554
TGACAGGGCAGA
>HJ509175.1 Sequence 735 from patent US 8586554
GACAGGGCAGAT
>HJ509174.1 Sequence 734 from patent US 8586554
CCAGACATCAGG
>HJ509169.1 Sequence 729 from patent US 8586554
CCAGGCCCATGA
>HJ509158.1 Sequence 718 from patent US 8586554
CTGGTGGTCAGC
>HJ509139.1 Sequence 699 from patent US 8586554
TCACCAGCTGGA
>HJ509134.1 Sequence 694 from patent US 8586554
CTGCAGGCCACT
>HJ509132.1 Sequence 692 from patent US 8586554
TGAGCCAGGTGA
>HJ509129.1 Sequence 689 from patent US 8586554
AGAGGATGCTGG
>HJ509128.1 Sequence 688 from patent US 8586554
CAGACCCCTCGC
>HJ509123.1 Sequence 683 from patent US 8586554
CCCGGAGTAGGC
>HJ508894.1 Sequence 408 from patent US 8586554
CGCCCTTCAGCA
>HJ508816.1 Sequence 300 from patent US 8586554
GGGCATTGAGGT
>HJ508815.1 Sequence 299 from patent US 8586554
GGCATTGAGGTT
>HJ508814.1 Sequence 298 from patent US 8586554
GCATTGAGGTTG
>HJ508813.1 Sequence 297 from patent US 8586554
CATTGAGGTTGA
>HJ508812.1 Sequence 296 from patent US 8586554
ATTGAGGTTGAC
>HJ508811.1 Sequence 295 from patent US 8586554
GCCGGAGACTGA
>HJ508810.1 Sequence 293 from patent US 8586554
GCACACAGCTGC
>HJ508808.1 Sequence 291 from patent US 8586554
CACACAGCTGCC
>HJ508807.1 Sequence 290 from patent US 8586554
ACACAGCTGCCC
>HJ508806.1 Sequence 289 from patent US 8586554
CACAGCTGCCCG
>HJ508805.1 Sequence 288 from patent US 8586554
CCATGGTGAAGA
>HJ508804.1 Sequence 287 from patent US 8586554
GCCAGCATGAGT
>HJ508803.1 Sequence 285 from patent US 8586554
CCAGCATGAGTC
>HJ508802.1 Sequence 284 from patent US 8586554
CAGCATGAGTCC
>HJ508801.1 Sequence 283 from patent US 8586554
GGGCATGAGCTT
>HJ508800.1 Sequence 281 from patent US 8586554
GGCATGAGCTTC
>HJ508798.1 Sequence 279 from patent US 8586554
GCATGAGCTTCA
>HJ508797.1 Sequence 278 from patent US 8586554
CATGAGCTTCAC
>HJ508796.1 Sequence 277 from patent US 8586554
GAGCAGCCCACC
>HJ508795.1 Sequence 276 from patent US 8586554
AGCAGCCCACCT
>HJ508794.1 Sequence 275 from patent US 8586554
GCAGCCCACCTC
>HJ508793.1 Sequence 274 from patent US 8586554
CCTGGCATGACC
>HJ508792.1 Sequence 272 from patent US 8586554
CTGGCATGACCA
>HJ508791.1 Sequence 271 from patent US 8586554
TGGCATGACCAT
>HJ508790.1 Sequence 270 from patent US 8586554
GGCATGACCATG
>HJ508789.1 Sequence 269 from patent US 8586554
GCATGACCATGA
>HJ508788.1 Sequence 268 from patent US 8586554
CATGACCATGAG
>HJ508787.1 Sequence 267 from patent US 8586554
CAGCTTCAGGTA
>HJ508786.1 Sequence 266 from patent US 8586554
GGACACCGTCAG
>HJ508785.1 Sequence 265 from patent US 8586554
GTATTTGTCGAA
>HJ508784.1 Sequence 264 from patent US 8586554
GACGAAGGTCTG
>HJ508783.1 Sequence 263 from patent US 8586554
GCCAGCCCTCCT
>HJ508782.1 Sequence 262 from patent US 8586554
CCAGCCCTCCTG
>HJ508781.1 Sequence 261 from patent US 8586554
CAGCCCTCCTGT
>HJ508780.1 Sequence 260 from patent US 8586554
AGCCCTCCTGTC
>HJ508779.1 Sequence 259 from patent US 8586554
GCCCTCCTGTCA
>HJ508778.1 Sequence 258 from patent US 8586554
CCCTCCTGTCAC
>HJ508777.1 Sequence 257 from patent US 8586554
ATCATGGTGATG
>HJ508776.1 Sequence 256 from patent US 8586554
TCATGGTGATGC
>HJ508775.1 Sequence 254 from patent US 8586554
CATGGTGATGCC
>HJ508774.1 Sequence 253 from patent US 8586554
ATGGTGATGCCC
>HJ508773.1 Sequence 252 from patent US 8586554
TGGTGATGCCCA
>HJ508772.1 Sequence 251 from patent US 8586554
ATGTTCCAGCCC
>HJ508771.1 Sequence 246 from patent US 8586554
TGTTCCAGCCCA
>HJ508769.1 Sequence 243 from patent US 8586554
AGATCTTGGTGA
>HJ508768.1 Sequence 242 from patent US 8586554
ACAGGTAGAGGC
>HJ508767.1 Sequence 241 from patent US 8586554
AGAGCGCATTCC
>HJ508766.1 Sequence 240 from patent US 8586554
CCAAGCCACTTG
>HJ508765.1 Sequence 239 from patent US 8586554
GCCAGGCCCACA
>HJ508764.1 Sequence 238 from patent US 8586554
CCAGGCCCACAA
>HJ508763.1 Sequence 237 from patent US 8586554
CAGGCCCACAAA
>HJ508762.1 Sequence 236 from patent US 8586554
CTGCCGATGTTG
>HJ498339.1 Sequence 12 from patent US 8566039
TTAAAAGGAGGC
>HJ498338.1 Sequence 11 from patent US 8566039
AAAAGGAGGCGC
>HJ498337.1 Sequence 10 from patent US 8566039
TAAAAGGAGGCG
>HJ496790.1 Sequence 14 from patent US 8563710
AGCGCTTAAAGG
>HJ495723.1 Sequence 154 from patent US 8563707
GAAACACTGGTC
>HJ495505.1 Sequence 59 from patent US 8563705
GGTCTCRTAGTC
>HJ494974.1 Sequence 16 from patent US 8563528
GGTAGTGGAGCG
>HJ494969.1 Sequence 11 from patent US 8563528
GGTAGTGGAGCG
>HJ494964.1 Sequence 6 from patent US 8563528
GGTAGTGGAGCG
>HJ494959.1 Sequence 1 from patent US 8563528
GGTAGTGGAGCG
>HJ494065.1 Sequence 39 from patent US 8563246
CCTCGACCNNNN
>HJ494058.1 Sequence 32 from patent US 8563246
GCGGTCCCCTGG
>HJ494057.1 Sequence 31 from patent US 8563246
CGCCAGGGTTTA
>HJ494056.1 Sequence 30 from patent US 8563246
CGCCAGGGTTTG
>HJ494055.1 Sequence 29 from patent US 8563246
CGCCAGGGTTTC
>HJ494054.1 Sequence 28 from patent US 8563246
CGCCAGGGTTAT
>HJ494053.1 Sequence 27 from patent US 8563246
CGCCAGGGTTGT
>HJ494052.1 Sequence 26 from patent US 8563246
CGCCAGGGTTCT
>HJ494051.1 Sequence 25 from patent US 8563246
CGCCAGGGTATT
>HJ494050.1 Sequence 24 from patent US 8563246
CGCCAGGGTGTT
>HJ494049.1 Sequence 23 from patent US 8563246
CGCCAGGGTCTT
>HJ494048.1 Sequence 22 from patent US 8563246
CGCCAGGGNANT
>HJ494047.1 Sequence 21 from patent US 8563246
CGCCAGGGNGNT
>HJ494046.1 Sequence 20 from patent US 8563246
CGCCAGGGNCNT
>HJ494045.1 Sequence 19 from patent US 8563246
CGCCAGGGNTNT
>HJ494044.1 Sequence 18 from patent US 8563246
CGCCAGGGANNT
>HJ494043.1 Sequence 17 from patent US 8563246
CGCCAGGGGNNT
>HJ494042.1 Sequence 16 from patent US 8563246
CGCCAGGGCNNT
>HJ494041.1 Sequence 15 from patent US 8563246
CGCCAGGGTNNT
>HJ494040.1 Sequence 14 from patent US 8563246
GCGGTCCCAAAG
>HJ494039.1 Sequence 13 from patent US 8563246
GCGGTCCCAAGA
>HJ494038.1 Sequence 12 from patent US 8563246
GCGGTCCCCTAA
>HJ494037.1 Sequence 11 from patent US 8563246
GCGGTCCCCCAA
>HJ494036.1 Sequence 10 from patent US 8563246
GCGGTCCCTGAA
>HJ494035.1 Sequence 9 from patent US 8563246
GCGGTCCCGCAA
>HJ494034.1 Sequence 8 from patent US 8563246
GCGGTCCCATAA
>HJ494033.1 Sequence 7 from patent US 8563246
GCGGTCCCAGAA
>HJ494032.1 Sequence 6 from patent US 8563246
GCGGTCCCTAAA
>HJ494031.1 Sequence 5 from patent US 8563246
GCGGTCCCCAAA
>HJ494030.1 Sequence 4 from patent US 8563246
GCGGTCCCCGAA
>HJ494029.1 Sequence 3 from patent US 8563246
GCGGTCCCACAA
>HJ494028.1 Sequence 2 from patent US 8563246
GCGGTCCCGAAA
>HJ494027.1 Sequence 1 from patent US 8563246
GCGGTCCCAAAA
>HJ493309.1 Sequence 31 from patent US 8562989
GATCCTGCCCGG
>HJ493248.1 Sequence 77 from patent US 8562984
AGCCATCAGCTG
>HJ493247.1 Sequence 76 from patent US 8562984
TAGCTTGAGTCT
>HJ493246.1 Sequence 75 from patent US 8562984
ATGGCTTAGCTT
>HJ579542.1 Sequence 35 from patent US 8598413
ACAGCACCGTCC
>HJ579417.1 Sequence 428 from patent US 8598335
GTTGGTGTGGGC
>HJ579416.1 Sequence 427 from patent US 8598335
GCCCACACCAAC
>HJ579415.1 Sequence 426 from patent US 8598335
TTGGTGTGGGCC
>HJ579414.1 Sequence 425 from patent US 8598335
GGCCCACACCAA
>HJ579413.1 Sequence 424 from patent US 8598335
TGGTGTGGGCCT
>HJ579412.1 Sequence 423 from patent US 8598335
AGGCCCACACCA
>HJ579411.1 Sequence 422 from patent US 8598335
GGTGTGGGCCTC
>HJ579410.1 Sequence 421 from patent US 8598335
GAGGCCCACACC
>HJ579409.1 Sequence 420 from patent US 8598335
GTGTGGGCCTCC
>HJ579408.1 Sequence 419 from patent US 8598335
GGAGGCCCACAC
>HJ579407.1 Sequence 418 from patent US 8598335
TGTGGGCCTCCA
>HJ579406.1 Sequence 417 from patent US 8598335
TGGAGGCCCACA
>HJ579405.1 Sequence 416 from patent US 8598335
GTGGGCCTCCAC
>HJ579404.1 Sequence 415 from patent US 8598335
GTGGAGGCCCAC
>HJ579403.1 Sequence 414 from patent US 8598335
TGGGCCTCCACC
>HJ579402.1 Sequence 413 from patent US 8598335
GGTGGAGGCCCA
>HJ579401.1 Sequence 412 from patent US 8598335
GGGCCTCCACCA
>HJ579400.1 Sequence 411 from patent US 8598335
TGGTGGAGGCCC
>HJ579399.1 Sequence 410 from patent US 8598335
GGCCTCCACCAG
>HJ579398.1 Sequence 409 from patent US 8598335
CTGGTGGAGGCC
>HJ579397.1 Sequence 408 from patent US 8598335
GCCTCCACCAGC
>HJ579396.1 Sequence 407 from patent US 8598335
GCTGGTGGAGGC
>HJ579395.1 Sequence 406 from patent US 8598335
CCTCCACCAGCT
>HJ579394.1 Sequence 405 from patent US 8598335
AGCTGGTGGAGG
>HJ579393.1 Sequence 404 from patent US 8598335
CCATCCAGAAGC
>HJ579392.1 Sequence 403 from patent US 8598335
GCTTCTGGATGG
>HJ579391.1 Sequence 402 from patent US 8598335
CATCCAGAAGCC
>HJ579390.1 Sequence 401 from patent US 8598335
GGCTTCTGGATG
>HJ579389.1 Sequence 400 from patent US 8598335
ATCCAGAAGCCA
>HJ579388.1 Sequence 399 from patent US 8598335
TGGCTTCTGGAT
>HJ579387.1 Sequence 398 from patent US 8598335
TCCAGAAGCCAA
>HJ579386.1 Sequence 397 from patent US 8598335
TTGGCTTCTGGA
>HJ579385.1 Sequence 396 from patent US 8598335
CCAGAAGCCAAA
>HJ579384.1 Sequence 395 from patent US 8598335
TTTGGCTTCTGG
>HJ579383.1 Sequence 394 from patent US 8598335
CAGAAGCCAAAC
>HJ579382.1 Sequence 393 from patent US 8598335
GTTTGGCTTCTG
>HJ579381.1 Sequence 392 from patent US 8598335
AGAAGCCAAACT
>HJ579380.1 Sequence 391 from patent US 8598335
AGTTTGGCTTCT
>HJ579379.1 Sequence 390 from patent US 8598335
GAAGCCAAACTG
>HJ579378.1 Sequence 389 from patent US 8598335
CAGTTTGGCTTC
>HJ579377.1 Sequence 388 from patent US 8598335
AAGCCAAACTGG
>HJ579376.1 Sequence 387 from patent US 8598335
CCAGTTTGGCTT
>HJ579375.1 Sequence 386 from patent US 8598335
AGCCAAACTGGC
>HJ579374.1 Sequence 385 from patent US 8598335
GCCAGTTTGGCT
>HJ579373.1 Sequence 384 from patent US 8598335
GCCAAACTGGCC
>HJ579372.1 Sequence 383 from patent US 8598335
GGCCAGTTTGGC
>HJ579371.1 Sequence 382 from patent US 8598335
CCAAACTGGCCA
>HJ579370.1 Sequence 381 from patent US 8598335
TGGCCAGTTTGG
>HJ579369.1 Sequence 380 from patent US 8598335
CAAACTGGCCAC
>HJ579368.1 Sequence 379 from patent US 8598335
GTGGCCAGTTTG
>HJ579367.1 Sequence 378 from patent US 8598335
AAACTGGCCACC
>HJ579366.1 Sequence 377 from patent US 8598335
GGTGGCCAGTTT
>HJ579365.1 Sequence 376 from patent US 8598335
AACTGGCCACCC
>HJ579364.1 Sequence 375 from patent US 8598335
GGGTGGCCAGTT
>HJ579363.1 Sequence 374 from patent US 8598335
ACTGGCCACCCA
>HJ579362.1 Sequence 373 from patent US 8598335
TGGGTGGCCAGT
>HJ579361.1 Sequence 372 from patent US 8598335
CCTTCCTGCTCA
>HJ579360.1 Sequence 371 from patent US 8598335
TGAGCAGGAAGG
>HJ579359.1 Sequence 370 from patent US 8598335
CTTCCTGCTCAG
>HJ579358.1 Sequence 369 from patent US 8598335
CTGAGCAGGAAG
>HJ579357.1 Sequence 368 from patent US 8598335
TTCCTGCTCAGG
>HJ579356.1 Sequence 367 from patent US 8598335
CCTGAGCAGGAA
>HJ579355.1 Sequence 366 from patent US 8598335
TCCTGCTCAGGG
>HJ579354.1 Sequence 365 from patent US 8598335
CCCTGAGCAGGA
>HJ579353.1 Sequence 364 from patent US 8598335
CCTGCTCAGGGT
>HJ579352.1 Sequence 363 from patent US 8598335
ACCCTGAGCAGG
>HJ579351.1 Sequence 362 from patent US 8598335
CTGCTCAGGGTG
>HJ579350.1 Sequence 361 from patent US 8598335
CACCCTGAGCAG
>HJ579349.1 Sequence 360 from patent US 8598335
TGCTCAGGGTGA
>HJ579348.1 Sequence 359 from patent US 8598335
TCACCCTGAGCA
>HJ579347.1 Sequence 358 from patent US 8598335
GCTCAGGGTGAT
>HJ579346.1 Sequence 357 from patent US 8598335
ATCACCCTGAGC
>HJ579345.1 Sequence 356 from patent US 8598335
CTCAGGGTGATA
>HJ579344.1 Sequence 355 from patent US 8598335
TATCACCCTGAG
>HJ579343.1 Sequence 354 from patent US 8598335
TCAGGGTGATAT
>HJ579342.1 Sequence 353 from patent US 8598335
ATATCACCCTGA
>HJ579341.1 Sequence 352 from patent US 8598335
GCCAGTCAGCCA
>HJ579340.1 Sequence 351 from patent US 8598335
TGGCTGACTGGC
>HJ579339.1 Sequence 350 from patent US 8598335
CCAGTCAGCCAT
>HJ579338.1 Sequence 349 from patent US 8598335
ATGGCTGACTGG
>HJ579337.1 Sequence 348 from patent US 8598335
CAGTCAGCCATG
>HJ579336.1 Sequence 347 from patent US 8598335
CATGGCTGACTG
>HJ579335.1 Sequence 346 from patent US 8598335
AGTCAGCCATGG
>HJ579334.1 Sequence 345 from patent US 8598335
CCATGGCTGACT
>HJ579333.1 Sequence 344 from patent US 8598335
GTCAGCCATGGA
>HJ579332.1 Sequence 343 from patent US 8598335
TCCATGGCTGAC
>HJ579331.1 Sequence 342 from patent US 8598335
TCAGCCATGGAG
>HJ579330.1 Sequence 341 from patent US 8598335
CTCCATGGCTGA
>HJ579329.1 Sequence 340 from patent US 8598335
CAGCCATGGAGA
>HJ579328.1 Sequence 339 from patent US 8598335
TCTCCATGGCTG
>HJ579327.1 Sequence 338 from patent US 8598335
TTGTTGCAGTAT
>HJ579326.1 Sequence 337 from patent US 8598335
ATACTGCAACAA
>HJ579325.1 Sequence 336 from patent US 8598335
TGTTGCAGTATT
>HJ579324.1 Sequence 335 from patent US 8598335
AATACTGCAACA
>HJ579323.1 Sequence 334 from patent US 8598335
GTTGCAGTATTT
>HJ579322.1 Sequence 333 from patent US 8598335
AAATACTGCAAC
>HJ579321.1 Sequence 332 from patent US 8598335
TTGCAGTATTTC
>HJ579320.1 Sequence 331 from patent US 8598335
GAAATACTGCAA
>HJ579319.1 Sequence 330 from patent US 8598335
TGCAGTATTTCT
>HJ579318.1 Sequence 329 from patent US 8598335
AGAAATACTGCA
>HJ579317.1 Sequence 328 from patent US 8598335
GCAGTATTTCTC
>HJ579316.1 Sequence 327 from patent US 8598335
GAGAAATACTGC
>HJ579315.1 Sequence 326 from patent US 8598335
CAGTATTTCTCC
>HJ579314.1 Sequence 325 from patent US 8598335
GGAGAAATACTG
>HJ579313.1 Sequence 324 from patent US 8598335
AGGTCGTGTTGT
>HJ579312.1 Sequence 323 from patent US 8598335
ACAACACGACCT
>HJ579311.1 Sequence 322 from patent US 8598335
GGTCGTGTTGTA
>HJ579310.1 Sequence 321 from patent US 8598335
TACAACACGACC
>HJ579309.1 Sequence 320 from patent US 8598335
GTCGTGTTGTAG
>HJ579308.1 Sequence 319 from patent US 8598335
CTACAACACGAC
>HJ579307.1 Sequence 318 from patent US 8598335
TCGTGTTGTAGT
>HJ579306.1 Sequence 317 from patent US 8598335
ACTACAACACGA
>HJ579305.1 Sequence 316 from patent US 8598335
CGTGTTGTAGTC
>HJ579304.1 Sequence 315 from patent US 8598335
GACTACAACACG
>HJ579303.1 Sequence 314 from patent US 8598335
GTGTTGTAGTCA
>HJ579302.1 Sequence 313 from patent US 8598335
TGACTACAACAC
>HJ579301.1 Sequence 312 from patent US 8598335
TGTTGTAGTCAC
>HJ579300.1 Sequence 311 from patent US 8598335
GTGACTACAACA
>HJ579299.1 Sequence 310 from patent US 8598335
GTTGTAGTCACT
>HJ579298.1 Sequence 309 from patent US 8598335
AGTGACTACAAC
>HJ579297.1 Sequence 308 from patent US 8598335
TTGTAGTCACTG
>HJ579296.1 Sequence 307 from patent US 8598335
CAGTGACTACAA
>HJ579295.1 Sequence 306 from patent US 8598335
TGTAGTCACTGT
>HJ579294.1 Sequence 305 from patent US 8598335
ACAGTGACTACA
>HJ579293.1 Sequence 304 from patent US 8598335
GTAGTCACTGTA
>HJ579292.1 Sequence 303 from patent US 8598335
TACAGTGACTAC
>HJ579291.1 Sequence 302 from patent US 8598335
TAGTCACTGTAG
>HJ579290.1 Sequence 301 from patent US 8598335
CTACAGTGACTA
>HJ579289.1 Sequence 300 from patent US 8598335
AAGGAAGTGCCT
>HJ579288.1 Sequence 299 from patent US 8598335
AGGCACTTCCTT
>HJ579287.1 Sequence 298 from patent US 8598335
AGGAAGTGCCTT
>HJ579286.1 Sequence 297 from patent US 8598335
AAGGCACTTCCT
>HJ579285.1 Sequence 296 from patent US 8598335
GGAAGTGCCTTC
>HJ579284.1 Sequence 295 from patent US 8598335
GAAGGCACTTCC
>HJ579283.1 Sequence 294 from patent US 8598335
GAAGTGCCTTCT
>HJ579282.1 Sequence 293 from patent US 8598335
AGAAGGCACTTC
>HJ579281.1 Sequence 292 from patent US 8598335
AAGTGCCTTCTC
>HJ579280.1 Sequence 291 from patent US 8598335
GAGAAGGCACTT
>HJ579279.1 Sequence 290 from patent US 8598335
AGTGCCTTCTCT
>HJ579278.1 Sequence 289 from patent US 8598335
AGAGAAGGCACT
>HJ579277.1 Sequence 288 from patent US 8598335
GTGCCTTCTCTG
>HJ579276.1 Sequence 287 from patent US 8598335
CAGAGAAGGCAC
>HJ579275.1 Sequence 286 from patent US 8598335
TGCCTTCTCTGT
>HJ579274.1 Sequence 285 from patent US 8598335
ACAGAGAAGGCA
>HJ579273.1 Sequence 284 from patent US 8598335
GCCTTCTCTGTC
>HJ579272.1 Sequence 283 from patent US 8598335
GACAGAGAAGGC
>HJ579271.1 Sequence 282 from patent US 8598335
CCTTCTCTGTCA
>HJ579270.1 Sequence 281 from patent US 8598335
TGACAGAGAAGG
>HJ579269.1 Sequence 280 from patent US 8598335
CTTCTCTGTCAT
>HJ579268.1 Sequence 279 from patent US 8598335
ATGACAGAGAAG
>HJ579267.1 Sequence 278 from patent US 8598335
TTCTCTGTCATG
>HJ579266.1 Sequence 277 from patent US 8598335
CATGACAGAGAA
>HJ579265.1 Sequence 276 from patent US 8598335
TCTCTGTCATGC
>HJ579264.1 Sequence 275 from patent US 8598335
GCATGACAGAGA
>HJ579263.1 Sequence 274 from patent US 8598335
CTCTGTCATGCC
>HJ579262.1 Sequence 273 from patent US 8598335
GGCATGACAGAG
>HJ579261.1 Sequence 272 from patent US 8598335
AGATGTTGGTGG
>HJ579260.1 Sequence 271 from patent US 8598335
CCACCAACATCT
>HJ579259.1 Sequence 270 from patent US 8598335
GATGTTGGTGGC
>HJ579258.1 Sequence 269 from patent US 8598335
GCCACCAACATC
>HJ579257.1 Sequence 268 from patent US 8598335
ATGTTGGTGGCC
>HJ579256.1 Sequence 267 from patent US 8598335
GGCCACCAACAT
>HJ579255.1 Sequence 266 from patent US 8598335
TGTTGGTGGCCT
>HJ579254.1 Sequence 265 from patent US 8598335
AGGCCACCAACA
>HJ579253.1 Sequence 264 from patent US 8598335
GTTGGTGGCCTG
>HJ579252.1 Sequence 263 from patent US 8598335
CAGGCCACCAAC
>HJ579251.1 Sequence 262 from patent US 8598335
TTGGTGGCCTGC
>HJ579250.1 Sequence 261 from patent US 8598335
GCAGGCCACCAA
>HJ579249.1 Sequence 260 from patent US 8598335
TGGTGGCCTGCA
>HJ579248.1 Sequence 259 from patent US 8598335
TGCAGGCCACCA
>HJ579247.1 Sequence 258 from patent US 8598335
GGTGGCCTGCAG
>HJ579246.1 Sequence 257 from patent US 8598335
CTGCAGGCCACC
>HJ579245.1 Sequence 256 from patent US 8598335
AGACGCTGACCT
>HJ579244.1 Sequence 255 from patent US 8598335
AGGTCAGCGTCT
>HJ579243.1 Sequence 254 from patent US 8598335
GACGCTGACCTC
>HJ579242.1 Sequence 253 from patent US 8598335
GAGGTCAGCGTC
>HJ579241.1 Sequence 252 from patent US 8598335
ACGCTGACCTCC
>HJ579240.1 Sequence 251 from patent US 8598335
GGAGGTCAGCGT
>HJ579239.1 Sequence 250 from patent US 8598335
CGCTGACCTCCC
>HJ579238.1 Sequence 249 from patent US 8598335
GGGAGGTCAGCG
>HJ579237.1 Sequence 248 from patent US 8598335
GCTGACCTCCCA
>HJ579236.1 Sequence 247 from patent US 8598335
TGGGAGGTCAGC
>HJ579235.1 Sequence 246 from patent US 8598335
CTGACCTCCCAG
>HJ579234.1 Sequence 245 from patent US 8598335
CTGGGAGGTCAG
>HJ579233.1 Sequence 244 from patent US 8598335
TGACCTCCCAGC
>HJ579232.1 Sequence 243 from patent US 8598335
GCTGGGAGGTCA
>HJ579231.1 Sequence 242 from patent US 8598335
GACCTCCCAGCT
>HJ579230.1 Sequence 241 from patent US 8598335
AGCTGGGAGGTC
>HJ579229.1 Sequence 240 from patent US 8598335
ACCTCCCAGCTC
>HJ579228.1 Sequence 239 from patent US 8598335
GAGCTGGGAGGT
>HJ579227.1 Sequence 238 from patent US 8598335
TTCAGCAGGTAC
>HJ579226.1 Sequence 237 from patent US 8598335
GTACCTGCTGAA
>HJ579225.1 Sequence 236 from patent US 8598335
TCAGCAGGTACT
>HJ579224.1 Sequence 235 from patent US 8598335
AGTACCTGCTGA
>HJ579223.1 Sequence 234 from patent US 8598335
CAGCAGGTACTT
>HJ579222.1 Sequence 233 from patent US 8598335
AAGTACCTGCTG
>HJ579221.1 Sequence 232 from patent US 8598335
AGCAGGTACTTC
>HJ579220.1 Sequence 231 from patent US 8598335
GAAGTACCTGCT
>HJ579219.1 Sequence 230 from patent US 8598335
GCAGGTACTTCT
>HJ579218.1 Sequence 229 from patent US 8598335
AGAAGTACCTGC
>HJ579217.1 Sequence 228 from patent US 8598335
CAGGTACTTCTT
>HJ579216.1 Sequence 227 from patent US 8598335
AAGAAGTACCTG
>HJ579215.1 Sequence 226 from patent US 8598335
AGGTACTTCTTC
>HJ579214.1 Sequence 225 from patent US 8598335
GAAGAAGTACCT
>HJ579213.1 Sequence 224 from patent US 8598335
GGTACTTCTTCA
>HJ579212.1 Sequence 223 from patent US 8598335
TGAAGAAGTACC
>HJ508761.1 Sequence 235 from patent US 8586554
TGCCGATGTTGC
>HJ508760.1 Sequence 234 from patent US 8586554
GCCGATGTTGCT
>HJ508759.1 Sequence 233 from patent US 8586554
CCGATGTTGCTG
>HJ508758.1 Sequence 232 from patent US 8586554
CGATGTTGCTGG
>HJ508757.1 Sequence 230 from patent US 8586554
GATGTTGCTGGC
>HJ508756.1 Sequence 229 from patent US 8586554
ACCGGCCACCAC
>HJ508755.1 Sequence 228 from patent US 8586554
CCGGCCACCACA
>HJ508754.1 Sequence 226 from patent US 8586554
TAGCCGCCCACA
>HJ508753.1 Sequence 225 from patent US 8586554
ACCACAAGCCAA
>HJ508752.1 Sequence 224 from patent US 8586554
CCAATGACCAGC
>HJ508751.1 Sequence 223 from patent US 8586554
CAATGACCAGCA
>HJ508750.1 Sequence 222 from patent US 8586554
AATGACCAGCAG
>HJ508749.1 Sequence 221 from patent US 8586554
ATGACCAGCAGG
>HJ508748.1 Sequence 219 from patent US 8586554
TGACCAGCAGGA
>HJ508747.1 Sequence 218 from patent US 8586554
GACCAGCAGGAA
>HJ508746.1 Sequence 217 from patent US 8586554
ACCAGCAGGAAA
>HJ508745.1 Sequence 216 from patent US 8586554
CCAGCAGGAAAT
>HJ508744.1 Sequence 215 from patent US 8586554
CAGCAGGAAATA
>HJ508743.1 Sequence 214 from patent US 8586554
TGTCAGCAGGAT
>HJ508075.1 Sequence 105 from patent US 8586526
CCAGAGNNNNNN
>HJ508074.1 Sequence 104 from patent US 8586526
CCAGAGNNNNNN
>HJ508073.1 Sequence 103 from patent US 8586526
GGTCTCNNNNNN
>HJ508072.1 Sequence 102 from patent US 8586526
GGTCTCNNNNNN
>HJ508031.1 Sequence 37 from patent US 8586524
CATGGGGAAGCA
>HJ508022.1 Sequence 28 from patent US 8586524
CATGGGGAGGCA
>HJ507923.1 Sequence 23 from patent US 8586363
GCGCTCGAGTCC
>HJ507922.1 Sequence 21 from patent US 8586363
GCGCTGGAGAGC
>HJ502630.1 Sequence 20 from patent US 8580947
CGCCATGCTGCT
>HJ502535.1 Sequence 4 from patent US 8580944
TTAGGGTTAGGG
>HJ501919.1 Sequence 65 from patent US 8580756
GCAAGCATCCTG
>HJ501912.1 Sequence 58 from patent US 8580756
GCAAGCATCCTG
>HJ501908.1 Sequence 54 from patent US 8580756
GCAAGCATCCTG
>HJ501904.1 Sequence 50 from patent US 8580756
GCAAGCATCCTG
>HJ501903.1 Sequence 49 from patent US 8580756
GCAAGCATCCTG
>HJ501902.1 Sequence 48 from patent US 8580756
GCAAGCATCCTG
>HJ501894.1 Sequence 40 from patent US 8580756
GCATTGGTATTC
>HJ501893.1 Sequence 39 from patent US 8580756
GCATTGGTATTC
>HJ501892.1 Sequence 38 from patent US 8580756
GCATTGGTATTC
>HJ501891.1 Sequence 37 from patent US 8580756
GCATTGGTATTC
>HJ501890.1 Sequence 36 from patent US 8580756
GCATTGGTATTC
>HJ501889.1 Sequence 35 from patent US 8580756
GCATTGGTATTC
>HJ501888.1 Sequence 34 from patent US 8580756
GCATTGGTATTC
>HJ501887.1 Sequence 33 from patent US 8580756
GCATTGGTATTC
>HJ501869.1 Sequence 15 from patent US 8580756
ATTGGTATTCAG
>HJ501868.1 Sequence 14 from patent US 8580756
CATTGGTATTCA
>HJ501867.1 Sequence 13 from patent US 8580756
GCATTGGTATTC
>HJ501866.1 Sequence 12 from patent US 8580756
AGCATTGGTATT
>HJ501865.1 Sequence 11 from patent US 8580756
CAGCATTGGTAT
>HJ500440.1 Sequence 235 from patent US 8580536
CGGACGCGTGGG
>HJ500191.1 Sequence 10 from patent US 8580523
ACGATCGACAGT
>HJ500189.1 Sequence 8 from patent US 8580523
ACTGTCACACTG
>HJ500187.1 Sequence 6 from patent US 8580523
ACACACTCACAG
>HJ500185.1 Sequence 4 from patent US 8580523
ACCAGAGTCTCA
>HJ500183.1 Sequence 2 from patent US 8580523
ACGGAATGATGT
>HJ500126.1 Sequence 10 from patent US 8580511
TAGGCCACCATG
>JX185557.1 Sus scrofa miR-29a miRNA, partial sequence
TCTGAAATCGGT
>HW314315.1 JP 2013529075-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ARGINYL-tRNA SYNTHETASES
CATATGGGATCC
>HW314314.1 JP 2013529075-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ARGINYL-tRNA SYNTHETASES
CTCGAGTAATGA
>HW314307.1 JP 2013529075-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ARGINYL-tRNA SYNTHETASES
TAATGACTCGAG
>HW314281.1 JP 2013527765-A/50: COMPOSITIONS FOR LINKING ZINC FINGER MODULES
AAAGCGGCTCCG
>HW314272.1 JP 2013527765-A/41: COMPOSITIONS FOR LINKING ZINC FINGER MODULES
ACTCTGTGGAAG
>HW314102.1 JP 2013528366-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASE
CATATGGGATCC
>HW314101.1 JP 2013528366-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASE
CTCGAGTAATGA
>HW314094.1 JP 2013528366-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASE
TAATGACTCGAG
>HW313878.1 JP 2013530160-A/8: ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMIAS
TGGTAACGGTTT
>HW308640.1 JP 2013147498-A/7: 6-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS
TTTTTTTTTTTT
>HW308639.1 JP 2013147498-A/6: 6-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS
TTTTTTTTTTTT
>HW308588.1 JP 2013162783-A/9: Method for detecting PON1 gene polymorphism (Q192R)
CCCCTACTTACA
>HW317045.1 JP 2013529472-A/244: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGACTAGTACTA
>HW317044.1 JP 2013529472-A/243: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTGTATAGCT
>HW317043.1 JP 2013529472-A/242: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGTAGCACTAC
>HW317042.1 JP 2013529472-A/241: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGACGTAGAGTC
>HW317041.1 JP 2013529472-A/240: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGACTAGTACTA
>HW317040.1 JP 2013529472-A/239: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTGTATAGCT
>HW316991.1 JP 2013529472-A/190: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGTAGCACTAC
>HW316990.1 JP 2013529472-A/189: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGACGTAGAGTC
>HW316989.1 JP 2013529472-A/188: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACAGACTGCAC
>HW316988.1 JP 2013529472-A/187: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGCAGCTCATAG
>HW316987.1 JP 2013529472-A/186: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTAGATATCGTC
>HW316986.1 JP 2013529472-A/185: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGATCGACGCTC
>HW316985.1 JP 2013529472-A/184: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGATAGCACATC
>HW316984.1 JP 2013529472-A/183: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGCATCGATAT
>HW316983.1 JP 2013529472-A/182: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTCTACAGTCAC
>HW316982.1 JP 2013529472-A/181: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATCATATGTAGC
>HW316981.1 JP 2013529472-A/180: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGCTCGACTAC
>HW316980.1 JP 2013529472-A/179: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATCGATGTCACG
>HW316979.1 JP 2013529472-A/178: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACATGCACTCA
>HW316978.1 JP 2013529472-A/177: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGATGCTATAC
>HW316977.1 JP 2013529472-A/176: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGATCATGCAG
>HW316976.1 JP 2013529472-A/175: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGAGTAGCACGC
>HW316975.1 JP 2013529472-A/174: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTAGTATCATGA
>HW316974.1 JP 2013529472-A/173: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACATAGTCTCG
>HW316973.1 JP 2013529472-A/172: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACAGTAGCGCAC
>HW316972.1 JP 2013529472-A/171: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACACGCTCTACT
>HW316971.1 JP 2013529472-A/170: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATCTACTGACGT
>HW316970.1 JP 2013529472-A/169: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGCGTGACATC
>HW316969.1 JP 2013529472-A/168: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACTCGTAGCGC
>HW316968.1 JP 2013529472-A/167: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGATGACGCTC
>HW316967.1 JP 2013529472-A/166: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TATGTGACATAC
>HW316966.1 JP 2013529472-A/165: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACTATCGCTCT
>HW316965.1 JP 2013529472-A/164: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTCTATCACAT
>HW316964.1 JP 2013529472-A/163: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGAGTCTGTAT
>HW316963.1 JP 2013529472-A/162: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTCGATGAGCT
>HW316962.1 JP 2013529472-A/161: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGCGAGCTCGTC
>HW316961.1 JP 2013529472-A/160: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGCTGCATAGCG
>HW316960.1 JP 2013529472-A/159: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACTGCTATCTC
>HW316959.1 JP 2013529472-A/158: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATGATCGTATAC
>HW316958.1 JP 2013529472-A/157: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTATCACGAGC
>HW316957.1 JP 2013529472-A/156: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGTACAGAGCT
>HW316956.1 JP 2013529472-A/155: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGCTCATCTAT
>HW316955.1 JP 2013529472-A/154: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTACATCGCT
>HW316954.1 JP 2013529472-A/153: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTGACGCTCA
>HW316953.1 JP 2013529472-A/152: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCATGCTGACGA
>HW316952.1 JP 2013529472-A/151: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATACTAGCATCA
>HW316951.1 JP 2013529472-A/150: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGATCATATGAG
>HW316950.1 JP 2013529472-A/149: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATCGACTATGCT
>HW316949.1 JP 2013529472-A/148: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCATATGATCGA
>HW316948.1 JP 2013529472-A/147: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTCACAGTGAC
>HW316947.1 JP 2013529472-A/146: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGACGCTGTCGA
>HW316946.1 JP 2013529472-A/145: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGTCTATACAT
>HW316945.1 JP 2013529472-A/144: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGTGATCACTA
>HW316944.1 JP 2013529472-A/143: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATATCGTAGCAT
>HW316943.1 JP 2013529472-A/142: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGACACGTACTA
>HW316942.1 JP 2013529472-A/141: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTATACAGAT
>HW316941.1 JP 2013529472-A/140: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGTGTCACTAC
>HW316940.1 JP 2013529472-A/139: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CATACTATCACG
>HW316939.1 JP 2013529472-A/138: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTGCATGATCG
>HW316938.1 JP 2013529472-A/137: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGTACACTCTA
>HW316937.1 JP 2013529472-A/136: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTGTGCTCAT
>HW316936.1 JP 2013529472-A/135: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTATGATCTCG
>HW316935.1 JP 2013529472-A/134: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGTACATGCTC
>HW316934.1 JP 2013529472-A/133: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACATGTGACGA
>HW316933.1 JP 2013529472-A/132: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGACGCTCATCT
>HW316932.1 JP 2013529472-A/131: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACACTCGTGCT
>HW316931.1 JP 2013529472-A/130: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGTCTGTGATA
>HW316930.1 JP 2013529472-A/129: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACAGATAGTCT
>HW316929.1 JP 2013529472-A/128: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTCATATCGA
>HW316928.1 JP 2013529472-A/127: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACACGAGCTCAT
>HW316927.1 JP 2013529472-A/126: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTCATATCGCA
>HW316926.1 JP 2013529472-A/125: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTGCACTAGACA
>HW316925.1 JP 2013529472-A/124: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACGTATAGTGA
>HW316924.1 JP 2013529472-A/123: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCTACTCGTGAC
>HW316923.1 JP 2013529472-A/122: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACATAGATGTC
>HW316922.1 JP 2013529472-A/121: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CATACTGTATCT
>HW316921.1 JP 2013529472-A/120: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGCTATCACTGA
>HW316920.1 JP 2013529472-A/119: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTCGTCTGACG
>HW316919.1 JP 2013529472-A/118: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGCGAGTGATA
>HW316918.1 JP 2013529472-A/117: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTCGACGTGAG
>HW316917.1 JP 2013529472-A/116: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGTCGTGAGCA
>HW316916.1 JP 2013529472-A/115: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGTGTCGACAGA
>HW316915.1 JP 2013529472-A/114: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGACGCTAGCG
>HW316914.1 JP 2013529472-A/113: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGCAGCGAGTAC
>HW316913.1 JP 2013529472-A/112: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TATAGCGATGAC
>HW316912.1 JP 2013529472-A/111: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGTCATATGCAG
>HW316911.1 JP 2013529472-A/110: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGACGCGTATAC
>HW316910.1 JP 2013529472-A/109: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGCATACACGC
>HW316909.1 JP 2013529472-A/108: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCATGACTAGTA
>HW316908.1 JP 2013529472-A/107: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGACTCGCTAC
>HW316907.1 JP 2013529472-A/106: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACACGTATGAG
>HW316906.1 JP 2013529472-A/105: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGCATATCGAG
>HW316905.1 JP 2013529472-A/104: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTAGCTGACGTA
>HW316904.1 JP 2013529472-A/103: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CATGAGTATAGC
>HW316903.1 JP 2013529472-A/102: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACACGCAGATCG
>HW316902.1 JP 2013529472-A/101: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCTATCGATGCA
>HW316901.1 JP 2013529472-A/100: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATGCAGATATCT
>HW316900.1 JP 2013529472-A/99: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGCTATAGTCT
>HW316899.1 JP 2013529472-A/98: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGTGATACAGA
>HW316898.1 JP 2013529472-A/97: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGCATACTATC
>HW316897.1 JP 2013529472-A/96: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGTAGTCTACA
>HW316896.1 JP 2013529472-A/95: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGAGACACTCGC
>HW316895.1 JP 2013529472-A/94: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGCATAGCGTAT
>HW316894.1 JP 2013529472-A/93: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATAGAGTCTCAT
>HW316893.1 JP 2013529472-A/92: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTCTCGACATC
>HW316892.1 JP 2013529472-A/91: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGCTCACTACA
>HW316891.1 JP 2013529472-A/90: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATCGCGAGTGAC
>HW316890.1 JP 2013529472-A/89: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTCATAGACTAC
>HW316889.1 JP 2013529472-A/88: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTGATAGTATCA
>HW316888.1 JP 2013529472-A/87: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGACTCTGAGTC
>HW316887.1 JP 2013529472-A/86: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGAGCTGATAT
>HW316886.1 JP 2013529472-A/85: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGTGATGCTCT
>HW316885.1 JP 2013529472-A/84: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGTGACAGATC
>HW316884.1 JP 2013529472-A/83: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTATGCTCGTC
>HW316883.1 JP 2013529472-A/82: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGCATAGAGCGC
>HW316882.1 JP 2013529472-A/81: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TATACTCTAGAT
>HW316881.1 JP 2013529472-A/80: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTGCAGACGA
>HW316880.1 JP 2013529472-A/79: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGCTATCATAC
>HW316879.1 JP 2013529472-A/78: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGCAGAGTGCTC
>HW316878.1 JP 2013529472-A/77: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CATATGAGATCG
>HW316877.1 JP 2013529472-A/76: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGTAGATCTAT
>HW316876.1 JP 2013529472-A/75: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACACTCTAGTCA
>HW316875.1 JP 2013529472-A/74: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCACGCGATGAG
>HW316874.1 JP 2013529472-A/73: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTCTATCGAC
>HW316873.1 JP 2013529472-A/72: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGATATGCTACA
>HW316872.1 JP 2013529472-A/71: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACAGTGTAGCGC
>HW316871.1 JP 2013529472-A/70: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACTATAGTCGA
>HW316870.1 JP 2013529472-A/69: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGCTAGACTGTA
>HW316869.1 JP 2013529472-A/68: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACATGACTCACG
>HW316868.1 JP 2013529472-A/67: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTCGTGCTATC
>HW316867.1 JP 2013529472-A/66: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CATACTCACGTA
>HW316866.1 JP 2013529472-A/65: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGCGTATACTAG
>HW316865.1 JP 2013529472-A/64: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTATCATGACAC
>HW316864.1 JP 2013529472-A/63: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACACTCATAGAT
>HW316863.1 JP 2013529472-A/62: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGCGATGAGAC
>HW316862.1 JP 2013529472-A/61: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGCGACATCACG
>HW316861.1 JP 2013529472-A/60: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACATCTCGTAT
>HW316860.1 JP 2013529472-A/59: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGACGCGTGAG
>HW316859.1 JP 2013529472-A/58: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACATACTGAGAC
>HW316858.1 JP 2013529472-A/57: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGACTGAGCTA
>HW316857.1 JP 2013529472-A/56: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGCGAGTCTACT
>HW316856.1 JP 2013529472-A/55: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTAGTACTGACG
>HW316855.1 JP 2013529472-A/54: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTGATAGACAC
>HW316854.1 JP 2013529472-A/53: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTACTATCATA
>HW316853.1 JP 2013529472-A/52: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTGCTAGTGTAT
>HW316852.1 JP 2013529472-A/51: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACAGTACTCGC
>HW316851.1 JP 2013529472-A/50: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CAGCACATAGAT
>HW316850.1 JP 2013529472-A/49: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACACTGTCTAT
>HW316849.1 JP 2013529472-A/48: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGAGCTGTCAC
>HW316848.1 JP 2013529472-A/47: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTCATCGTGCT
>HW316847.1 JP 2013529472-A/46: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATCTGCTATGAC
>HW316846.1 JP 2013529472-A/45: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGAGATACAGTA
>HW316845.1 JP 2013529472-A/44: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTATGCACTGAT
>HW316844.1 JP 2013529472-A/43: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGCACTCTAGA
>HW316843.1 JP 2013529472-A/42: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCTAGCTCATGA
>HW316842.1 JP 2013529472-A/41: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CATCTGCTATAG
>HW316841.1 JP 2013529472-A/40: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGTAGCGCACA
>HW316840.1 JP 2013529472-A/39: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTGTCTCGAGC
>HW316839.1 JP 2013529472-A/38: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTATACACGAT
>HW316838.1 JP 2013529472-A/37: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGAGATGACTCT
>HW316837.1 JP 2013529472-A/36: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTAGTATCGCAG
>HW316836.1 JP 2013529472-A/35: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGCATCTATAC
>HW316835.1 JP 2013529472-A/34: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGCGTACTGCAG
>HW316834.1 JP 2013529472-A/33: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CGACGTGCTCGC
>HW316833.1 JP 2013529472-A/32: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGCGATGCTCAT
>HW316832.1 JP 2013529472-A/31: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACTCGTACATC
>HW316831.1 JP 2013529472-A/30: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCTGATCGAGCA
>HW316830.1 JP 2013529472-A/29: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTGCTCGAGTC
>HW316829.1 JP 2013529472-A/28: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CATAGCAGTGTC
>HW316828.1 JP 2013529472-A/27: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGCTGTCTCGAG
>HW316827.1 JP 2013529472-A/26: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGTGAGCGCAC
>HW316826.1 JP 2013529472-A/25: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CACGATGACATC
>HW316825.1 JP 2013529472-A/24: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGTATCGTGCTC
>HW316824.1 JP 2013529472-A/23: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATACTAGTGCTC
>HW316823.1 JP 2013529472-A/22: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACTAGCTGACG
>HW316822.1 JP 2013529472-A/21: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGACTCGCGTAT
>HW316821.1 JP 2013529472-A/20: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATAGTCACGCGT
>HW316820.1 JP 2013529472-A/19: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTACACGTCTC
>HW316819.1 JP 2013529472-A/18: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACTAGTACACGC
>HW316818.1 JP 2013529472-A/17: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TAGATCGTACAT
>HW316817.1 JP 2013529472-A/16: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ATCTCGTGACAG
>HW316816.1 JP 2013529472-A/15: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACAGATGCACGC
>HW316815.1 JP 2013529472-A/14: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGATCGTATAGC
>HW316814.1 JP 2013529472-A/13: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCATATCGCGAT
>HW316813.1 JP 2013529472-A/12: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGTGTCTATCA
>HW316812.1 JP 2013529472-A/11: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACATGCTGAGC
>HW316811.1 JP 2013529472-A/10: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
AGATATCGAGCT
>HW316810.1 JP 2013529472-A/9: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TATCTGCTCATA
>HW316809.1 JP 2013529472-A/8: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGCTGTAGTGAC
>HW316808.1 JP 2013529472-A/7: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCTGTATACTCA
>HW316807.1 JP 2013529472-A/6: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
ACGTCTAGACAC
>HW316806.1 JP 2013529472-A/5: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
CTCGATGAGTAC
>HW316805.1 JP 2013529472-A/4: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACAGATGCTGA
>HW316804.1 JP 2013529472-A/3: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TACATCGCACTA
>HW316803.1 JP 2013529472-A/2: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TGACACGATGCT
>HW316802.1 JP 2013529472-A/1: NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING
TCGCAGACATCA
>HW315831.1 JP 2013529085-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF LEUCYL-tRNA SYNTHETASES
CATATGGGATCC
>HW315830.1 JP 2013529085-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF LEUCYL-tRNA SYNTHETASES
CTCGAGTAATGA
>HW315823.1 JP 2013529085-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF LEUCYL-tRNA SYNTHETASES
TAATGACTCGAG
>HW315427.1 JP 2013529083-A/40: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
CCAGAGNNNNNN
>HW315426.1 JP 2013529083-A/39: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
CCAGAGNNNNNN
>HW315425.1 JP 2013529083-A/38: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
GGTCTCNNNNNN
>HW315424.1 JP 2013529083-A/37: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
GGTCTCNNNNNN
>HW144866.1 JP 2013063041-A/12: Silencing inhibitors and a method for obtaining thereof
AAGGGGGAGTAC
>HW106555.1 JP 2012017344-A/26: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
ATTGACGTCAAT
>HW071447.1 JP 2012530787-A/2: METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS
GCTAAAGCTGCT
>HW071446.1 JP 2012530787-A/1: METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS
TCAAAAGAAACC
>HW043356.1 WO 2012147805-A/1: FUNCTIONAL NUCLEOTIDE AND USE THEREOF
CATGACGTTCCT
>HW049041.1 JP 2012524777-A/21: INNATE IMMUNE SUPPRESSION ENABLES REPEATED DELIVERY OF LONG RNA MOLECULES
ACCGGTGCTCGC
>HV961183.1 WO 2012133947-A/28: FUNCTIONAL NUCLEIC ACID MOLECULE AND USE THEREOF
TGCTAGAGGAGG
>HV961182.1 WO 2012133947-A/27: FUNCTIONAL NUCLEIC ACID MOLECULE AND USE THEREOF
GTCAGGCAATCC
>HV961181.1 WO 2012133947-A/26: FUNCTIONAL NUCLEIC ACID MOLECULE AND USE THEREOF
TGCTAGAGGAGG
>HV956193.1 JP 2012519476-A/44: NUCLEIC ACIDS FOR CLONING AND EXPRESSING MULTIPROTEIN COMPLEXES
CCATCTAATTGG
>HV956192.1 JP 2012519476-A/43: NUCLEIC ACIDS FOR CLONING AND EXPRESSING MULTIPROTEIN COMPLEXES
CCATGTGCCTGG
>HV956191.1 JP 2012519476-A/42: NUCLEIC ACIDS FOR CLONING AND EXPRESSING MULTIPROTEIN COMPLEXES
CCANNNNNNTGG
>HV946273.1 JP 2012516677-A/187: METHODS OF PRODUCING ISOPRENE AND A CO-PRODUCT
CCANNNNNNTGG
>HV780026.1 JP 2012514475-A/208: Recurrent Gene Fusions in Cancer
GAGCGCGGCAGG
>HV780022.1 JP 2012514475-A/204: Recurrent Gene Fusions in Cancer
TGCTTCTCCCGG
>HV779994.1 JP 2012514475-A/176: Recurrent Gene Fusions in Cancer
CAGAATCTCCAC
>HV779975.1 JP 2012514475-A/157: Recurrent Gene Fusions in Cancer
ACTCATCACAGC
>HV779956.1 JP 2012514475-A/138: Recurrent Gene Fusions in Cancer
GGTCCTCACCAG
>HV779938.1 JP 2012514475-A/120: Recurrent Gene Fusions in Cancer
GACGCGTACGTG
>HV779928.1 JP 2012514475-A/110: Recurrent Gene Fusions in Cancer
GAGAGAAGACTC
>HV753931.1 JP 2012507999-A/63: Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
CTGCAGGACGTG
>HV753892.1 JP 2012507999-A/24: Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
CGTGAGATCATC
>HV753877.1 JP 2012507999-A/9: Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
CGTGAGGTGTAT
>HV753875.1 JP 2012507999-A/7: Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
CTRCAGCAGCRA
>HV753873.1 JP 2012507999-A/5: Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
TAAAAGATGTCT
>HV753871.1 JP 2012507999-A/3: Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
CTGCAGATTCYA
>HW287489.1 JP 2013139450-A/37: MODULATORS OF PHARMACOLOGICAL AGENTS
CATGGGGAAGCA
>HW287480.1 JP 2013139450-A/28: MODULATORS OF PHARMACOLOGICAL AGENTS
CATGGGGAGGCA
>HW303214.1 JP 2013525332-A/428: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTTGGTGTGGGC
>HW303213.1 JP 2013525332-A/427: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCCCACACCAAC
>HW303212.1 JP 2013525332-A/426: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTGGTGTGGGCC
>HW303211.1 JP 2013525332-A/425: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGCCCACACCAA
>HW303210.1 JP 2013525332-A/424: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGTGTGGGCCT
>HW303209.1 JP 2013525332-A/423: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGGCCCACACCA
>HW303208.1 JP 2013525332-A/422: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGTGTGGGCCTC
>HW303207.1 JP 2013525332-A/421: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAGGCCCACACC
>HW303206.1 JP 2013525332-A/420: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTGTGGGCCTCC
>HW303205.1 JP 2013525332-A/419: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGAGGCCCACAC
>HW303204.1 JP 2013525332-A/418: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGTGGGCCTCCA
>HW303203.1 JP 2013525332-A/417: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGAGGCCCACA
>HW303202.1 JP 2013525332-A/416: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTGGGCCTCCAC
>HW303201.1 JP 2013525332-A/415: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTGGAGGCCCAC
>HW303200.1 JP 2013525332-A/414: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGGCCTCCACC
>HW303199.1 JP 2013525332-A/413: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGTGGAGGCCCA
>HW303198.1 JP 2013525332-A/412: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGGCCTCCACCA
>HW303197.1 JP 2013525332-A/411: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGTGGAGGCCC
>HW303196.1 JP 2013525332-A/410: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGCCTCCACCAG
>HW303195.1 JP 2013525332-A/409: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTGGTGGAGGCC
>HW303194.1 JP 2013525332-A/408: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCCTCCACCAGC
>HW303193.1 JP 2013525332-A/407: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCTGGTGGAGGC
>HW303192.1 JP 2013525332-A/406: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCTCCACCAGCT
>HW303191.1 JP 2013525332-A/405: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGCTGGTGGAGG
>HW303190.1 JP 2013525332-A/404: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCATCCAGAAGC
>HW303189.1 JP 2013525332-A/403: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCTTCTGGATGG
>HW303188.1 JP 2013525332-A/402: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CATCCAGAAGCC
>HW303187.1 JP 2013525332-A/401: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGCTTCTGGATG
>HW303186.1 JP 2013525332-A/400: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ATCCAGAAGCCA
>HW303185.1 JP 2013525332-A/399: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGCTTCTGGAT
>HW303184.1 JP 2013525332-A/398: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCCAGAAGCCAA
>HW303183.1 JP 2013525332-A/397: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTGGCTTCTGGA
>HW303182.1 JP 2013525332-A/396: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCAGAAGCCAAA
>HW303181.1 JP 2013525332-A/395: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTTGGCTTCTGG
>HW303180.1 JP 2013525332-A/394: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGAAGCCAAAC
>HW303179.1 JP 2013525332-A/393: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTTTGGCTTCTG
>HW303178.1 JP 2013525332-A/392: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGAAGCCAAACT
>HW303177.1 JP 2013525332-A/391: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGTTTGGCTTCT
>HW303176.1 JP 2013525332-A/390: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAAGCCAAACTG
>HW303175.1 JP 2013525332-A/389: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGTTTGGCTTC
>HW303174.1 JP 2013525332-A/388: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAGCCAAACTGG
>HW303173.1 JP 2013525332-A/387: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCAGTTTGGCTT
>HW303172.1 JP 2013525332-A/386: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGCCAAACTGGC
>HW303171.1 JP 2013525332-A/385: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCCAGTTTGGCT
>HW303170.1 JP 2013525332-A/384: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCCAAACTGGCC
>HW303169.1 JP 2013525332-A/383: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGCCAGTTTGGC
>HW303168.1 JP 2013525332-A/382: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCAAACTGGCCA
>HW303167.1 JP 2013525332-A/381: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGCCAGTTTGG
>HW303166.1 JP 2013525332-A/380: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAAACTGGCCAC
>HW303165.1 JP 2013525332-A/379: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTGGCCAGTTTG
>HW303164.1 JP 2013525332-A/378: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAACTGGCCACC
>HW303163.1 JP 2013525332-A/377: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGTGGCCAGTTT
>HW303162.1 JP 2013525332-A/376: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AACTGGCCACCC
>HW303161.1 JP 2013525332-A/375: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGGTGGCCAGTT
>HW303160.1 JP 2013525332-A/374: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACTGGCCACCCA
>HW303159.1 JP 2013525332-A/373: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGGTGGCCAGT
>HW303158.1 JP 2013525332-A/372: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCTTCCTGCTCA
>HW303157.1 JP 2013525332-A/371: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGAGCAGGAAGG
>HW303156.1 JP 2013525332-A/370: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTTCCTGCTCAG
>HW303155.1 JP 2013525332-A/369: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTGAGCAGGAAG
>HW303154.1 JP 2013525332-A/368: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTCCTGCTCAGG
>HW303153.1 JP 2013525332-A/367: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCTGAGCAGGAA
>HW303152.1 JP 2013525332-A/366: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCCTGCTCAGGG
>HW303151.1 JP 2013525332-A/365: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCCTGAGCAGGA
>HW303150.1 JP 2013525332-A/364: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCTGCTCAGGGT
>HW303149.1 JP 2013525332-A/363: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACCCTGAGCAGG
>HW303148.1 JP 2013525332-A/362: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTGCTCAGGGTG
>HW303147.1 JP 2013525332-A/361: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CACCCTGAGCAG
>HW303146.1 JP 2013525332-A/360: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGCTCAGGGTGA
>HW303145.1 JP 2013525332-A/359: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCACCCTGAGCA
>HW303144.1 JP 2013525332-A/358: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCTCAGGGTGAT
>HW303143.1 JP 2013525332-A/357: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ATCACCCTGAGC
>HW303142.1 JP 2013525332-A/356: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTCAGGGTGATA
>HW303141.1 JP 2013525332-A/355: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TATCACCCTGAG
>HW303140.1 JP 2013525332-A/354: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCAGGGTGATAT
>HW303139.1 JP 2013525332-A/353: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ATATCACCCTGA
>HW303138.1 JP 2013525332-A/352: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCCAGTCAGCCA
>HW303137.1 JP 2013525332-A/351: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGCTGACTGGC
>HW303136.1 JP 2013525332-A/350: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCAGTCAGCCAT
>HW303135.1 JP 2013525332-A/349: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ATGGCTGACTGG
>HW303134.1 JP 2013525332-A/348: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGTCAGCCATG
>HW303133.1 JP 2013525332-A/347: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CATGGCTGACTG
>HW303132.1 JP 2013525332-A/346: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGTCAGCCATGG
>HW303131.1 JP 2013525332-A/345: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCATGGCTGACT
>HW303130.1 JP 2013525332-A/344: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTCAGCCATGGA
>HW303129.1 JP 2013525332-A/343: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCCATGGCTGAC
>HW303128.1 JP 2013525332-A/342: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCAGCCATGGAG
>HW303127.1 JP 2013525332-A/341: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTCCATGGCTGA
>HW303126.1 JP 2013525332-A/340: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGCCATGGAGA
>HW303125.1 JP 2013525332-A/339: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCTCCATGGCTG
>HW303124.1 JP 2013525332-A/338: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTGTTGCAGTAT
>HW303123.1 JP 2013525332-A/337: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ATACTGCAACAA
>HW303122.1 JP 2013525332-A/336: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGTTGCAGTATT
>HW303121.1 JP 2013525332-A/335: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AATACTGCAACA
>HW303120.1 JP 2013525332-A/334: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTTGCAGTATTT
>HW303119.1 JP 2013525332-A/333: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAATACTGCAAC
>HW303118.1 JP 2013525332-A/332: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTGCAGTATTTC
>HW303117.1 JP 2013525332-A/331: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAAATACTGCAA
>HW303116.1 JP 2013525332-A/330: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGCAGTATTTCT
>HW303115.1 JP 2013525332-A/329: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGAAATACTGCA
>HW303114.1 JP 2013525332-A/328: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCAGTATTTCTC
>HW303113.1 JP 2013525332-A/327: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAGAAATACTGC
>HW303112.1 JP 2013525332-A/326: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGTATTTCTCC
>HW303111.1 JP 2013525332-A/325: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGAGAAATACTG
>HW303110.1 JP 2013525332-A/324: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGGTCGTGTTGT
>HW303109.1 JP 2013525332-A/323: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACAACACGACCT
>HW303108.1 JP 2013525332-A/322: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGTCGTGTTGTA
>HW303107.1 JP 2013525332-A/321: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TACAACACGACC
>HW303106.1 JP 2013525332-A/320: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTCGTGTTGTAG
>HW303105.1 JP 2013525332-A/319: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTACAACACGAC
>HW303104.1 JP 2013525332-A/318: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCGTGTTGTAGT
>HW303103.1 JP 2013525332-A/317: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACTACAACACGA
>HW303102.1 JP 2013525332-A/316: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CGTGTTGTAGTC
>HW303101.1 JP 2013525332-A/315: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GACTACAACACG
>HW303100.1 JP 2013525332-A/314: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTGTTGTAGTCA
>HW303099.1 JP 2013525332-A/313: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGACTACAACAC
>HW303098.1 JP 2013525332-A/312: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGTTGTAGTCAC
>HW303097.1 JP 2013525332-A/311: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTGACTACAACA
>HW303096.1 JP 2013525332-A/310: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTTGTAGTCACT
>HW303095.1 JP 2013525332-A/309: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGTGACTACAAC
>HW303094.1 JP 2013525332-A/308: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTGTAGTCACTG
>HW303093.1 JP 2013525332-A/307: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGTGACTACAA
>HW303092.1 JP 2013525332-A/306: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGTAGTCACTGT
>HW303091.1 JP 2013525332-A/305: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACAGTGACTACA
>HW303090.1 JP 2013525332-A/304: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTAGTCACTGTA
>HW303089.1 JP 2013525332-A/303: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TACAGTGACTAC
>HW303088.1 JP 2013525332-A/302: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TAGTCACTGTAG
>HW303087.1 JP 2013525332-A/301: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTACAGTGACTA
>HW303086.1 JP 2013525332-A/300: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAGGAAGTGCCT
>HW303085.1 JP 2013525332-A/299: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGGCACTTCCTT
>HW303084.1 JP 2013525332-A/298: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGGAAGTGCCTT
>HW303083.1 JP 2013525332-A/297: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAGGCACTTCCT
>HW303082.1 JP 2013525332-A/296: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGAAGTGCCTTC
>HW303081.1 JP 2013525332-A/295: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAAGGCACTTCC
>HW303080.1 JP 2013525332-A/294: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAAGTGCCTTCT
>HW303079.1 JP 2013525332-A/293: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGAAGGCACTTC
>HW303078.1 JP 2013525332-A/292: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAGTGCCTTCTC
>HW303077.1 JP 2013525332-A/291: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAGAAGGCACTT
>HW303076.1 JP 2013525332-A/290: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGTGCCTTCTCT
>HW303075.1 JP 2013525332-A/289: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGAGAAGGCACT
>HW303074.1 JP 2013525332-A/288: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTGCCTTCTCTG
>HW303073.1 JP 2013525332-A/287: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGAGAAGGCAC
>HW303072.1 JP 2013525332-A/286: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGCCTTCTCTGT
>HW303071.1 JP 2013525332-A/285: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACAGAGAAGGCA
>HW303070.1 JP 2013525332-A/284: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCCTTCTCTGTC
>HW303069.1 JP 2013525332-A/283: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GACAGAGAAGGC
>HW303068.1 JP 2013525332-A/282: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCTTCTCTGTCA
>HW303067.1 JP 2013525332-A/281: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGACAGAGAAGG
>HW303066.1 JP 2013525332-A/280: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTTCTCTGTCAT
>HW303065.1 JP 2013525332-A/279: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ATGACAGAGAAG
>HW303064.1 JP 2013525332-A/278: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTCTCTGTCATG
>HW303063.1 JP 2013525332-A/277: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CATGACAGAGAA
>HW303062.1 JP 2013525332-A/276: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCTCTGTCATGC
>HW303061.1 JP 2013525332-A/275: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCATGACAGAGA
>HW303060.1 JP 2013525332-A/274: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTCTGTCATGCC
>HW303059.1 JP 2013525332-A/273: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGCATGACAGAG
>HW303058.1 JP 2013525332-A/272: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGATGTTGGTGG
>HW303057.1 JP 2013525332-A/271: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CCACCAACATCT
>HW303056.1 JP 2013525332-A/270: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GATGTTGGTGGC
>HW303055.1 JP 2013525332-A/269: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCCACCAACATC
>HW303054.1 JP 2013525332-A/268: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ATGTTGGTGGCC
>HW303053.1 JP 2013525332-A/267: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGCCACCAACAT
>HW303052.1 JP 2013525332-A/266: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGTTGGTGGCCT
>HW303051.1 JP 2013525332-A/265: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGGCCACCAACA
>HW303050.1 JP 2013525332-A/264: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTTGGTGGCCTG
>HW303049.1 JP 2013525332-A/263: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGGCCACCAAC
>HW303048.1 JP 2013525332-A/262: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTGGTGGCCTGC
>HW303047.1 JP 2013525332-A/261: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCAGGCCACCAA
>HW303046.1 JP 2013525332-A/260: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGTGGCCTGCA
>HW303045.1 JP 2013525332-A/259: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGCAGGCCACCA
>HW303044.1 JP 2013525332-A/258: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGTGGCCTGCAG
>HW303043.1 JP 2013525332-A/257: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTGCAGGCCACC
>HW303042.1 JP 2013525332-A/256: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGACGCTGACCT
>HW303041.1 JP 2013525332-A/255: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGGTCAGCGTCT
>HW303040.1 JP 2013525332-A/254: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GACGCTGACCTC
>HW303039.1 JP 2013525332-A/253: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAGGTCAGCGTC
>HW303038.1 JP 2013525332-A/252: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACGCTGACCTCC
>HW303037.1 JP 2013525332-A/251: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGAGGTCAGCGT
>HW303036.1 JP 2013525332-A/250: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CGCTGACCTCCC
>HW303035.1 JP 2013525332-A/249: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGGAGGTCAGCG
>HW303034.1 JP 2013525332-A/248: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCTGACCTCCCA
>HW303033.1 JP 2013525332-A/247: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGGGAGGTCAGC
>HW303032.1 JP 2013525332-A/246: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTGACCTCCCAG
>HW303031.1 JP 2013525332-A/245: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CTGGGAGGTCAG
>HW303030.1 JP 2013525332-A/244: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGACCTCCCAGC
>HW303029.1 JP 2013525332-A/243: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCTGGGAGGTCA
>HW303028.1 JP 2013525332-A/242: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GACCTCCCAGCT
>HW303027.1 JP 2013525332-A/241: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGCTGGGAGGTC
>HW303026.1 JP 2013525332-A/240: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
ACCTCCCAGCTC
>HW303025.1 JP 2013525332-A/239: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAGCTGGGAGGT
>HW303024.1 JP 2013525332-A/238: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TTCAGCAGGTAC
>HW303023.1 JP 2013525332-A/237: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GTACCTGCTGAA
>HW303022.1 JP 2013525332-A/236: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TCAGCAGGTACT
>HW303021.1 JP 2013525332-A/235: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGTACCTGCTGA
>HW303020.1 JP 2013525332-A/234: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGCAGGTACTT
>HW303019.1 JP 2013525332-A/233: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAGTACCTGCTG
>HW303018.1 JP 2013525332-A/232: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGCAGGTACTTC
>HW303017.1 JP 2013525332-A/231: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAAGTACCTGCT
>HW303016.1 JP 2013525332-A/230: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GCAGGTACTTCT
>HW303015.1 JP 2013525332-A/229: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGAAGTACCTGC
>HW303014.1 JP 2013525332-A/228: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
CAGGTACTTCTT
>HW303013.1 JP 2013525332-A/227: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AAGAAGTACCTG
>HW303012.1 JP 2013525332-A/226: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
AGGTACTTCTTC
>HW303011.1 JP 2013525332-A/225: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GAAGAAGTACCT
>HW303010.1 JP 2013525332-A/224: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
GGTACTTCTTCA
>HW303009.1 JP 2013525332-A/223: ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
TGAAGAAGTACC
>HW286782.1 JP 2013143941-A/7: Methods and Compositions for Modification of the Human Glucocorticoid Receptor Locus
TCAGATCAGGAG
>HW286780.1 JP 2013143941-A/5: Methods and Compositions for Modification of the Human Glucocorticoid Receptor Locus
GTTGAGGAGCTG
>HW286779.1 JP 2013143941-A/4: Methods and Compositions for Modification of the Human Glucocorticoid Receptor Locus
CAACAGGACCAC
>HW286778.1 JP 2013143941-A/3: Methods and Compositions for Modification of the Human Glucocorticoid Receptor Locus
TCCAAGGACTCT
>HW286636.1 JP 2013136574-A/6: 13-TRANSMEMBRANE PROTEIN EXPRESSED IN PROSTATE CANCER
GGCCCGTCCTAG
>HW307552.1 JP 2013526870-A/11: METHOD OF DNA SEQUENCING BY HYBRIDISATION
AGCCGTCCCACA
>HW307551.1 JP 2013526870-A/10: METHOD OF DNA SEQUENCING BY HYBRIDISATION
AGCCGTGCGACA
>HW307550.1 JP 2013526870-A/9: METHOD OF DNA SEQUENCING BY HYBRIDISATION
AGCCGTCCGACA
>HW307549.1 JP 2013526870-A/8: METHOD OF DNA SEQUENCING BY HYBRIDISATION
AGCCGACCGTCA
>HW307548.1 JP 2013526870-A/7: METHOD OF DNA SEQUENCING BY HYBRIDISATION
AGCCGACCGACT
>HW307547.1 JP 2013526870-A/6: METHOD OF DNA SEQUENCING BY HYBRIDISATION
AGCCGACCGACA
>HW307546.1 JP 2013526870-A/5: METHOD OF DNA SEQUENCING BY HYBRIDISATION
TCGGCTGGCTGT
>HW307542.1 JP 2013526870-A/1: METHOD OF DNA SEQUENCING BY HYBRIDISATION
ACAGCCAGCCGA
>HW307487.1 JP 2013526273-A/6: Kit and method
AAGTGTGGTTGA
>HW293701.1 JP 2013525483-A/132: TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN
GCTAGTCTGTTG
>HW293613.1 JP 2013525483-A/44: TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN
GTCTGATGGAGA
>HW293612.1 JP 2013525483-A/43: TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN
GTCTGATGGAGA
>HW293611.1 JP 2013525483-A/42: TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN
GTCTGATGGAGA
>HW293019.1 JP 2013520994-A/35: Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
TTTGGAATGCAC
>HW292991.1 JP 2013520994-A/7: Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
TTTGGAATGCAC
>DI212046.1 KR 1020100127787-A/38: NOVEL DNA CAPABLE OF BEING AMPLIFIED BY PCR WITH HIGH SELECTIVITY AND HIGH EFFICIENCY
CCCNTTACNGTG
>DI212045.1 KR 1020100127787-A/37: NOVEL DNA CAPABLE OF BEING AMPLIFIED BY PCR WITH HIGH SELECTIVITY AND HIGH EFFICIENCY
CACNGTAANGGG
>DI246053.1 KR 1020120107521-A/114: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GTGGATACAGCT
>DI246024.1 KR 1020120107521-A/85: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GGTATAACCGGA
>DI246022.1 KR 1020120107521-A/83: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GGTATAACTGGA
>DI246020.1 KR 1020120107521-A/81: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GGTACAACTGGA
>DI233167.1 KR 1020110121696-A/38: TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
CCTCCCCCACGC
>DI245057.1 KR 1020120104381-A/3172: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CAAACAGCACCG
>DI245056.1 KR 1020120104381-A/3171: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AAACAGCACCGG
>DI245055.1 KR 1020120104381-A/3170: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AACAGCACCGGC
>DI245054.1 KR 1020120104381-A/3158: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CCACGGAGCCGG
>DI245053.1 KR 1020120104381-A/3149: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GGAGACAGGAGC
>DI245052.1 KR 1020120104381-A/3027: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GACACGCACCAG
>DI245051.1 KR 1020120104381-A/3026: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
ACACGCACCAGG
>DI245050.1 KR 1020120104381-A/3010: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GGCAGGAGCCAG
>DI245049.1 KR 1020120104381-A/3009: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GCAGGAGCCAGC
>DI245048.1 KR 1020120104381-A/2858: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CCCGCCACAGAG
>DI245047.1 KR 1020120104381-A/2857: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CCGCCACAGAGC
>DI245046.1 KR 1020120104381-A/2856: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CGCCACAGAGCC
>DI245045.1 KR 1020120104381-A/2756: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GCCGCACGAAGC
>DI245044.1 KR 1020120104381-A/2651: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CAGGAAGGCCGG
>DI245043.1 KR 1020120104381-A/2650: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AGGAAGGCCGGG
>DI245042.1 KR 1020120104381-A/2649: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GGAAGGCCGGGA
>DI245041.1 KR 1020120104381-A/2648: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GAAGGCCGGGAC
>DI245040.1 KR 1020120104381-A/2647: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AAGGCCGGGACG
>DI245039.1 KR 1020120104381-A/2620: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GACACCGGGAGC
>DI245038.1 KR 1020120104381-A/2619: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GGACACCGGGAG
>DI245037.1 KR 1020120104381-A/2605: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CAGGGAAGCAGC
>DI245036.1 KR 1020120104381-A/2523: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AGCAGCCACGGC
>DI245035.1 KR 1020120104381-A/2522: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GAGCAGCCACGG
>DI245034.1 KR 1020120104381-A/2489: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CAAGGAGGAGCC
>DI245033.1 KR 1020120104381-A/2476: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AGACGAGAGGCC
>DI245032.1 KR 1020120104381-A/2351: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AGCAACAGAAAG
>DI245031.1 KR 1020120104381-A/2350: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CAGCAACAGAAA
>DI245030.1 KR 1020120104381-A/2349: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CCAGCAACAGAA
>DI245029.1 KR 1020120104381-A/2348: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CCCAGCAACAGA
>DI245028.1 KR 1020120104381-A/2347: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GCCCAGCAACAG
>DI245027.1 KR 1020120104381-A/2208: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GCCAGGAGCAGC
>DI245026.1 KR 1020120104381-A/2189: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AGCACAACAACA
>DI245025.1 KR 1020120104381-A/2188: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AAGCACAACAAC
>DI245024.1 KR 1020120104381-A/2187: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CAAGCACAACAA
>DI245023.1 KR 1020120104381-A/2152: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GACCAGGGCCAG
>DI245022.1 KR 1020120104381-A/2151: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CGACCAGGGCCA
>DI245021.1 KR 1020120104381-A/2139: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
ACCCGGACACCG
>DI245020.1 KR 1020120104381-A/2138: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GACCCGGACACC
>DI245019.1 KR 1020120104381-A/2137: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
CGACCCGGACAC
>DI245018.1 KR 1020120104381-A/2136: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GCGACCCGGACA
>DI245017.1 KR 1020120104381-A/2135: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
AGCGACCCGGAC
>DI245016.1 KR 1020120104381-A/2134: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
GAGCGACCCGGA
>DI232482.1 KR 1020110111474-A/208: RECURRENT GENE FUSIONS IN CANCER
GAGCGCGGCAGG
>DI232478.1 KR 1020110111474-A/204: RECURRENT GENE FUSIONS IN CANCER
TGCTTCTCCCGG
>DI232450.1 KR 1020110111474-A/176: RECURRENT GENE FUSIONS IN CANCER
CAGAATCTCCAC
>DI232431.1 KR 1020110111474-A/157: RECURRENT GENE FUSIONS IN CANCER
ACTCATCACAGC
>DI232412.1 KR 1020110111474-A/138: RECURRENT GENE FUSIONS IN CANCER
GGTCCTCACCAG
>DI232394.1 KR 1020110111474-A/120: RECURRENT GENE FUSIONS IN CANCER
GACGCGTACGTG
>DI232384.1 KR 1020110111474-A/110: RECURRENT GENE FUSIONS IN CANCER
GAGAGAAGACTC
>DI232020.1 KR 1020110099333-A/1: SULFURIZING REAGENTS AND THEIR USE FOR OLIGONUCLEOTIDES SYNTHESIS
GTGAGTGAGTGA
>DI207753.1 KR 1020100018029-A/20: IMMUNO STIMULATING COMPLEX AND OLIGONUCLEOTIDE FORMULATIONS FOR INDUCING ENHANCED INTERFERON-GAMMA RESPONSES
GGGGGGCCCCCC
>DI207752.1 KR 1020100018029-A/19: IMMUNO STIMULATING COMPLEX AND OLIGONUCLEOTIDE FORMULATIONS FOR INDUCING ENHANCED INTERFERON-GAMMA RESPONSES
CCCCCCGGGGGG
>DI207750.1 KR 1020100018029-A/17: IMMUNO STIMULATING COMPLEX AND OLIGONUCLEOTIDE FORMULATIONS FOR INDUCING ENHANCED INTERFERON-GAMMA RESPONSES
CGACGTTCGTCG
>DI244607.1 KR 1020120101532-A/23: TAL EFFECTOR-MEDIATED DNA MODIFICATION
GCGCTCGAGTCC
>DI244606.1 KR 1020120101532-A/21: TAL EFFECTOR-MEDIATED DNA MODIFICATION
GCGCTGGAGAGC
>DI231838.1 KR 1020110110776-A/112: Extended dicer substrate agents and methods for the specific inhibition of gene expression
CCAAGGTTGGCA
>DI231837.1 KR 1020110110776-A/111: Extended dicer substrate agents and methods for the specific inhibition of gene expression
TGCCAACCTTGG
>DI231833.1 KR 1020110110776-A/90: Extended dicer substrate agents and methods for the specific inhibition of gene expression
AAGTATCGCTTC
>DI231832.1 KR 1020110110776-A/89: Extended dicer substrate agents and methods for the specific inhibition of gene expression
GAAGCGATACTT
>DI230461.1 KR 1020110086610-A/15: ANTIGENS THAT ELICIT IMMUNE RESPONSE AGAINST FLAVIVIRUS AND METHODS OF USING SAME
GGTACCGCCACC
>DI204683.1 KR 1020120044395-A/4: Selection method of aptamer capable of specifically binding to protective antigen of anthrax toxin
CTACACCCACAT
>DI243850.1 KR 1020120109500-A/28: COMPOSITIONS FOR INCREASING POLYPEPTIDE STABILITY AND ACTIVITY, AND RELATED METHODS
TTTTTTTTTTTT
>DI243781.1 KR 1020120107088-A/16: METHOD FOR GENERATION AND REGULATION OF iPS CELLS AND COMPOSITIONS THEREOF
AATAGGTCATAG
>DI243780.1 KR 1020120107088-A/15: METHOD FOR GENERATION AND REGULATION OF iPS CELLS AND COMPOSITIONS THEREOF
AATAGCACTTTG
>DI200613.1 KR 1020110115886-A/9: Single Nucleotide Polymorphisms Associated with Coronary Heart Disease and uses Thereof
ACGACCTCANAA
>DI200612.1 KR 1020110115886-A/8: Single Nucleotide Polymorphisms Associated with Coronary Heart Disease and uses Thereof
ACCTCANAAAAG
>DI198596.1 KR 1020110092381-A/2: The vaccine for preventing the infection of H5N1 serotype highly pathogenic avian influenza by using baculovirus expression system
AGGAAAAGCAGG
>DI227371.1 KR 1020110081812-A/29: MULTISPECIFIC ANTIBODIES
TGGGSTTCCNNK
>DI227367.1 KR 1020110081812-A/25: MULTISPECIFIC ANTIBODIES
CATNNKNNKRST
>DI227372.1 KR 1020110081812-A/30: MULTISPECIFIC ANTIBODIES
KGGGSTTCCTMT
>DI227368.1 KR 1020110081812-A/26: MULTISPECIFIC ANTIBODIES
KMTNNNNNNRST
>DI227373.1 KR 1020110081812-A/31: MULTISPECIFIC ANTIBODIES
NNKGSTTCCTMT
>DI227369.1 KR 1020110081812-A/27: MULTISPECIFIC ANTIBODIES
DGGNNNNNNRST
>DI227370.1 KR 1020110081812-A/28: MULTISPECIFIC ANTIBODIES
NNKGSTTCCNNK
>DI197325.1 KR 1020100020963-A/91: CHIMERIC PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF
CTAGGCGGCCGC
>DI195959.1 KR 1020100019429-A/71: NUCLEIC ACID ENZYMES AND COMPLEXES AND METHODS FOR THEIR USE
GGAGGTTAGCTC
>DI195939.1 KR 1020100019429-A/49: NUCLEIC ACID ENZYMES AND COMPLEXES AND METHODS FOR THEIR USE
GGAGGTGGGCTC
>DI226398.1 KR 1020110074846-A/19: HUMAN NOTCH3 BASED FUSION PROTEINS AS DECOY INHIBITORS OF NOTCH3 SIGNALING
GAGGAGCCGCGG
>DI226399.1 KR 1020110074846-A/20: HUMAN NOTCH3 BASED FUSION PROTEINS AS DECOY INHIBITORS OF NOTCH3 SIGNALING
CCGCGGCTCCTC
>DI194870.1 KR 1020100014724-A/12: Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
TANNNCANNNTG
>DI194871.1 KR 1020100014724-A/13: Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
TGNNNTANNNCA
>DI194872.1 KR 1020100014724-A/14: Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
CANNNTANNNTG
>DI194869.1 KR 1020100014724-A/11: Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
TANNNTGNNNCA
>DI192422.1 KR 1020090117697-A/9: RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA)-BASED VACCINE FOR THE AVIAN FLU
AGCAAAAGCAGG
>DI190325.1 KR 1020110072889-A/2: Pantoea ananatis B1-9 that promotes crop yield
TTAAGCTACCTA
>DI190324.1 KR 1020110072889-A/1: Pantoea ananatis B1-9 that promotes crop yield
TTCTCGGGTGAC
>DI190273.1 KR 1020110072273-A/17: Polypeptides binding specifically to vascular endothelial cell growth factor receptor-2 and method for preparation thereof
ATTGATGTTTCT
>DI222876.1 KR 1020110025993-A/4: Methods and devices for single-molecule whole genome analysis
CACCCTGCTTGC
>DI240730.1 KR 1020120100890-A/14: AN ASSAY FOR DETERMINING A MOLECULAR RISK ASSESSMENT OF A COMPLEX POLYMICROBIAL SAMPLE SUSPECTED TO CONTAIN AN EHEC
AGTACGCCACAA
>DI240696.1 KR 1020120046767-A/23: TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)
GGTCTGGAGAGG
>DI240695.1 KR 1020120046767-A/22: TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)
TGGAGAGGTTCT
>DI240694.1 KR 1020120046767-A/21: TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)
CCTGGTCTGGAG
>DI240693.1 KR 1020120046767-A/20: TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)
CAGCTCTGCCTA
>DI240692.1 KR 1020120046767-A/19: TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)
GGCCAGCTCTGC
>DI221897.1 KR 1020110026474-A/38: METHODS AND COMPOSITIONS FOR GENERATION OF BAX- AND BAK-DEFICIENT CELL LINES
CGTCTGGACAAG
>DI221887.1 KR 1020110026474-A/24: METHODS AND COMPOSITIONS FOR GENERATION OF BAX- AND BAK-DEFICIENT CELL LINES
GTGGCGGCCCTG
>DI221885.1 KR 1020110026474-A/22: METHODS AND COMPOSITIONS FOR GENERATION OF BAX- AND BAK-DEFICIENT CELL LINES
GATCCAGACAAG
>DI221884.1 KR 1020110026474-A/21: METHODS AND COMPOSITIONS FOR GENERATION OF BAX- AND BAK-DEFICIENT CELL LINES
CAGGGTGGCTGG
>DI185914.1 KR 1020110024042-A/6: Fluorescent sensor for detecting potassium ion and DNA sequence analysis using the same
CCCAATTATCTC
>DI185913.1 KR 1020110024042-A/5: Fluorescent sensor for detecting potassium ion and DNA sequence analysis using the same
CCCAACCCCAAT
>DI185912.1 KR 1020110024042-A/4: Fluorescent sensor for detecting potassium ion and DNA sequence analysis using the same
CCCAAGCCCAAT
>DI185911.1 KR 1020110024042-A/3: Fluorescent sensor for detecting potassium ion and DNA sequence analysis using the same
CCCAAACCCAAT
>DI185910.1 KR 1020110024042-A/2: Fluorescent sensor for detecting potassium ion and DNA sequence analysis using the same
CCCAATCCCAAT
>DI239510.1 KR 1020120048563-A/30: METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS
GCTAAAGCTGCT
>DI239509.1 KR 1020120048563-A/29: METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS
TCAAAAGAAACC
>DI239466.1 KR 1020120093138-A/23: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
ATTCACTTTCAT
>DI239465.1 KR 1020120093138-A/22: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTCACTTTCATA
>DI239464.1 KR 1020120093138-A/21: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TCACTTTCATAA
>DI239462.1 KR 1020120093138-A/19: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
CACTTTCATAAT
>DI239460.1 KR 1020120093138-A/17: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
ACTTTCATAATG
>DI239458.1 KR 1020120093138-A/15: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
CTTTCATAATGC
>DI239456.1 KR 1020120093138-A/13: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTTCATAATGCT
>DI239454.1 KR 1020120093138-A/11: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTCATAATGCTG
>DI239452.1 KR 1020120093138-A/9: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TCATAATGCTGG
>JB866677.1 Sequence 9 from Patent EP2615182
CCCCTACTTACA
>DI210465.1 KR 1020100092041-A/69: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
CTCAAAATAGAT
>DI210464.1 KR 1020100092041-A/68: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
CTCAAAAATGAT
>DI210455.1 KR 1020100092041-A/59: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
GGAGATTACATA
>DI210454.1 KR 1020100092041-A/58: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
GGAGATTGTATA
>DI210451.1 KR 1020100092041-A/55: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
AAATCAATTAAA
>DI210450.1 KR 1020100092041-A/54: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
AAATCAGTTAAA
>DI180589.1 KR 1020090006230-A/14: Method of treating hepatitis delta viral infection
TAAGACGGGGTA
>DI180119.1 KR 1020080110908-A/12: Recombinant attenuated Clostridium organisms and vaccine
AATGCGGATCCT
>DI178774.1 KR 1020080107384-A/128: PRIMER SET FOR AMPLIFICATION OF OBESITY GENE, REAGENT FOR AMPLIFICATION OF OBESITY GENE COMPRISING THE PRIMER SET, AND USE OF THE PRIMER SET
CTCGGAGTCCAG
>DI178768.1 KR 1020080107384-A/122: PRIMER SET FOR AMPLIFICATION OF OBESITY GENE, REAGENT FOR AMPLIFICATION OF OBESITY GENE COMPRISING THE PRIMER SET, AND USE OF THE PRIMER SET
CTCGGAGTCCGG
>DI177024.1 KR 1020100032028-A/27: Polypeptides or fusion proteins thereof having an inhibitory activity against growth of cancer cells and preventive or treating activity against inflammatory diseases
TATTTCTGCCGA
>DI176762.1 KR 1020100027831-A/5: Biosensor having screen-printed electrode based on catalytic activity of hydrazine for detecting biomolecule and preparation method thereof
TCTATCCTACGC
>DI237752.1 KR 1020120124029-A/11: PROBE FOR DETECTING POLYMORPHISM, METHOD OF DETECTING POLYMORPHISM, METHOD OF EVALUATING DRUG EFFICACY AND REAGENT KIT FOR DETECTING POLYMORPHISM
CCAAGACTCTTC
>DI237751.1 KR 1020120124029-A/10: PROBE FOR DETECTING POLYMORPHISM, METHOD OF DETECTING POLYMORPHISM, METHOD OF EVALUATING DRUG EFFICACY AND REAGENT KIT FOR DETECTING POLYMORPHISM
CTAAGACTCTTC
>DI217301.1 KR 1020120100629-A/4: Nanoparticle-nucleic acid complex and method for linearizing target nucleic acid using thereof
AGGTCGCCGCCC
>DI174741.1 KR 1020090123149-A/38: Stroke early diagnosing chip and screening analysis thereof
ACACGTGGGGAG
>DI215556.1 KR 1020110004918-A/128: PRIMER SET FOR AMPLIFICATION OF OBESITY GENE, REAGENT FOR AMPLIFICATION OF OBESITY GENE COMPRISING THE PRIMER SET, AND USE OF THE PRIMER SET
CTCGGAGTCCAG
>DI215550.1 KR 1020110004918-A/122: PRIMER SET FOR AMPLIFICATION OF OBESITY GENE, REAGENT FOR AMPLIFICATION OF OBESITY GENE COMPRISING THE PRIMER SET, AND USE OF THE PRIMER SET
CTCGGAGTCCGG
>DI215361.1 KR 1020110014661-A/74: Albumin-Fused Kunitz Domain Peptides
GCANNNNNNTCG
>DI169652.1 KR 1020060028691-A/69: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
CTCAAAATAGAT
>DI169651.1 KR 1020060028691-A/68: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
CTCAAAAATGAT
>DI169642.1 KR 1020060028691-A/59: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
GGAGATTACATA
>DI169641.1 KR 1020060028691-A/58: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
GGAGATTGTATA
>DI169638.1 KR 1020060028691-A/55: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
AAATCAATTAAA
>DI169637.1 KR 1020060028691-A/54: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
AAATCAGTTAAA
>DI213967.1 KR 1020110020798-A/17: AFFINITY MATURED CRIg VARIANTS
GTCACCTGGNNN
>DI213661.1 KR 1020110007202-A/129: Peptide nucleic acid probes, kits and methods for expression profiling of microRNAs
GCTGAGAGTGTA
>DI213653.1 KR 1020110007202-A/121: Peptide nucleic acid probes, kits and methods for expression profiling of microRNAs
GCAGAACTTAGC
>DI213633.1 KR 1020110007202-A/101: Peptide nucleic acid probes, kits and methods for expression profiling of microRNAs
TCATTACCAGGC
>DI213562.1 KR 1020110007202-A/30: Peptide nucleic acid probes, kits and methods for expression profiling of microRNAs
CCAGCAGACAAT
>DI213561.1 KR 1020110007202-A/29: Peptide nucleic acid probes, kits and methods for expression profiling of microRNAs
GACAATGTAGCT
>DI168591.1 KR 1020000076597-A/8: Oligonucleotide primers for efficient reverse transcription of hepatitis C virus (HCV) RNA and methods of use thereof
TCAGCACTCTCT
>DI168585.1 KR 1020000076597-A/2: Oligonucleotide primers for efficient reverse transcription of hepatitis C virus (HCV) RNA and methods of use thereof
GTATCAGCACTC
>DI168572.1 KR 1020010014470-A/2: Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2, methods of use thereof and a kit comprising the same
CCCTGTGGCGCC
>JB833801.1 Sequence 23 from Patent EP1877579
GCTCACATATTT
>JB833798.1 Sequence 20 from Patent EP1877579
CAGGGCCATTAT
>HJ493139.1 Sequence 9 from patent US 8558058
AAGGACGAGCTC
>HJ492827.1 Sequence 117 from patent US 8557973
TGCAGTGCCTGT
>HJ492824.1 Sequence 114 from patent US 8557973
ACCATCGCGTTC
>HJ492778.1 Sequence 68 from patent US 8557973
TCGGTTTTGGTC
>HJ492760.1 Sequence 49 from patent US 8557973
TTCCTGGCGCAG
>HJ492751.1 Sequence 40 from patent US 8557973
AGGGGAGTCTGC
>HJ492750.1 Sequence 39 from patent US 8557973
CGCCGCATTACG
>HJ492541.1 Sequence 18 from patent US 8557964
ACTGATTACTAC
>HJ492092.1 Sequence 4 from patent US 8557789
TTAGGGTTAGGG
>HJ490803.1 Sequence 17 from patent US 8557543
ATTGATGTTTCT
>HJ488778.1 Sequence 7 from patent US 8551768
GGGTAGGGCGGG
>HJ488777.1 Sequence 6 from patent US 8551768
GGGCGGGTTGGG
>HJ488048.1 Sequence 4 from patent US 8551739
GTGTCGCCCTTA
>HJ488047.1 Sequence 3 from patent US 8551739
TGTCGCCCTTAT
>HJ488046.1 Sequence 2 from patent US 8551739
TCGCCCTTATTC
>HJ488045.1 Sequence 1 from patent US 8551739
GCCCTTATTCCC
>HJ487869.1 Sequence 110 from patent US 8551710
GTCTAGCTACAG
>HJ487864.1 Sequence 105 from patent US 8551710
ATCTCGATGGAG
>HJ487788.1 Sequence 29 from patent US 8551710
GTAGTTGGAGCT
>HJ487783.1 Sequence 24 from patent US 8551710
TGGAGCTGGGTG
>HJ487777.1 Sequence 18 from patent US 8551710
TAGTTGGAGCTG
>HJ487769.1 Sequence 10 from patent US 8551710
TGGCGTAGGCAA
>HJ487763.1 Sequence 4 from patent US 8551710
GTGGCGTAGGCA
>HJ487757.1 Sequence 113 from patent US 8551708
CGTAGGCAAGAG
>HJ487754.1 Sequence 110 from patent US 8551708
GTCTAGCTACAG
>HJ487749.1 Sequence 105 from patent US 8551708
ATCTCGATGGAG
>HJ487673.1 Sequence 29 from patent US 8551708
GTAGTTGGAGCT
>HJ487668.1 Sequence 23 from patent US 8551708
TTGGAGCTGGTG
>HJ487663.1 Sequence 18 from patent US 8551708
TAGTTGGAGCTG
>HJ487655.1 Sequence 10 from patent US 8551708
TGGCGTAGGCAA
>HJ487649.1 Sequence 4 from patent US 8551708
GTGGCGTAGGCA
>HJ485377.1 Sequence 2 from patent US 8546556
TTTTTTTTTTTT
>HJ485376.1 Sequence 1 from patent US 8546556
TTTTTTTTTTTT
>HJ481912.1 Sequence 10 from patent US 8546309
NGTNTCGTNCCG
>HJ481910.1 Sequence 8 from patent US 8546309
AGACNTTNGANT
>HJ481909.1 Sequence 7 from patent US 8546309
NNTCNNNNGNCN
>HJ481908.1 Sequence 6 from patent US 8546309
GTNTAATTNNAG
>HJ481907.1 Sequence 5 from patent US 8546309
CNNNNNTNNNNC
>HJ481220.1 Sequence 39 from patent US 8546126
ACTAGTACCCAG
>HJ479891.1 Sequence 727 from patent US 8546082
ACACGAGCTGAC
>JB759876.1 Sequence 84 from Patent WO2013113326
GGGTTTTTTGGG
>JB759865.1 Sequence 73 from Patent WO2013113326
GGTTTTTTTTGG
>JB759968.1 Sequence 59 from Patent WO2013113325
GGTTTTTTTTGG
>JB765047.1 Sequence 29 from Patent EP2603609
TTTATGCTAATT
>JB761200.1 Sequence 70 from Patent WO2013113502
GGGTTTTTTGGG
>JB761189.1 Sequence 59 from Patent WO2013113502
GGTTTTTTTTGG
>JB777012.1 Sequence 5 from Patent WO2013071954
AATAAATCATAA
>JB760553.1 Sequence 84 from Patent WO2013113501
GGGTTTTTTGGG
>JB760542.1 Sequence 73 from Patent WO2013113501
GGTTTTTTTTGG
>JB760405.1 Sequence 84 from Patent WO2013113736
GGGTTTTTTGGG
>JB760394.1 Sequence 73 from Patent WO2013113736
GGTTTTTTTTGG
>JB759979.1 Sequence 70 from Patent WO2013113325
GGGTTTTTTGGG
>HJ422392.1 Sequence 205 from patent US 8541565
GSGGGGSGGGGS
>HJ421275.1 Sequence 122 from patent US 8541386
AGGCACACACAT
>HW268938.1 JP 2012095665-A/1: 2'-Nitrobenzyl-Modified Ribonucleotides
AACTGCGGCGAT
>HW285396.1 JP 2012157369-A/1: 2'-Nitrobenzyl-Modified Ribonucleotides
AACTGCGGCGAT
>HW277192.1 JP 2012120543-A/586: GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HAEMOPHILUS INFLUENZAE
GGGGGGGGGGGG
>HW276323.1 JP 2012140448-A/22: Albumin Fusion Proteins
GGGGACTTTCCC
>JB751276.1 Sequence 38 from Patent WO2013090633
GGAACTGGGCCC
>JB750561.1 Sequence 28 from Patent WO2013090293
GAGCAGCTGATA
>JB749362.1 Sequence 11 from Patent WO2013090040
CACTCCTGTGCA
>JB748029.1 Sequence 135 from Patent WO2013064895
AAAATTAATTAA
>JB748028.1 Sequence 134 from Patent WO2013064895
AAAAGGCGCGCC
>JB742486.1 Sequence 42 from Patent EP2593468
TTAATTGTTGCA
>JB614641.1 Sequence 112 from Patent WO2013068441
AACAAAGTCACA
>JB614639.1 Sequence 110 from Patent WO2013068441
CAAAGTCACATA
>JB614637.1 Sequence 108 from Patent WO2013068441
AAGTCACATAAC
>JB614635.1 Sequence 106 from Patent WO2013068441
GTCACATAACTA
>JB614633.1 Sequence 104 from Patent WO2013068441
CACATAACTACA
>JB614558.1 Sequence 29 from Patent WO2013068441
AACAAAGTCACA
>JB614556.1 Sequence 27 from Patent WO2013068441
CAAAGTCACATA
>JB614554.1 Sequence 25 from Patent WO2013068441
AAGTCACATAAC
>JB614552.1 Sequence 23 from Patent WO2013068441
GTCACATAACTA
>JB614550.1 Sequence 21 from Patent WO2013068441
CACATAACTACA
>JB616677.1 Sequence 3 from Patent WO2013060777
ACCAGATTACAA
>JB616676.1 Sequence 2 from Patent WO2013060777
GGAGGACCAGTA
>JB616675.1 Sequence 1 from Patent WO2013060777
TAACATTCAGAG
>JB623854.1 Sequence 4 from Patent EP2610341
RMSCSGCNGMWR
>JB623819.1 Sequence 4 from Patent EP2610340
RMSCSGCNGMWR
>JB623285.1 Sequence 50 from Patent EP2586313
GAATTCAGATCT
>JB623277.1 Sequence 42 from Patent EP2586313
GAATTCAGATCT
>JB621597.1 Sequence 313 from Patent WO2013061163
TTTTTTTTTTTT
>JB621596.1 Sequence 312 from Patent WO2013061163
TGTGTGTGTGTG
>JB420943.1 Sequence 325 from Patent EP2589610
GGGAAAGGGAAA
>JB417251.1 Sequence 244 from Patent EP2599877
CGACTAGTACTA
>JB417250.1 Sequence 243 from Patent EP2599877
CACTGTATAGCT
>JB417249.1 Sequence 242 from Patent EP2599877
CAGTAGCACTAC
>JB417248.1 Sequence 241 from Patent EP2599877
CGACGTAGAGTC
>JB417247.1 Sequence 240 from Patent EP2599877
CGACTAGTACTA
>JB417246.1 Sequence 239 from Patent EP2599877
CACTGTATAGCT
>JB417197.1 Sequence 190 from Patent EP2599877
CAGTAGCACTAC
>JB417196.1 Sequence 189 from Patent EP2599877
CGACGTAGAGTC
>JB417195.1 Sequence 188 from Patent EP2599877
TACAGACTGCAC
>JB417194.1 Sequence 187 from Patent EP2599877
TGCAGCTCATAG
>JB417193.1 Sequence 186 from Patent EP2599877
CTAGATATCGTC
>JB417192.1 Sequence 185 from Patent EP2599877
TGATCGACGCTC
>JB417191.1 Sequence 184 from Patent EP2599877
AGATAGCACATC
>JB417190.1 Sequence 183 from Patent EP2599877
TAGCATCGATAT
>JB417189.1 Sequence 182 from Patent EP2599877
CTCTACAGTCAC
>JB417188.1 Sequence 181 from Patent EP2599877
ATCATATGTAGC
>JB417187.1 Sequence 180 from Patent EP2599877
CAGCTCGACTAC
>JB417186.1 Sequence 179 from Patent EP2599877
ATCGATGTCACG
>JB417185.1 Sequence 178 from Patent EP2599877
TACATGCACTCA
>JB417184.1 Sequence 177 from Patent EP2599877
TAGATGCTATAC
>JB417183.1 Sequence 176 from Patent EP2599877
TCGATCATGCAG
>JB417182.1 Sequence 175 from Patent EP2599877
TGAGTAGCACGC
>JB417181.1 Sequence 174 from Patent EP2599877
CTAGTATCATGA
>JB417180.1 Sequence 173 from Patent EP2599877
TACATAGTCTCG
>JB417179.1 Sequence 172 from Patent EP2599877
ACAGTAGCGCAC
>JB417178.1 Sequence 171 from Patent EP2599877
ACACGCTCTACT
>JB417177.1 Sequence 170 from Patent EP2599877
ATCTACTGACGT
>JB417176.1 Sequence 169 from Patent EP2599877
TCGCGTGACATC
>JB417175.1 Sequence 168 from Patent EP2599877
TACTCGTAGCGC
>JB417174.1 Sequence 167 from Patent EP2599877
TAGATGACGCTC
>JB417173.1 Sequence 166 from Patent EP2599877
TATGTGACATAC
>JB417172.1 Sequence 165 from Patent EP2599877
TACTATCGCTCT
>JB417171.1 Sequence 164 from Patent EP2599877
TGTCTATCACAT
>JB417170.1 Sequence 163 from Patent EP2599877
TAGAGTCTGTAT
>JB417169.1 Sequence 162 from Patent EP2599877
ACTCGATGAGCT
>JB417168.1 Sequence 161 from Patent EP2599877
CGCGAGCTCGTC
>JB417167.1 Sequence 160 from Patent EP2599877
CGCTGCATAGCG
>JB417166.1 Sequence 159 from Patent EP2599877
TACTGCTATCTC
>JB417165.1 Sequence 158 from Patent EP2599877
ATGATCGTATAC
>JB417164.1 Sequence 157 from Patent EP2599877
TGTATCACGAGC
>JB417163.1 Sequence 156 from Patent EP2599877
TAGTACAGAGCT
>JB417162.1 Sequence 155 from Patent EP2599877
TCGCTCATCTAT
>JB417161.1 Sequence 154 from Patent EP2599877
CACTACATCGCT
>JB417160.1 Sequence 153 from Patent EP2599877
CACTGACGCTCA
>JB417159.1 Sequence 152 from Patent EP2599877
TCATGCTGACGA
>JB417158.1 Sequence 151 from Patent EP2599877
ATACTAGCATCA
>JB417157.1 Sequence 150 from Patent EP2599877
CGATCATATGAG
>JB417156.1 Sequence 149 from Patent EP2599877
ATCGACTATGCT
>JB417155.1 Sequence 148 from Patent EP2599877
TCATATGATCGA
>JB417154.1 Sequence 147 from Patent EP2599877
TGTCACAGTGAC
>JB417153.1 Sequence 146 from Patent EP2599877
AGACGCTGTCGA
>JB417152.1 Sequence 145 from Patent EP2599877
TAGTCTATACAT
>JB417151.1 Sequence 144 from Patent EP2599877
TCGTGATCACTA
>JB417150.1 Sequence 143 from Patent EP2599877
ATATCGTAGCAT
>JB417149.1 Sequence 142 from Patent EP2599877
CGACACGTACTA
>JB417148.1 Sequence 141 from Patent EP2599877
CACTATACAGAT
>JB417147.1 Sequence 140 from Patent EP2599877
TCGTGTCACTAC
>JB417146.1 Sequence 139 from Patent EP2599877
CATACTATCACG
>JB417145.1 Sequence 138 from Patent EP2599877
ACTGCATGATCG
>JB417144.1 Sequence 137 from Patent EP2599877
CAGTACACTCTA
>JB417143.1 Sequence 136 from Patent EP2599877
CACTGTGCTCAT
>JB417142.1 Sequence 135 from Patent EP2599877
TGTATGATCTCG
>JB417141.1 Sequence 134 from Patent EP2599877
TCGTACATGCTC
>JB417140.1 Sequence 133 from Patent EP2599877
TACATGTGACGA
>JB417139.1 Sequence 132 from Patent EP2599877
TGACGCTCATCT
>JB417138.1 Sequence 131 from Patent EP2599877
TACACTCGTGCT
>JB417137.1 Sequence 130 from Patent EP2599877
TCGTCTGTGATA
>JB417136.1 Sequence 129 from Patent EP2599877
TACAGATAGTCT
>JB417135.1 Sequence 128 from Patent EP2599877
CACTCATATCGA
>JB417134.1 Sequence 127 from Patent EP2599877
ACACGAGCTCAT
>JB417133.1 Sequence 126 from Patent EP2599877
ACTCATATCGCA
>JB417132.1 Sequence 125 from Patent EP2599877
CTGCACTAGACA
>JB417131.1 Sequence 124 from Patent EP2599877
CACGTATAGTGA
>JB417130.1 Sequence 123 from Patent EP2599877
TCTACTCGTGAC
>JB417129.1 Sequence 122 from Patent EP2599877
TACATAGATGTC
>JB417128.1 Sequence 121 from Patent EP2599877
CATACTGTATCT
>JB417127.1 Sequence 120 from Patent EP2599877
TGCTATCACTGA
>JB417126.1 Sequence 119 from Patent EP2599877
ACTCGTCTGACG
>JB417125.1 Sequence 118 from Patent EP2599877
ACGCGAGTGATA
>JB417124.1 Sequence 117 from Patent EP2599877
ACTCGACGTGAG
>JB417123.1 Sequence 116 from Patent EP2599877
CAGTCGTGAGCA
>JB417122.1 Sequence 115 from Patent EP2599877
CGTGTCGACAGA
>JB417121.1 Sequence 114 from Patent EP2599877
TCGACGCTAGCG
>JB417120.1 Sequence 113 from Patent EP2599877
TGCAGCGAGTAC
>JB417119.1 Sequence 112 from Patent EP2599877
TATAGCGATGAC
>JB417118.1 Sequence 111 from Patent EP2599877
CGTCATATGCAG
>JB417117.1 Sequence 110 from Patent EP2599877
TGACGCGTATAC
>JB417116.1 Sequence 109 from Patent EP2599877
TAGCATACACGC
>JB417115.1 Sequence 108 from Patent EP2599877
TCATGACTAGTA
>JB417114.1 Sequence 107 from Patent EP2599877
ACGACTCGCTAC
>JB417113.1 Sequence 106 from Patent EP2599877
TACACGTATGAG
>JB417112.1 Sequence 105 from Patent EP2599877
TAGCATATCGAG
>JB417111.1 Sequence 104 from Patent EP2599877
CTAGCTGACGTA
>JB417110.1 Sequence 103 from Patent EP2599877
CATGAGTATAGC
>JB417109.1 Sequence 102 from Patent EP2599877
ACACGCAGATCG
>JB417108.1 Sequence 101 from Patent EP2599877
TCTATCGATGCA
>JB417107.1 Sequence 100 from Patent EP2599877
ATGCAGATATCT
>JB417106.1 Sequence 99 from Patent EP2599877
CAGCTATAGTCT
>JB417105.1 Sequence 98 from Patent EP2599877
TCGTGATACAGA
>JB417104.1 Sequence 97 from Patent EP2599877
CAGCATACTATC
>JB417103.1 Sequence 96 from Patent EP2599877
TCGTAGTCTACA
>JB417102.1 Sequence 95 from Patent EP2599877
CGAGACACTCGC
>JB417101.1 Sequence 94 from Patent EP2599877
CGCATAGCGTAT
>JB417100.1 Sequence 93 from Patent EP2599877
ATAGAGTCTCAT
>JB417099.1 Sequence 92 from Patent EP2599877
TGTCTCGACATC
>JB417098.1 Sequence 91 from Patent EP2599877
TCGCTCACTACA
>JB417097.1 Sequence 90 from Patent EP2599877
ATCGCGAGTGAC
>JB417096.1 Sequence 89 from Patent EP2599877
CTCATAGACTAC
>JB417095.1 Sequence 88 from Patent EP2599877
CTGATAGTATCA
>JB417094.1 Sequence 87 from Patent EP2599877
AGACTCTGAGTC
>JB417093.1 Sequence 86 from Patent EP2599877
ACGAGCTGATAT
>JB417092.1 Sequence 85 from Patent EP2599877
TAGTGATGCTCT
>JB417091.1 Sequence 84 from Patent EP2599877
TCGTGACAGATC
>JB417090.1 Sequence 83 from Patent EP2599877
TGTATGCTCGTC
>JB417089.1 Sequence 82 from Patent EP2599877
TGCATAGAGCGC
>JB417088.1 Sequence 81 from Patent EP2599877
TATACTCTAGAT
>JB417087.1 Sequence 80 from Patent EP2599877
CACTGCAGACGA
>JB417086.1 Sequence 79 from Patent EP2599877
CAGCTATCATAC
>JB417085.1 Sequence 78 from Patent EP2599877
AGCAGAGTGCTC
>JB417084.1 Sequence 77 from Patent EP2599877
CATATGAGATCG
>JB417083.1 Sequence 76 from Patent EP2599877
ACGTAGATCTAT
>JB417082.1 Sequence 75 from Patent EP2599877
ACACTCTAGTCA
>JB417081.1 Sequence 74 from Patent EP2599877
TCACGCGATGAG
>JB417080.1 Sequence 73 from Patent EP2599877
CACTCTATCGAC
>JB417079.1 Sequence 72 from Patent EP2599877
TGATATGCTACA
>JB417078.1 Sequence 71 from Patent EP2599877
ACAGTGTAGCGC
>JB417077.1 Sequence 70 from Patent EP2599877
TACTATAGTCGA
>JB417076.1 Sequence 69 from Patent EP2599877
CGCTAGACTGTA
>JB417075.1 Sequence 68 from Patent EP2599877
ACATGACTCACG
>JB417074.1 Sequence 67 from Patent EP2599877
TGTCGTGCTATC
>JB417073.1 Sequence 66 from Patent EP2599877
CATACTCACGTA
>JB417072.1 Sequence 65 from Patent EP2599877
AGCGTATACTAG
>JB417071.1 Sequence 64 from Patent EP2599877
CTATCATGACAC
>JB417070.1 Sequence 63 from Patent EP2599877
ACACTCATAGAT
>JB417069.1 Sequence 62 from Patent EP2599877
TAGCGATGAGAC
>JB417068.1 Sequence 61 from Patent EP2599877
CGCGACATCACG
>JB417067.1 Sequence 60 from Patent EP2599877
TACATCTCGTAT
>JB417066.1 Sequence 59 from Patent EP2599877
CAGACGCGTGAG
>JB417065.1 Sequence 58 from Patent EP2599877
ACATACTGAGAC
>JB417064.1 Sequence 57 from Patent EP2599877
TAGACTGAGCTA
>JB417063.1 Sequence 56 from Patent EP2599877
AGCGAGTCTACT
>JB417062.1 Sequence 55 from Patent EP2599877
CTAGTACTGACG
>JB417061.1 Sequence 54 from Patent EP2599877
TGTGATAGACAC
>JB417060.1 Sequence 53 from Patent EP2599877
TGTACTATCATA
>JB417059.1 Sequence 52 from Patent EP2599877
CTGCTAGTGTAT
>JB417058.1 Sequence 51 from Patent EP2599877
CACAGTACTCGC
>JB417057.1 Sequence 50 from Patent EP2599877
CAGCACATAGAT
>JB417056.1 Sequence 49 from Patent EP2599877
TACACTGTCTAT
>JB417055.1 Sequence 48 from Patent EP2599877
TAGAGCTGTCAC
>JB417054.1 Sequence 47 from Patent EP2599877
ACTCATCGTGCT
>JB417053.1 Sequence 46 from Patent EP2599877
ATCTGCTATGAC
>JB417052.1 Sequence 45 from Patent EP2599877
TGAGATACAGTA
>JB417051.1 Sequence 44 from Patent EP2599877
CTATGCACTGAT
>JB417050.1 Sequence 43 from Patent EP2599877
ACGCACTCTAGA
>JB417049.1 Sequence 42 from Patent EP2599877
TCTAGCTCATGA
>JB417048.1 Sequence 41 from Patent EP2599877
CATCTGCTATAG
>JB417047.1 Sequence 40 from Patent EP2599877
ACGTAGCGCACA
>JB417046.1 Sequence 39 from Patent EP2599877
ACTGTCTCGAGC
>JB417045.1 Sequence 38 from Patent EP2599877
TGTATACACGAT
>JB417044.1 Sequence 37 from Patent EP2599877
CGAGATGACTCT
>JB417043.1 Sequence 36 from Patent EP2599877
CTAGTATCGCAG
>JB417042.1 Sequence 35 from Patent EP2599877
ACGCATCTATAC
>JB417041.1 Sequence 34 from Patent EP2599877
CGCGTACTGCAG
>JB417040.1 Sequence 33 from Patent EP2599877
CGACGTGCTCGC
>JB417039.1 Sequence 32 from Patent EP2599877
AGCGATGCTCAT
>JB417038.1 Sequence 31 from Patent EP2599877
CACTCGTACATC
>JB417037.1 Sequence 30 from Patent EP2599877
TCTGATCGAGCA
>JB417036.1 Sequence 29 from Patent EP2599877
TGTGCTCGAGTC
>JB417035.1 Sequence 28 from Patent EP2599877
CATAGCAGTGTC
>JB417034.1 Sequence 27 from Patent EP2599877
TGCTGTCTCGAG
>JB417033.1 Sequence 26 from Patent EP2599877
TAGTGAGCGCAC
>JB417032.1 Sequence 25 from Patent EP2599877
CACGATGACATC
>JB417031.1 Sequence 24 from Patent EP2599877
TGTATCGTGCTC
>JB417030.1 Sequence 23 from Patent EP2599877
ATACTAGTGCTC
>JB417029.1 Sequence 22 from Patent EP2599877
TACTAGCTGACG
>JB417028.1 Sequence 21 from Patent EP2599877
AGACTCGCGTAT
>JB417027.1 Sequence 20 from Patent EP2599877
ATAGTCACGCGT
>JB417026.1 Sequence 19 from Patent EP2599877
ACTACACGTCTC
>JB417025.1 Sequence 18 from Patent EP2599877
ACTAGTACACGC
>JB417024.1 Sequence 17 from Patent EP2599877
TAGATCGTACAT
>JB417023.1 Sequence 16 from Patent EP2599877
ATCTCGTGACAG
>JB417022.1 Sequence 15 from Patent EP2599877
ACAGATGCACGC
>JB417021.1 Sequence 14 from Patent EP2599877
AGATCGTATAGC
>JB417020.1 Sequence 13 from Patent EP2599877
TCATATCGCGAT
>JB417019.1 Sequence 12 from Patent EP2599877
ACGTGTCTATCA
>JB417018.1 Sequence 11 from Patent EP2599877
TACATGCTGAGC
>JB417017.1 Sequence 10 from Patent EP2599877
AGATATCGAGCT
>JB417016.1 Sequence 9 from Patent EP2599877
TATCTGCTCATA
>JB417015.1 Sequence 8 from Patent EP2599877
TGCTGTAGTGAC
>JB417014.1 Sequence 7 from Patent EP2599877
TCTGTATACTCA
>JB417013.1 Sequence 6 from Patent EP2599877
ACGTCTAGACAC
>JB417012.1 Sequence 5 from Patent EP2599877
CTCGATGAGTAC
>JB417011.1 Sequence 4 from Patent EP2599877
TACAGATGCTGA
>JB417010.1 Sequence 3 from Patent EP2599877
TACATCGCACTA
>JB417009.1 Sequence 2 from Patent EP2599877
TGACACGATGCT
>JB417008.1 Sequence 1 from Patent EP2599877
TCGCAGACATCA
>JB416421.1 Sequence 84 from Patent EP2623121
GGGTTTTTTGGG
>JB416410.1 Sequence 73 from Patent EP2623121
GGTTTTTTTTGG
>JB407954.1 Sequence 14 from Patent WO2012103035
CATGACGTTCCT
>JB407415.1 Sequence 358 from Patent WO2012116811
GGGTTTTTTGGG
>JB407405.1 Sequence 347 from Patent WO2012116811
GGTTTTTTTTGG
>JB406005.1 Sequence 54 from Patent WO2012150960
CAGGCAGGCAGG
>JB405999.1 Sequence 48 from Patent WO2012150960
GCAGCAGCAGCA
>JB405995.1 Sequence 44 from Patent WO2012150960
AGCAGCAGCAGC
>JB405991.1 Sequence 40 from Patent WO2012150960
CAGCAGCAGCAG
>JB415903.1 Sequence 33 from Patent WO2012042052
GCAGAGCGTCGA
>JB415899.1 Sequence 29 from Patent WO2012042052
CCAGAGCGTCGA
>JB415897.1 Sequence 27 from Patent WO2012042052
ACTTCTGCGTCG
>JB415874.1 Sequence 4 from Patent WO2012042052
AGGTACGTTCGC
>JB402449.1 Sequence 358 from Patent WO2012116715
GGGTTTTTTGGG
>JB402439.1 Sequence 347 from Patent WO2012116715
GGTTTTTTTTGG
>JB399489.1 Sequence 38 from Patent WO2012033653
AAACATCACGCG
>JB399488.1 Sequence 37 from Patent WO2012033653
AAAGCTGCCGCG
>JB399485.1 Sequence 34 from Patent WO2012033653
CATCCTCTGCAT
>JB399484.1 Sequence 33 from Patent WO2012033653
GCTCCTCTGGCT
>JB397274.1 Sequence 14 from Patent WO2012103038
CATGACGTTCCT
>JB394742.1 Sequence 57 from Patent WO2013014208
GCGGCCGCTAGC
>JB385109.1 Sequence 39 from Patent WO2012064991
GAAAAGTGCGCT
>JB380983.1 Sequence 17 from Patent WO2012127464
TCTAGAGCCGAG
>JB380665.1 Sequence 81 from Patent WO2013032032
ACATCACTCCGT
>JB379243.1 Sequence 70 from Patent WO2012113513
GGGTTTTTTGGG
>JB379233.1 Sequence 59 from Patent WO2012113513
GGTTTTTTTTGG
>JB379013.1 Sequence 10 from Patent WO2012041633
GAACAGGACCGA
>JB378000.1 Sequence 358 from Patent WO2012116714
GGGTTTTTTGGG
>JB377990.1 Sequence 347 from Patent WO2012116714
GGTTTTTTTTGG
>JB376657.1 Sequence 31 from Patent WO2012033848
ANTCGTTGCTNA
>JB376654.1 Sequence 28 from Patent WO2012033848
ANTCGTTGCTNA
>JB376651.1 Sequence 25 from Patent WO2012033848
ATCGTNNTGCTA
>JB376650.1 Sequence 24 from Patent WO2012033848
ATCGNNTTGCTA
>JB376648.1 Sequence 22 from Patent WO2012033848
ATCNGTTNGCTA
>JB376647.1 Sequence 21 from Patent WO2012033848
ATCNNGTTGCTA
>JB376519.1 Sequence 30 from Patent WO2012042053
GCAGAGCGTCGA
>JB376515.1 Sequence 26 from Patent WO2012042053
CCAGAGCGTCGA
>JB376513.1 Sequence 24 from Patent WO2012042053
ACTTCTGCGTCG
>JB376490.1 Sequence 1 from Patent WO2012042053
AGGTACGTTCGC
>JB368926.1 Sequence 131 from Patent WO2012044847
ACGGTACAGCAG
>JB368925.1 Sequence 130 from Patent WO2012044847
GCCGTACAGCAG
>JB368815.1 Sequence 20 from Patent WO2012044847
GCCGTACAGCAG
>JB368811.1 Sequence 16 from Patent WO2012044847
CAAGGCGGATGT
>JB368806.1 Sequence 11 from Patent WO2012044847
ACATCCGCCTTG
>JB368800.1 Sequence 5 from Patent WO2012044847
GCCGTACAGCAG
>JB368797.1 Sequence 2 from Patent WO2012044847
ACGGTACAGCAG
>JB358317.1 Sequence 51 from Patent EP2551347
ATGAACCGCGTG
>JB356617.1 Sequence 67 from Patent EP2554670
CTGAGGGTCCTC
>JB356614.1 Sequence 64 from Patent EP2554670
GTGGGGTGGCCC
>JB356602.1 Sequence 52 from Patent EP2554670
GGGCCGGGGTTG
>JB356596.1 Sequence 46 from Patent EP2554670
TCGGAGCTCCGA
>JB345618.1 Sequence 8 from Patent EP2616556
CATGCTGATCAC
>JB345616.1 Sequence 6 from Patent EP2616556
CGTACGACTCTG
>JB387651.1 Sequence 358 from Patent WO2012116810
GGGTTTTTTGGG
>JB387641.1 Sequence 347 from Patent WO2012116810
GGTTTTTTTTGG
>JB386351.1 Sequence 11 from Patent WO2012032510
ACTACTACTACT
>HW267793.1 JP 2013518924-A/8: Composition for repression of hyperlipidemia and obesity through repression of intestinal cholesterol absorption
CGCCTCAACCTC
>HW267310.1 JP 2013518602-A/53: TARGETED GENOMIC MODIFICATION WITH PARTIALLY SINGLE-STRANDED DONOR MOLECULES
TGGGGCCACTAG
>HW267309.1 JP 2013518602-A/52: TARGETED GENOMIC MODIFICATION WITH PARTIALLY SINGLE-STRANDED DONOR MOLECULES
GGAACTGGATGG
>HW267307.1 JP 2013518602-A/50: TARGETED GENOMIC MODIFICATION WITH PARTIALLY SINGLE-STRANDED DONOR MOLECULES
ATCAAGCTTATC
>HW259680.1 JP 2013515503-A/9: Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof
CACGACGAGTTG
>JB338852.1 Sequence 112 from Patent EP2379083
CCAAGGTTGGCA
>JB338851.1 Sequence 111 from Patent EP2379083
TGCCAACCTTGG
>JB338830.1 Sequence 90 from Patent EP2379083
AAGTATCGCTTC
>JB338829.1 Sequence 89 from Patent EP2379083
GAAGCGATACTT
>JB338828.1 Sequence 88 from Patent EP2379083
AAGTATCGCTTC
>JB338827.1 Sequence 87 from Patent EP2379083
GAAGCGATACTT
>JB338307.1 Sequence 59 from Patent EP2474318
GGGGACTTTCCC
>JB335592.1 Sequence 249 from Patent EP2504032
GCCTATGACTTG
>JB334331.1 Sequence 9 from Patent EP2596101
TAGGGACAGGAT
>JB334330.1 Sequence 8 from Patent EP2596101
ACCCCACAGTGG
>JB334007.1 Sequence 43 from Patent EP2441774
CCCCGCCCCGCG
>JB325506.1 Sequence 278 from Patent EP2567970
CTGCTGGAGAAG
>JB325400.1 Sequence 165 from Patent EP2567970
GGTCGCCGACAG
>JB324593.1 Sequence 14 from Patent EP2560001
CAGCAGCAGCAG
>JB314597.1 Sequence 40 from Patent EP2478092
CCANNNNNNTGG
>JB314590.1 Sequence 33 from Patent EP2478092
CACCACATGCAT
>JB314330.1 Sequence 50 from Patent EP2620509
GGTATATATATA
>JB314325.1 Sequence 45 from Patent EP2620509
TATATATATATA
>JB314323.1 Sequence 43 from Patent EP2620509
GGTATATATATA
>JB314321.1 Sequence 41 from Patent EP2620509
TATATATATATA
>JB313345.1 Sequence 104 from Patent EP2566972
AAAGCGGCTCCG
>JB313336.1 Sequence 95 from Patent EP2566972
ACTCTGTGGAAG
>JB302741.1 Sequence 2 from Patent EP2425018
TTACTGTTGCGG
>JB302740.1 Sequence 1 from Patent EP2425018
CCGCAACAGTAA
>JB301583.1 Sequence 249 from Patent EP2504031
GCCTATGACTTG
>JB292440.1 Sequence 83 from Patent EP2542256
TTTGGAATGCAC
>JB292375.1 Sequence 14 from Patent EP2542256
TTTGGAATGCAC
>JB288785.1 Sequence 16 from Patent EP2493930
ACATCACTCCGT
>JB275419.1 Sequence 69 from Patent EP2332896
GTGGGCGCGACT
>JB275417.1 Sequence 67 from Patent EP2332896
GGGATGCCCCGG
>JB275415.1 Sequence 65 from Patent EP2332896
CGCGCCCACCCG
>JB275414.1 Sequence 64 from Patent EP2332896
GGGCATCCCCAG
>JB275412.1 Sequence 62 from Patent EP2332896
GATCCGCCCCGG
>JB275409.1 Sequence 59 from Patent EP2332896
GGGCGGATCCAG
>JB275407.1 Sequence 57 from Patent EP2332896
GTGCACGCGACT
>JB275406.1 Sequence 56 from Patent EP2332896
CGCGTGCACCCG
>JB287270.1 Sequence 17 from Patent EP2526199
GGGGCCGGAGCC
>JB258027.1 Sequence 10 from Patent EP2380896
GTGAGGTTCCTT
>JB258026.1 Sequence 9 from Patent EP2380896
TCAACGCGCATT
>JB258025.1 Sequence 8 from Patent EP2380896
GTGAGGTTCCTT
>JB258024.1 Sequence 7 from Patent EP2380896
TCAACGCGCATT
>JB256913.1 Sequence 50 from Patent EP2487181
GGTAACCGTACG
>JB256912.1 Sequence 49 from Patent EP2487181
CGTACGGTTACC
>JB256911.1 Sequence 48 from Patent EP2487181
GGTAATNGTGCG
>JB256910.1 Sequence 47 from Patent EP2487181
CGCAGNATTACC
>JB256909.1 Sequence 46 from Patent EP2487181
GGTAATCGTGCG
>JB256908.1 Sequence 45 from Patent EP2487181
CGCACGATTACC
>JB256907.1 Sequence 44 from Patent EP2487181
GGCAACGCTGCG
>JB256906.1 Sequence 43 from Patent EP2487181
CGCAGCGTTGCC
>JB256905.1 Sequence 42 from Patent EP2487181
GGTAACCATGCG
>JB256904.1 Sequence 41 from Patent EP2487181
CGCACGGTTACC
>JB256903.1 Sequence 40 from Patent EP2487181
CGCAGGGTTACC
>JB256902.1 Sequence 39 from Patent EP2487181
CGCAAGGTTACC
>JB256901.1 Sequence 38 from Patent EP2487181
CGCATGGTTACC
>JB256900.1 Sequence 37 from Patent EP2487181
GGTAACGATGCG
>JB256899.1 Sequence 36 from Patent EP2487181
CGCATCGTTACC
>JB256898.1 Sequence 35 from Patent EP2487181
GGTTCGCCGTCG
>JB256897.1 Sequence 34 from Patent EP2487181
CGACGGCGAACC
>JB256896.1 Sequence 33 from Patent EP2487181
GGTTNGCNGTCG
>JB256895.1 Sequence 32 from Patent EP2487181
CGACNGCNAACC
>JB256894.1 Sequence 31 from Patent EP2487181
GGTANCNATGCG
>JB256893.1 Sequence 30 from Patent EP2487181
CGCATNGNTACC
>JB256892.1 Sequence 29 from Patent EP2487181
GGTAANNATGCG
>JB256891.1 Sequence 28 from Patent EP2487181
CGCATNNGTACC
>JB256890.1 Sequence 27 from Patent EP2487181
GGTAACNGTACG
>JB256889.1 Sequence 26 from Patent EP2487181
CGTACNGTTACC
>JB256888.1 Sequence 25 from Patent EP2487181
GGTAACAGTACG
>JB256887.1 Sequence 24 from Patent EP2487181
CGTACTGTTACC
>JB256886.1 Sequence 23 from Patent EP2487181
GGTAACGATACG
>JB256885.1 Sequence 22 from Patent EP2487181
CGTATCGTTACC
>JB256884.1 Sequence 21 from Patent EP2487181
GGTAACNATGCG
>JB256883.1 Sequence 20 from Patent EP2487181
CGCATNGTTACC
>JB256882.1 Sequence 19 from Patent EP2487181
GGTAACGATGCG
>JB256881.1 Sequence 18 from Patent EP2487181
CGCATCGTTACC
>JB256880.1 Sequence 17 from Patent EP2487181
GGCAANGATGCG
>JB256879.1 Sequence 16 from Patent EP2487181
CGCATCNTTGCC
>JB256878.1 Sequence 15 from Patent EP2487181
GGCAACGNTGCG
>JB256877.1 Sequence 14 from Patent EP2487181
CGCANCGTTGCC
>JB256876.1 Sequence 13 from Patent EP2487181
GGCAACGGTGCG
>JB256875.1 Sequence 12 from Patent EP2487181
CGCATCGTTGCC
>JB256874.1 Sequence 11 from Patent EP2487181
GGCAACGATGCG
>JB256873.1 Sequence 10 from Patent EP2487181
CGCATCGTTGCC
>JB256872.1 Sequence 9 from Patent EP2487181
GGTTCGNCGTCG
>JB256871.1 Sequence 8 from Patent EP2487181
CGACGNCGAACC
>JB256870.1 Sequence 7 from Patent EP2487181
GGTTCGCCGTCG
>JB256869.1 Sequence 6 from Patent EP2487181
CGACGGCGAACC
>JB256868.1 Sequence 5 from Patent EP2487181
CGCANGNTTACC
>JB256867.1 Sequence 4 from Patent EP2487181
GGTAANNNTGCG
>JB256866.1 Sequence 3 from Patent EP2487181
CGCANNNTTACC
>JB256865.1 Sequence 2 from Patent EP2487181
GGTAACNATGCG
>JB256864.1 Sequence 1 from Patent EP2487181
CGCATNGTTACC
>JB251022.1 Sequence 249 from Patent EP2504030
GCCTATGACTTG
>JB250206.1 Sequence 1 from Patent EP2476704
CTCGAGACCACC
>JB249982.1 Sequence 15 from Patent EP2495337
CGATCGATCGAT
>JB243391.1 Sequence 100 from Patent EP2527368
TGCCAACAATGG
>JB239944.1 Sequence 4 from Patent EP2584038
RMSCSGCNGMWR
>JB238933.1 Sequence 7 from Patent EP2619333
TTTGGCCAAAAA
>JB238752.1 Sequence 1 from Patent EP2434009
TTAGGGTTAGGG
>JB236264.1 Sequence 56 from Patent EP2441769
CCGTACGTACGG
>JB236263.1 Sequence 55 from Patent EP2441769
AGCGGCGCCGCT
>JB236236.1 Sequence 28 from Patent EP2441769
ACTGGGNNNNNA
>JB236211.1 Sequence 3 from Patent EP2441769
ANBNCNGAAGAG
>JB234361.1 Sequence 50 from Patent EP2449091
TCRNNNNNNACG
>JB234247.1 Sequence 13 from Patent EP2527435
AAGGACACACTG
>JB234242.1 Sequence 8 from Patent EP2527435
GTCTCGGATGCT
>HJ417706.1 Sequence 36 from patent US 8513380
GGACACCGGCCA
>HJ417705.1 Sequence 35 from patent US 8513380
GGACCCCGGCCA
>HJ417704.1 Sequence 34 from patent US 8513380
GGACCCCGGGTA
>HJ417703.1 Sequence 33 from patent US 8513380
GGATCCCCGGAA
>HJ417512.1 Sequence 112 from patent US 8513207
CCAAGGTTGGCA
>HJ417511.1 Sequence 111 from patent US 8513207
TGCCAACCTTGG
>HJ417490.1 Sequence 90 from patent US 8513207
AAGTATCGCTTC
>HJ417489.1 Sequence 89 from patent US 8513207
GAAGCGATACTT
>HJ417488.1 Sequence 88 from patent US 8513207
AAGTATCGCTTC
>HJ417487.1 Sequence 87 from patent US 8513207
GAAGCGATACTT
>HJ417373.1 Sequence 325 from patent US 8513199
GGGAAAGGGAAA
>HJ416719.1 Sequence 1119 from patent US 8513189
GGGGACTTTCCC
>HJ414134.1 Sequence 45 from patent US 8512953
AGCAGAAGCGGG
>HJ356387.1 Sequence 22 from patent US 8532937
ACCACTACCTCA
>HJ356215.1 Sequence 59 from patent US 8530633
AGCAAGGGCGAG
>HJ354819.1 Sequence 251 from patent US 8530432
TTTCTGCCCTCA
>HJ354115.1 Sequence 89 from patent US 8530190
CTGTGCTATAAG
>HJ354038.1 Sequence 95 from patent US 8530181
TTAAATTTCCAG
>HJ353542.1 Sequence 8 from patent US 8530162
GAAAAATGTGAC
>HJ353315.1 Sequence 143 from patent US 8529913
GTGCGTACTAGT
>HJ353314.1 Sequence 142 from patent US 8529913
GTGCGTGCTAGC
>HJ353313.1 Sequence 141 from patent US 8529913
GTGCGTCATATG
>HJ351054.1 Sequence 69 from patent US 8524872
GATCCTGCCCGG
>HJ350461.1 Sequence 178 from patent US 8524500
GAAGTCTGCCGT
>HJ350447.1 Sequence 157 from patent US 8524500
AAAGCGGCTCCG
>HJ350446.1 Sequence 152 from patent US 8524500
ACTCTGTGGAAG
>HJ350431.1 Sequence 114 from patent US 8524500
ACTCTGTGGAAG
>HJ350418.1 Sequence 84 from patent US 8524500
AACTCGGATAAT
>HJ350411.1 Sequence 73 from patent US 8524500
AAGGTGAACGTG
>HJ350410.1 Sequence 68 from patent US 8524500
GGGCAGTAACGG
>HJ350403.1 Sequence 53 from patent US 8524500
TACAAGAACTCG
>HJ350401.1 Sequence 43 from patent US 8524500
AACTCGGATAAT
>HJ350394.1 Sequence 32 from patent US 8524500
GCGGCGCCGGCG
>HJ350393.1 Sequence 27 from patent US 8524500
CATGGGGTTCCT
>HJ350097.1 Sequence 7 from patent US 8524455
TGAAACTGACTT
>HJ348324.1 Sequence 127 from patent US 8524248
GCAGAGTTCCTC
>HJ347010.1 Sequence 19 from patent US 8524221
GACAAGCAGCGG
>HJ347009.1 Sequence 9 from patent US 8524221
AAACTGCAAAAG
>HJ347008.1 Sequence 1 from patent US 8524221
GATGAGGATGAC
>HJ346780.1 Sequence 32 from patent US 8501996
GGGGGGGGGGGG
>HJ346536.1 Sequence 83 from patent US 8501920
AATTCGTCGACG
>HJ346490.1 Sequence 37 from patent US 8501920
GACACAATGTAG
>HJ346372.1 Sequence 7 from patent US 8501805
GCGTTTTTTGCT
>HJ345528.1 Sequence 9 from patent US 8501427
AATCAAAATCAT
>HJ345527.1 Sequence 7 from patent US 8501427
AATCAAAATTAT
>HJ344784.1 Sequence 4 from patent US 8501188
TTAGGGTTAGGG
>CBTH010000091.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00091, whole genome shotgun sequence
AAGTCTTTTTCG
>AVFS01000317.1 Planktothrix agardhii NIVA-CYA 15 contig00041, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000318.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy1, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000319.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy2, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000320.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy3, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000321.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy4, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000322.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy5, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000323.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy6, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000324.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy7, whole genome shotgun sequence
CTGTTTCATTTT
>AVFS01000325.1 Planktothrix agardhii NIVA-CYA 15 contig00041_copy8, whole genome shotgun sequence
CTGTTTCATTTT
>HW235880.1 JP 2013100292-A/1693: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CARCARGCNCAR
>HW235879.1 JP 2013100292-A/1692: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CARGCNCARCAR
>HW235878.1 JP 2013100292-A/1691: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GCNCARCARCAR
>HW235877.1 JP 2013100292-A/1690: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CARCARCARGCN
>HW235777.1 JP 2013100292-A/1590: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CARCARACNCAR
>HW235776.1 JP 2013100292-A/1589: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CARACNCARCAR
>HW235775.1 JP 2013100292-A/1588: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
ACNCARCARCAR
>HW235774.1 JP 2013100292-A/1587: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CARCARCARACN
>HW235674.1 JP 2013100292-A/1487: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGAYGGN
>HW235673.1 JP 2013100292-A/1486: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGAYGGNGGN
>HW235672.1 JP 2013100292-A/1485: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GAYGGNGGNGGN
>HW235671.1 JP 2013100292-A/1484: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNGAY
>HW235571.1 JP 2013100292-A/1384: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNAAYGGN
>HW235570.1 JP 2013100292-A/1383: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNAAYGGNGGN
>HW235569.1 JP 2013100292-A/1382: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
AAYGGNGGNGGN
>HW235568.1 JP 2013100292-A/1381: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNAAY
>HW235468.1 JP 2013100292-A/1281: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNCAYGGN
>HW235467.1 JP 2013100292-A/1280: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNCAYGGNGGN
>HW235466.1 JP 2013100292-A/1279: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CAYGGNGGNGGN
>HW235465.1 JP 2013100292-A/1278: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNCAY
>HW235365.1 JP 2013100292-A/1178: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGARGGN
>HW235364.1 JP 2013100292-A/1177: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGARGGNGGN
>HW235363.1 JP 2013100292-A/1176: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GARGGNGGNGGN
>HW235362.1 JP 2013100292-A/1175: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNGAR
>HW247550.1 JP 2013514321-A/3193: Organic Compositions to Treat HSF1-Related Diseases
TCTGACTATGAA
>HW247549.1 JP 2013514321-A/3192: Organic Compositions to Treat HSF1-Related Diseases
CTGACTATGAAC
>HW247548.1 JP 2013514321-A/3191: Organic Compositions to Treat HSF1-Related Diseases
TGACTATGAACA
>HW247547.1 JP 2013514321-A/3190: Organic Compositions to Treat HSF1-Related Diseases
GACTATGAACAA
>HW247546.1 JP 2013514321-A/3189: Organic Compositions to Treat HSF1-Related Diseases
ACTATGAACAAC
>HW247545.1 JP 2013514321-A/3188: Organic Compositions to Treat HSF1-Related Diseases
CTATGAACAACC
>HW247544.1 JP 2013514321-A/3187: Organic Compositions to Treat HSF1-Related Diseases
TATGAACAACCT
>HW247543.1 JP 2013514321-A/3186: Organic Compositions to Treat HSF1-Related Diseases
ATGAACAACCTG
>HW247542.1 JP 2013514321-A/3185: Organic Compositions to Treat HSF1-Related Diseases
GTCAGCAGGGAG
>HW247541.1 JP 2013514321-A/3184: Organic Compositions to Treat HSF1-Related Diseases
TCAGCAGGGAGA
>HW247540.1 JP 2013514321-A/3183: Organic Compositions to Treat HSF1-Related Diseases
CAGCAGGGAGAT
>HW247539.1 JP 2013514321-A/3182: Organic Compositions to Treat HSF1-Related Diseases
AGCAGGGAGATG
>HW247538.1 JP 2013514321-A/3181: Organic Compositions to Treat HSF1-Related Diseases
GCAGGGAGATGG
>HW247537.1 JP 2013514321-A/3180: Organic Compositions to Treat HSF1-Related Diseases
CAGGGAGATGGT
>HW247536.1 JP 2013514321-A/3179: Organic Compositions to Treat HSF1-Related Diseases
AGGGAGATGGTG
>HW247535.1 JP 2013514321-A/3178: Organic Compositions to Treat HSF1-Related Diseases
GGGAGATGGTGG
>HW247534.1 JP 2013514321-A/3177: Organic Compositions to Treat HSF1-Related Diseases
CCAGCTCAAACA
>HW247533.1 JP 2013514321-A/3176: Organic Compositions to Treat HSF1-Related Diseases
CAGCTCAAACAG
>HW247532.1 JP 2013514321-A/3175: Organic Compositions to Treat HSF1-Related Diseases
AGCTCAAACAGC
>HW247531.1 JP 2013514321-A/3174: Organic Compositions to Treat HSF1-Related Diseases
GCTCAAACAGCA
>HW247530.1 JP 2013514321-A/3173: Organic Compositions to Treat HSF1-Related Diseases
CTCAAACAGCAC
>HW247529.1 JP 2013514321-A/3172: Organic Compositions to Treat HSF1-Related Diseases
TCAAACAGCACC
>HW247528.1 JP 2013514321-A/3171: Organic Compositions to Treat HSF1-Related Diseases
CAAACAGCACCG
>HW247527.1 JP 2013514321-A/3170: Organic Compositions to Treat HSF1-Related Diseases
AAACAGCACCGG
>HW247526.1 JP 2013514321-A/3169: Organic Compositions to Treat HSF1-Related Diseases
AACAGCACCGGC
>HW247525.1 JP 2013514321-A/3168: Organic Compositions to Treat HSF1-Related Diseases
GCTCCCGGTGTC
>HW247524.1 JP 2013514321-A/3167: Organic Compositions to Treat HSF1-Related Diseases
CTCCCGGTGTCC
>HW247523.1 JP 2013514321-A/3166: Organic Compositions to Treat HSF1-Related Diseases
TCCCGGTGTCCA
>HW247522.1 JP 2013514321-A/3165: Organic Compositions to Treat HSF1-Related Diseases
CCCGGTGTCCAC
>HW247521.1 JP 2013514321-A/3164: Organic Compositions to Treat HSF1-Related Diseases
CCGGTGTCCACG
>HW247520.1 JP 2013514321-A/3163: Organic Compositions to Treat HSF1-Related Diseases
CGGTGTCCACGG
>HW247519.1 JP 2013514321-A/3162: Organic Compositions to Treat HSF1-Related Diseases
GGTGTCCACGGA
>HW247518.1 JP 2013514321-A/3161: Organic Compositions to Treat HSF1-Related Diseases
GTGTCCACGGAG
>HW247517.1 JP 2013514321-A/3160: Organic Compositions to Treat HSF1-Related Diseases
TGTCCACGGAGC
>HW247516.1 JP 2013514321-A/3159: Organic Compositions to Treat HSF1-Related Diseases
GTCCACGGAGCC
>HW247515.1 JP 2013514321-A/3158: Organic Compositions to Treat HSF1-Related Diseases
TCCACGGAGCCG
>HW247514.1 JP 2013514321-A/3157: Organic Compositions to Treat HSF1-Related Diseases
CCACGGAGCCGG
>HW247513.1 JP 2013514321-A/3156: Organic Compositions to Treat HSF1-Related Diseases
CCAGCTGCTTCC
>HW247512.1 JP 2013514321-A/3155: Organic Compositions to Treat HSF1-Related Diseases
CAGCTGCTTCCC
>HW247511.1 JP 2013514321-A/3154: Organic Compositions to Treat HSF1-Related Diseases
AGCTGCTTCCCT
>HW247510.1 JP 2013514321-A/3153: Organic Compositions to Treat HSF1-Related Diseases
GCTGCTTCCCTG
>HW247509.1 JP 2013514321-A/3152: Organic Compositions to Treat HSF1-Related Diseases
CTGCTTCCCTGA
>HW247508.1 JP 2013514321-A/3151: Organic Compositions to Treat HSF1-Related Diseases
TGCTTCCCTGAA
>HW247507.1 JP 2013514321-A/3150: Organic Compositions to Treat HSF1-Related Diseases
GCTTCCCTGAAT
>HW247506.1 JP 2013514321-A/3149: Organic Compositions to Treat HSF1-Related Diseases
CTTCCCTGAATC
>HW247505.1 JP 2013514321-A/3148: Organic Compositions to Treat HSF1-Related Diseases
GGAGACAGGAGC
>HW247504.1 JP 2013514321-A/3147: Organic Compositions to Treat HSF1-Related Diseases
GAGACAGGAGCT
>HW247503.1 JP 2013514321-A/3146: Organic Compositions to Treat HSF1-Related Diseases
AGACAGGAGCTC
>HW247502.1 JP 2013514321-A/3145: Organic Compositions to Treat HSF1-Related Diseases
GACAGGAGCTCT
>HW247501.1 JP 2013514321-A/3144: Organic Compositions to Treat HSF1-Related Diseases
ACAGGAGCTCTT
>HW247500.1 JP 2013514321-A/3143: Organic Compositions to Treat HSF1-Related Diseases
CAGGAGCTCTTG
>HW247499.1 JP 2013514321-A/3142: Organic Compositions to Treat HSF1-Related Diseases
AGGAGCTCTTGG
>HW247498.1 JP 2013514321-A/3141: Organic Compositions to Treat HSF1-Related Diseases
GGAGCTCTTGGA
>HW247497.1 JP 2013514321-A/3140: Organic Compositions to Treat HSF1-Related Diseases
GAGCTCTTGGAT
>HW247496.1 JP 2013514321-A/3139: Organic Compositions to Treat HSF1-Related Diseases
AGCTCTTGGATA
>HW247495.1 JP 2013514321-A/3138: Organic Compositions to Treat HSF1-Related Diseases
GCTCTTGGATAC
>HW247494.1 JP 2013514321-A/3137: Organic Compositions to Treat HSF1-Related Diseases
CCAGGCTGCTGT
>HW247493.1 JP 2013514321-A/3136: Organic Compositions to Treat HSF1-Related Diseases
CAGGCTGCTGTC
>HW247492.1 JP 2013514321-A/3135: Organic Compositions to Treat HSF1-Related Diseases
AGGCTGCTGTCA
>HW247491.1 JP 2013514321-A/3134: Organic Compositions to Treat HSF1-Related Diseases
GGCTGCTGTCAA
>HW247490.1 JP 2013514321-A/3133: Organic Compositions to Treat HSF1-Related Diseases
GCTGCTGTCAAG
>HW247489.1 JP 2013514321-A/3132: Organic Compositions to Treat HSF1-Related Diseases
CTGCTGTCAAGG
>HW247488.1 JP 2013514321-A/3131: Organic Compositions to Treat HSF1-Related Diseases
TGCTGTCAAGGT
>HW247487.1 JP 2013514321-A/3130: Organic Compositions to Treat HSF1-Related Diseases
GCTGTCAAGGTC
>HW247486.1 JP 2013514321-A/3129: Organic Compositions to Treat HSF1-Related Diseases
CTGTCAAGGTCA
>HW247485.1 JP 2013514321-A/3128: Organic Compositions to Treat HSF1-Related Diseases
TGTCAAGGTCAG
>HW247484.1 JP 2013514321-A/3127: Organic Compositions to Treat HSF1-Related Diseases
GTCAAGGTCAGG
>HW247483.1 JP 2013514321-A/3126: Organic Compositions to Treat HSF1-Related Diseases
TCAAGGTCAGGC
>HW247482.1 JP 2013514321-A/3125: Organic Compositions to Treat HSF1-Related Diseases
CAAGGTCAGGCA
>HW247481.1 JP 2013514321-A/3124: Organic Compositions to Treat HSF1-Related Diseases
AAGGTCAGGCAG
>HW247480.1 JP 2013514321-A/3123: Organic Compositions to Treat HSF1-Related Diseases
AGGTCAGGCAGG
>HW247479.1 JP 2013514321-A/3122: Organic Compositions to Treat HSF1-Related Diseases
GGTCAGGCAGGC
>HW247478.1 JP 2013514321-A/3121: Organic Compositions to Treat HSF1-Related Diseases
GTCAGGCAGGCT
>HW247477.1 JP 2013514321-A/3120: Organic Compositions to Treat HSF1-Related Diseases
TCAGGCAGGCTC
>HW247476.1 JP 2013514321-A/3119: Organic Compositions to Treat HSF1-Related Diseases
CAGGCAGGCTCA
>HW247475.1 JP 2013514321-A/3118: Organic Compositions to Treat HSF1-Related Diseases
AGGCAGGCTCAT
>HW247474.1 JP 2013514321-A/3117: Organic Compositions to Treat HSF1-Related Diseases
GGCAGGCTCATG
>HW247473.1 JP 2013514321-A/3116: Organic Compositions to Treat HSF1-Related Diseases
GCAGGCTCATGT
>HW247472.1 JP 2013514321-A/3115: Organic Compositions to Treat HSF1-Related Diseases
CAGGCTCATGTC
>HW247471.1 JP 2013514321-A/3114: Organic Compositions to Treat HSF1-Related Diseases
AGGCTCATGTCG
>HW247470.1 JP 2013514321-A/3113: Organic Compositions to Treat HSF1-Related Diseases
GGCTCATGTCGG
>HW247469.1 JP 2013514321-A/3112: Organic Compositions to Treat HSF1-Related Diseases
GCTCATGTCGGG
>HW247468.1 JP 2013514321-A/3111: Organic Compositions to Treat HSF1-Related Diseases
CTCATGTCGGGC
>HW247467.1 JP 2013514321-A/3110: Organic Compositions to Treat HSF1-Related Diseases
TCATGTCGGGCA
>HW247466.1 JP 2013514321-A/3109: Organic Compositions to Treat HSF1-Related Diseases
CATGTCGGGCAC
>HW247465.1 JP 2013514321-A/3108: Organic Compositions to Treat HSF1-Related Diseases
ATGTCGGGCACG
>HW247464.1 JP 2013514321-A/3107: Organic Compositions to Treat HSF1-Related Diseases
TGTCGGGCACGG
>HW247463.1 JP 2013514321-A/3106: Organic Compositions to Treat HSF1-Related Diseases
GTCGGGCACGGT
>HW247462.1 JP 2013514321-A/3105: Organic Compositions to Treat HSF1-Related Diseases
TCGGGCACGGTC
>HW247461.1 JP 2013514321-A/3104: Organic Compositions to Treat HSF1-Related Diseases
CGGGCACGGTCA
>HW247460.1 JP 2013514321-A/3103: Organic Compositions to Treat HSF1-Related Diseases
GGGCACGGTCAC
>HW247459.1 JP 2013514321-A/3102: Organic Compositions to Treat HSF1-Related Diseases
GGCACGGTCACC
>HW247458.1 JP 2013514321-A/3101: Organic Compositions to Treat HSF1-Related Diseases
GCACGGTCACCG
>HW247457.1 JP 2013514321-A/3100: Organic Compositions to Treat HSF1-Related Diseases
CACGGTCACCGA
>HW247456.1 JP 2013514321-A/3099: Organic Compositions to Treat HSF1-Related Diseases
ACGGTCACCGAG
>HW247455.1 JP 2013514321-A/3098: Organic Compositions to Treat HSF1-Related Diseases
CGGTCACCGAGG
>HW247454.1 JP 2013514321-A/3097: Organic Compositions to Treat HSF1-Related Diseases
GGCTGAACAGGT
>HW247453.1 JP 2013514321-A/3096: Organic Compositions to Treat HSF1-Related Diseases
GCTGAACAGGTC
>HW247452.1 JP 2013514321-A/3095: Organic Compositions to Treat HSF1-Related Diseases
CTGAACAGGTCC
>HW247451.1 JP 2013514321-A/3094: Organic Compositions to Treat HSF1-Related Diseases
TGAACAGGTCCA
>HW247450.1 JP 2013514321-A/3093: Organic Compositions to Treat HSF1-Related Diseases
GAACAGGTCCAG
>HW247449.1 JP 2013514321-A/3092: Organic Compositions to Treat HSF1-Related Diseases
AACAGGTCCAGC
>HW247448.1 JP 2013514321-A/3091: Organic Compositions to Treat HSF1-Related Diseases
ACAGGTCCAGCA
>HW247447.1 JP 2013514321-A/3090: Organic Compositions to Treat HSF1-Related Diseases
CAGGTCCAGCAG
>HW247446.1 JP 2013514321-A/3089: Organic Compositions to Treat HSF1-Related Diseases
AGGTCCAGCAGG
>HW247445.1 JP 2013514321-A/3088: Organic Compositions to Treat HSF1-Related Diseases
GGTCCAGCAGGG
>HW247444.1 JP 2013514321-A/3087: Organic Compositions to Treat HSF1-Related Diseases
TGGTGTCCACGC
>HW247443.1 JP 2013514321-A/3086: Organic Compositions to Treat HSF1-Related Diseases
GGTGTCCACGCT
>HW247442.1 JP 2013514321-A/3085: Organic Compositions to Treat HSF1-Related Diseases
GTGTCCACGCTG
>HW247441.1 JP 2013514321-A/3084: Organic Compositions to Treat HSF1-Related Diseases
TGTCCACGCTGA
>HW247440.1 JP 2013514321-A/3083: Organic Compositions to Treat HSF1-Related Diseases
GTCCACGCTGAA
>HW247439.1 JP 2013514321-A/3082: Organic Compositions to Treat HSF1-Related Diseases
TCCACGCTGAAG
>HW247438.1 JP 2013514321-A/3081: Organic Compositions to Treat HSF1-Related Diseases
CCACGCTGAAGC
>HW247437.1 JP 2013514321-A/3080: Organic Compositions to Treat HSF1-Related Diseases
CACGCTGAAGCC
>HW247436.1 JP 2013514321-A/3079: Organic Compositions to Treat HSF1-Related Diseases
ACGCTGAAGCCG
>HW247435.1 JP 2013514321-A/3078: Organic Compositions to Treat HSF1-Related Diseases
CGCTGAAGCCGT
>HW247434.1 JP 2013514321-A/3077: Organic Compositions to Treat HSF1-Related Diseases
GCTGAAGCCGTG
>HW247433.1 JP 2013514321-A/3076: Organic Compositions to Treat HSF1-Related Diseases
CTGAAGCCGTGG
>HW247432.1 JP 2013514321-A/3075: Organic Compositions to Treat HSF1-Related Diseases
TGAAGCCGTGGC
>HW247431.1 JP 2013514321-A/3074: Organic Compositions to Treat HSF1-Related Diseases
GAAGCCGTGGCT
>HW247430.1 JP 2013514321-A/3073: Organic Compositions to Treat HSF1-Related Diseases
AAGCCGTGGCTG
>HW247429.1 JP 2013514321-A/3072: Organic Compositions to Treat HSF1-Related Diseases
AGCCGTGGCTGC
>HW247428.1 JP 2013514321-A/3071: Organic Compositions to Treat HSF1-Related Diseases
GCCGTGGCTGCT
>HW247427.1 JP 2013514321-A/3070: Organic Compositions to Treat HSF1-Related Diseases
CCGTGGCTGCTC
>HW247426.1 JP 2013514321-A/3069: Organic Compositions to Treat HSF1-Related Diseases
CGTGGCTGCTCA
>HW247425.1 JP 2013514321-A/3068: Organic Compositions to Treat HSF1-Related Diseases
GTGGCTGCTCAG
>HW247424.1 JP 2013514321-A/3067: Organic Compositions to Treat HSF1-Related Diseases
TGGCTGCTCAGC
>HW247423.1 JP 2013514321-A/3066: Organic Compositions to Treat HSF1-Related Diseases
GGCTGCTCAGCA
>HW247422.1 JP 2013514321-A/3065: Organic Compositions to Treat HSF1-Related Diseases
GCTGCTCAGCAT
>HW247421.1 JP 2013514321-A/3064: Organic Compositions to Treat HSF1-Related Diseases
CTGCTCAGCATG
>HW247420.1 JP 2013514321-A/3063: Organic Compositions to Treat HSF1-Related Diseases
TGCTCAGCATGG
>HW247419.1 JP 2013514321-A/3062: Organic Compositions to Treat HSF1-Related Diseases
GCTCAGCATGGT
>HW247418.1 JP 2013514321-A/3061: Organic Compositions to Treat HSF1-Related Diseases
CTCAGCATGGTC
>HW247417.1 JP 2013514321-A/3060: Organic Compositions to Treat HSF1-Related Diseases
TCAGCATGGTCT
>HW247416.1 JP 2013514321-A/3059: Organic Compositions to Treat HSF1-Related Diseases
CAGCATGGTCTG
>HW247415.1 JP 2013514321-A/3058: Organic Compositions to Treat HSF1-Related Diseases
AGCATGGTCTGC
>HW247414.1 JP 2013514321-A/3057: Organic Compositions to Treat HSF1-Related Diseases
GCATGGTCTGCA
>HW247413.1 JP 2013514321-A/3056: Organic Compositions to Treat HSF1-Related Diseases
CATGGTCTGCAG
>HW247412.1 JP 2013514321-A/3055: Organic Compositions to Treat HSF1-Related Diseases
ATGGTCTGCAGG
>HW247411.1 JP 2013514321-A/3054: Organic Compositions to Treat HSF1-Related Diseases
TGGTCTGCAGGT
>HW247410.1 JP 2013514321-A/3053: Organic Compositions to Treat HSF1-Related Diseases
CCAGGTTGGAGT
>HW247409.1 JP 2013514321-A/3052: Organic Compositions to Treat HSF1-Related Diseases
CAGGTTGGAGTC
>HW247408.1 JP 2013514321-A/3051: Organic Compositions to Treat HSF1-Related Diseases
AGGTTGGAGTCC
>HW247407.1 JP 2013514321-A/3050: Organic Compositions to Treat HSF1-Related Diseases
GGTTGGAGTCCA
>HW247406.1 JP 2013514321-A/3049: Organic Compositions to Treat HSF1-Related Diseases
GTTGGAGTCCAT
>HW247405.1 JP 2013514321-A/3048: Organic Compositions to Treat HSF1-Related Diseases
TTGGAGTCCATA
>HW247404.1 JP 2013514321-A/3047: Organic Compositions to Treat HSF1-Related Diseases
TGGAGTCCATAG
>HW247403.1 JP 2013514321-A/3046: Organic Compositions to Treat HSF1-Related Diseases
GGAGTCCATAGC
>HW247402.1 JP 2013514321-A/3045: Organic Compositions to Treat HSF1-Related Diseases
GAGTCCATAGCA
>HW247401.1 JP 2013514321-A/3044: Organic Compositions to Treat HSF1-Related Diseases
AGTCCATAGCAT
>HW247400.1 JP 2013514321-A/3043: Organic Compositions to Treat HSF1-Related Diseases
GTCCATAGCATC
>HW247399.1 JP 2013514321-A/3042: Organic Compositions to Treat HSF1-Related Diseases
TCCATAGCATCC
>HW247398.1 JP 2013514321-A/3041: Organic Compositions to Treat HSF1-Related Diseases
CCATAGCATCCA
>HW247397.1 JP 2013514321-A/3040: Organic Compositions to Treat HSF1-Related Diseases
CATAGCATCCAA
>HW247396.1 JP 2013514321-A/3039: Organic Compositions to Treat HSF1-Related Diseases
ATAGCATCCAAG
>HW247395.1 JP 2013514321-A/3038: Organic Compositions to Treat HSF1-Related Diseases
TAGCATCCAAGT
>HW247394.1 JP 2013514321-A/3037: Organic Compositions to Treat HSF1-Related Diseases
GGCTCCTCCTTG
>HW247393.1 JP 2013514321-A/3036: Organic Compositions to Treat HSF1-Related Diseases
GCTCCTCCTTGA
>HW247392.1 JP 2013514321-A/3035: Organic Compositions to Treat HSF1-Related Diseases
CTCCTCCTTGAC
>HW247391.1 JP 2013514321-A/3034: Organic Compositions to Treat HSF1-Related Diseases
TCCTCCTTGACA
>HW247390.1 JP 2013514321-A/3033: Organic Compositions to Treat HSF1-Related Diseases
CCTCCTTGACAC
>HW247389.1 JP 2013514321-A/3032: Organic Compositions to Treat HSF1-Related Diseases
CTCCTTGACACG
>HW247388.1 JP 2013514321-A/3031: Organic Compositions to Treat HSF1-Related Diseases
TCCTTGACACGC
>HW247387.1 JP 2013514321-A/3030: Organic Compositions to Treat HSF1-Related Diseases
CCTTGACACGCA
>HW247386.1 JP 2013514321-A/3029: Organic Compositions to Treat HSF1-Related Diseases
CTTGACACGCAC
>HW247385.1 JP 2013514321-A/3028: Organic Compositions to Treat HSF1-Related Diseases
TTGACACGCACC
>HW247384.1 JP 2013514321-A/3027: Organic Compositions to Treat HSF1-Related Diseases
TGACACGCACCA
>HW247383.1 JP 2013514321-A/3026: Organic Compositions to Treat HSF1-Related Diseases
GACACGCACCAG
>HW247382.1 JP 2013514321-A/3025: Organic Compositions to Treat HSF1-Related Diseases
ACACGCACCAGG
>HW247381.1 JP 2013514321-A/3024: Organic Compositions to Treat HSF1-Related Diseases
GGCCTCTCGTCT
>HW247380.1 JP 2013514321-A/3023: Organic Compositions to Treat HSF1-Related Diseases
GCCTCTCGTCTA
>HW247379.1 JP 2013514321-A/3022: Organic Compositions to Treat HSF1-Related Diseases
CCTCTCGTCTAT
>HW235262.1 JP 2013100292-A/1075: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNCARGGN
>HW235261.1 JP 2013100292-A/1074: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNCARGGNGGN
>HW235260.1 JP 2013100292-A/1073: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
CARGGNGGNGGN
>HW235259.1 JP 2013100292-A/1072: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNCAR
>HW235159.1 JP 2013100292-A/972: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNAGYGGN
>HW235158.1 JP 2013100292-A/971: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNAGYGGNGGN
>HW235157.1 JP 2013100292-A/970: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
AGYGGNGGNGGN
>HW235156.1 JP 2013100292-A/969: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNAGY
>HW247378.1 JP 2013514321-A/3021: Organic Compositions to Treat HSF1-Related Diseases
CTCTCGTCTATG
>HW235056.1 JP 2013100292-A/869: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGCNGGN
>HW235055.1 JP 2013100292-A/868: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGCNGGNGGN
>HW235054.1 JP 2013100292-A/867: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GCNGGNGGNGGN
>HW235053.1 JP 2013100292-A/866: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNGCN
>HW234953.1 JP 2013100292-A/766: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNACNGGN
>HW234952.1 JP 2013100292-A/765: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNACNGGNGGN
>HW234951.1 JP 2013100292-A/764: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
ACNGGNGGNGGN
>HW234950.1 JP 2013100292-A/763: CONJUGATES OF BIOLOGICALLY ACTIVE PROTEINS HAVING A MODIFIED IN VIVO HALF-LIFE
GGNGGNGGNACN
>HW247377.1 JP 2013514321-A/3020: Organic Compositions to Treat HSF1-Related Diseases
TCTCGTCTATGC
>HW247376.1 JP 2013514321-A/3019: Organic Compositions to Treat HSF1-Related Diseases
CTCGTCTATGCT
>HW247375.1 JP 2013514321-A/3018: Organic Compositions to Treat HSF1-Related Diseases
TCGTCTATGCTC
>HW247374.1 JP 2013514321-A/3017: Organic Compositions to Treat HSF1-Related Diseases
CGTCTATGCTCC
>HW247373.1 JP 2013514321-A/3016: Organic Compositions to Treat HSF1-Related Diseases
GTCTATGCTCCC
>HW247372.1 JP 2013514321-A/3015: Organic Compositions to Treat HSF1-Related Diseases
TCTATGCTCCCG
>HW247371.1 JP 2013514321-A/3014: Organic Compositions to Treat HSF1-Related Diseases
CTATGCTCCCGC
>HW247370.1 JP 2013514321-A/3013: Organic Compositions to Treat HSF1-Related Diseases
GGCTGGCAGGAG
>HW247369.1 JP 2013514321-A/3012: Organic Compositions to Treat HSF1-Related Diseases
GCTGGCAGGAGC
>HW247368.1 JP 2013514321-A/3011: Organic Compositions to Treat HSF1-Related Diseases
CTGGCAGGAGCC
>HW247367.1 JP 2013514321-A/3010: Organic Compositions to Treat HSF1-Related Diseases
TGGCAGGAGCCA
>HW247366.1 JP 2013514321-A/3009: Organic Compositions to Treat HSF1-Related Diseases
GGCAGGAGCCAG
>HW247365.1 JP 2013514321-A/3008: Organic Compositions to Treat HSF1-Related Diseases
GCAGGAGCCAGC
>HW247364.1 JP 2013514321-A/3007: Organic Compositions to Treat HSF1-Related Diseases
CAGGAGCCAGCT
>HW247363.1 JP 2013514321-A/3006: Organic Compositions to Treat HSF1-Related Diseases
AGGAGCCAGCTC
>HW247362.1 JP 2013514321-A/3005: Organic Compositions to Treat HSF1-Related Diseases
GGAGCCAGCTCG
>HW247361.1 JP 2013514321-A/3004: Organic Compositions to Treat HSF1-Related Diseases
GAGCCAGCTCGG
>HW247360.1 JP 2013514321-A/3003: Organic Compositions to Treat HSF1-Related Diseases
AGCCAGCTCGGT
>HW247359.1 JP 2013514321-A/3002: Organic Compositions to Treat HSF1-Related Diseases
GCCAGCTCGGTG
>HW247358.1 JP 2013514321-A/3001: Organic Compositions to Treat HSF1-Related Diseases
CCAGCTCGGTGA
>HW247357.1 JP 2013514321-A/3000: Organic Compositions to Treat HSF1-Related Diseases
CAGCTCGGTGAT
>HW247356.1 JP 2013514321-A/2999: Organic Compositions to Treat HSF1-Related Diseases
AGCTCGGTGATG
>HW247355.1 JP 2013514321-A/2998: Organic Compositions to Treat HSF1-Related Diseases
GCTCGGTGATGT
>HW247354.1 JP 2013514321-A/2997: Organic Compositions to Treat HSF1-Related Diseases
CTCGGTGATGTC
>HW247353.1 JP 2013514321-A/2996: Organic Compositions to Treat HSF1-Related Diseases
TCGGTGATGTCG
>HW247352.1 JP 2013514321-A/2995: Organic Compositions to Treat HSF1-Related Diseases
CGGTGATGTCGG
>HW247351.1 JP 2013514321-A/2994: Organic Compositions to Treat HSF1-Related Diseases
GGTGATGTCGGA
>HW247350.1 JP 2013514321-A/2993: Organic Compositions to Treat HSF1-Related Diseases
AGCCGTGGACGT
>HW247349.1 JP 2013514321-A/2992: Organic Compositions to Treat HSF1-Related Diseases
GCCGTGGACGTG
>HW247348.1 JP 2013514321-A/2991: Organic Compositions to Treat HSF1-Related Diseases
CCGTGGACGTGC
>HW247347.1 JP 2013514321-A/2990: Organic Compositions to Treat HSF1-Related Diseases
CGTGGACGTGCT
>HW247346.1 JP 2013514321-A/2989: Organic Compositions to Treat HSF1-Related Diseases
GTGGACGTGCTC
>HW247345.1 JP 2013514321-A/2988: Organic Compositions to Treat HSF1-Related Diseases
TGGACGTGCTCC
>HW247344.1 JP 2013514321-A/2987: Organic Compositions to Treat HSF1-Related Diseases
GGACGTGCTCCA
>HW247343.1 JP 2013514321-A/2986: Organic Compositions to Treat HSF1-Related Diseases
GACGTGCTCCAG
>HW247342.1 JP 2013514321-A/2985: Organic Compositions to Treat HSF1-Related Diseases
ACGTGCTCCAGG
>HW247341.1 JP 2013514321-A/2984: Organic Compositions to Treat HSF1-Related Diseases
CGTGCTCCAGGG
>HW247340.1 JP 2013514321-A/2983: Organic Compositions to Treat HSF1-Related Diseases
GTGCTCCAGGGA
>HW247339.1 JP 2013514321-A/2982: Organic Compositions to Treat HSF1-Related Diseases
TGCTCCAGGGAG
>HW247338.1 JP 2013514321-A/2981: Organic Compositions to Treat HSF1-Related Diseases
GCTCCAGGGAGA
>HW247337.1 JP 2013514321-A/2980: Organic Compositions to Treat HSF1-Related Diseases
CTCCAGGGAGAA
>HW247336.1 JP 2013514321-A/2979: Organic Compositions to Treat HSF1-Related Diseases
TCCAGGGAGAAC
>HW247335.1 JP 2013514321-A/2978: Organic Compositions to Treat HSF1-Related Diseases
CCAGGGAGAACT
>HW247334.1 JP 2013514321-A/2977: Organic Compositions to Treat HSF1-Related Diseases
CAGGGAGAACTG
>HW247333.1 JP 2013514321-A/2976: Organic Compositions to Treat HSF1-Related Diseases
AGGGAGAACTGC
>HW247332.1 JP 2013514321-A/2975: Organic Compositions to Treat HSF1-Related Diseases
GGGAGAACTGCC
>HW247331.1 JP 2013514321-A/2974: Organic Compositions to Treat HSF1-Related Diseases
GGAGAACTGCCG
>HW247330.1 JP 2013514321-A/2973: Organic Compositions to Treat HSF1-Related Diseases
GAGAACTGCCGG
>HW247329.1 JP 2013514321-A/2972: Organic Compositions to Treat HSF1-Related Diseases
TACTTGGGCATG
>HW247328.1 JP 2013514321-A/2971: Organic Compositions to Treat HSF1-Related Diseases
ACTTGGGCATGG
>HW247327.1 JP 2013514321-A/2970: Organic Compositions to Treat HSF1-Related Diseases
CTTGGGCATGGA
>HW247326.1 JP 2013514321-A/2969: Organic Compositions to Treat HSF1-Related Diseases
TTGGGCATGGAA
>HW247325.1 JP 2013514321-A/2968: Organic Compositions to Treat HSF1-Related Diseases
TGGGCATGGAAT
>HW247324.1 JP 2013514321-A/2967: Organic Compositions to Treat HSF1-Related Diseases
GGGCATGGAATG
>HW247323.1 JP 2013514321-A/2966: Organic Compositions to Treat HSF1-Related Diseases
GGCATGGAATGT
>HW247322.1 JP 2013514321-A/2965: Organic Compositions to Treat HSF1-Related Diseases
GCATGGAATGTG
>HW247321.1 JP 2013514321-A/2964: Organic Compositions to Treat HSF1-Related Diseases
CATGGAATGTGC
>HW247320.1 JP 2013514321-A/2963: Organic Compositions to Treat HSF1-Related Diseases
ATGGAATGTGCT
>HW247319.1 JP 2013514321-A/2962: Organic Compositions to Treat HSF1-Related Diseases
TGGAATGTGCTG
>HW247318.1 JP 2013514321-A/2961: Organic Compositions to Treat HSF1-Related Diseases
GGAATGTGCTGA
>HW247317.1 JP 2013514321-A/2960: Organic Compositions to Treat HSF1-Related Diseases
GAATGTGCTGAG
>HW247316.1 JP 2013514321-A/2959: Organic Compositions to Treat HSF1-Related Diseases
AATGTGCTGAGC
>HW247315.1 JP 2013514321-A/2958: Organic Compositions to Treat HSF1-Related Diseases
ATGTGCTGAGCC
>HW247314.1 JP 2013514321-A/2957: Organic Compositions to Treat HSF1-Related Diseases
TGTGCTGAGCCA
>HW247313.1 JP 2013514321-A/2956: Organic Compositions to Treat HSF1-Related Diseases
GTGCTGAGCCAC
>HW247312.1 JP 2013514321-A/2955: Organic Compositions to Treat HSF1-Related Diseases
TGCTGAGCCACT
>HW247311.1 JP 2013514321-A/2954: Organic Compositions to Treat HSF1-Related Diseases
GCTGAGCCACTG
>HW247310.1 JP 2013514321-A/2953: Organic Compositions to Treat HSF1-Related Diseases
CTGAGCCACTGT
>HW247309.1 JP 2013514321-A/2952: Organic Compositions to Treat HSF1-Related Diseases
TGAGCCACTGTC
>HW247308.1 JP 2013514321-A/2951: Organic Compositions to Treat HSF1-Related Diseases
GAGCCACTGTCG
>HW247307.1 JP 2013514321-A/2950: Organic Compositions to Treat HSF1-Related Diseases
AGCCACTGTCGT
>HW247306.1 JP 2013514321-A/2949: Organic Compositions to Treat HSF1-Related Diseases
GCCACTGTCGTT
>HW247305.1 JP 2013514321-A/2948: Organic Compositions to Treat HSF1-Related Diseases
CCACTGTCGTTC
>HW247304.1 JP 2013514321-A/2947: Organic Compositions to Treat HSF1-Related Diseases
CACTGTCGTTCA
>HW247303.1 JP 2013514321-A/2946: Organic Compositions to Treat HSF1-Related Diseases
ACTGTCGTTCAG
>HW247302.1 JP 2013514321-A/2945: Organic Compositions to Treat HSF1-Related Diseases
CTGTCGTTCAGC
>HW247301.1 JP 2013514321-A/2944: Organic Compositions to Treat HSF1-Related Diseases
TGTCGTTCAGCA
>HW247300.1 JP 2013514321-A/2943: Organic Compositions to Treat HSF1-Related Diseases
GTCGTTCAGCAT
>HW247299.1 JP 2013514321-A/2942: Organic Compositions to Treat HSF1-Related Diseases
TCGTTCAGCATC
>HW247298.1 JP 2013514321-A/2941: Organic Compositions to Treat HSF1-Related Diseases
CGTTCAGCATCA
>HW247297.1 JP 2013514321-A/2940: Organic Compositions to Treat HSF1-Related Diseases
GTTCAGCATCAG
>HW247296.1 JP 2013514321-A/2939: Organic Compositions to Treat HSF1-Related Diseases
TTCAGCATCAGG
>HW247295.1 JP 2013514321-A/2938: Organic Compositions to Treat HSF1-Related Diseases
CCAGGATCCGGT
>HW247294.1 JP 2013514321-A/2937: Organic Compositions to Treat HSF1-Related Diseases
CAGGATCCGGTT
>HW247293.1 JP 2013514321-A/2936: Organic Compositions to Treat HSF1-Related Diseases
AGGATCCGGTTT
>HW247292.1 JP 2013514321-A/2935: Organic Compositions to Treat HSF1-Related Diseases
GGATCCGGTTTG
>HW247291.1 JP 2013514321-A/2934: Organic Compositions to Treat HSF1-Related Diseases
GATCCGGTTTGA
>HW247290.1 JP 2013514321-A/2933: Organic Compositions to Treat HSF1-Related Diseases
ATCCGGTTTGAC
>HW247289.1 JP 2013514321-A/2932: Organic Compositions to Treat HSF1-Related Diseases
TCCGGTTTGACT
>HW247288.1 JP 2013514321-A/2931: Organic Compositions to Treat HSF1-Related Diseases
CCGGTTTGACTG
>HW247287.1 JP 2013514321-A/2930: Organic Compositions to Treat HSF1-Related Diseases
CGGTTTGACTGC
>HW247286.1 JP 2013514321-A/2929: Organic Compositions to Treat HSF1-Related Diseases
GGTTTGACTGCA
>HW247285.1 JP 2013514321-A/2928: Organic Compositions to Treat HSF1-Related Diseases
GTTTGACTGCAC
>HW247284.1 JP 2013514321-A/2927: Organic Compositions to Treat HSF1-Related Diseases
TTTGACTGCACC
>HW247283.1 JP 2013514321-A/2926: Organic Compositions to Treat HSF1-Related Diseases
TTGACTGCACCA
>HW247282.1 JP 2013514321-A/2925: Organic Compositions to Treat HSF1-Related Diseases
TGACTGCACCAG
>HW247281.1 JP 2013514321-A/2924: Organic Compositions to Treat HSF1-Related Diseases
GACTGCACCAGT
>HW247280.1 JP 2013514321-A/2923: Organic Compositions to Treat HSF1-Related Diseases
ACTGCACCAGTG
>HW247279.1 JP 2013514321-A/2922: Organic Compositions to Treat HSF1-Related Diseases
CTGCACCAGTGA
>HW247278.1 JP 2013514321-A/2921: Organic Compositions to Treat HSF1-Related Diseases
TGCACCAGTGAG
>HW247277.1 JP 2013514321-A/2920: Organic Compositions to Treat HSF1-Related Diseases
GCACCAGTGAGA
>HW247276.1 JP 2013514321-A/2919: Organic Compositions to Treat HSF1-Related Diseases
CACCAGTGAGAT
>HW247275.1 JP 2013514321-A/2918: Organic Compositions to Treat HSF1-Related Diseases
ACCAGTGAGATC
>HW247274.1 JP 2013514321-A/2917: Organic Compositions to Treat HSF1-Related Diseases
CCAGTGAGATCA
>HW247273.1 JP 2013514321-A/2916: Organic Compositions to Treat HSF1-Related Diseases
CAGTGAGATCAG
>HW247272.1 JP 2013514321-A/2915: Organic Compositions to Treat HSF1-Related Diseases
AGTGAGATCAGG
>HW247271.1 JP 2013514321-A/2914: Organic Compositions to Treat HSF1-Related Diseases
GTGAGATCAGGA
>HW247270.1 JP 2013514321-A/2913: Organic Compositions to Treat HSF1-Related Diseases
TGAGATCAGGAA
>HW247269.1 JP 2013514321-A/2912: Organic Compositions to Treat HSF1-Related Diseases
GAGATCAGGAAC
>HW247268.1 JP 2013514321-A/2911: Organic Compositions to Treat HSF1-Related Diseases
AGATCAGGAACT
>HW247267.1 JP 2013514321-A/2910: Organic Compositions to Treat HSF1-Related Diseases
GATCAGGAACTG
>HW247266.1 JP 2013514321-A/2909: Organic Compositions to Treat HSF1-Related Diseases
ATCAGGAACTGA
>HW247265.1 JP 2013514321-A/2908: Organic Compositions to Treat HSF1-Related Diseases
TCAGGAACTGAA
>HW247264.1 JP 2013514321-A/2907: Organic Compositions to Treat HSF1-Related Diseases
CAGGAACTGAAT
>HW247263.1 JP 2013514321-A/2906: Organic Compositions to Treat HSF1-Related Diseases
AGGAACTGAATG
>HW247262.1 JP 2013514321-A/2905: Organic Compositions to Treat HSF1-Related Diseases
GGAACTGAATGA
>HW247261.1 JP 2013514321-A/2904: Organic Compositions to Treat HSF1-Related Diseases
GAACTGAATGAG
>HW247260.1 JP 2013514321-A/2903: Organic Compositions to Treat HSF1-Related Diseases
AACTGAATGAGC
>HW247259.1 JP 2013514321-A/2902: Organic Compositions to Treat HSF1-Related Diseases
ACTGAATGAGCT
>HW247258.1 JP 2013514321-A/2901: Organic Compositions to Treat HSF1-Related Diseases
CTGAATGAGCTT
>HW247257.1 JP 2013514321-A/2900: Organic Compositions to Treat HSF1-Related Diseases
ACTTTCTGTTGC
>HW247256.1 JP 2013514321-A/2899: Organic Compositions to Treat HSF1-Related Diseases
CTTTCTGTTGCT
>HW247255.1 JP 2013514321-A/2898: Organic Compositions to Treat HSF1-Related Diseases
TTTCTGTTGCTG
>HW247254.1 JP 2013514321-A/2897: Organic Compositions to Treat HSF1-Related Diseases
TTCTGTTGCTGG
>HW247253.1 JP 2013514321-A/2896: Organic Compositions to Treat HSF1-Related Diseases
TCTGTTGCTGGG
>HW247252.1 JP 2013514321-A/2895: Organic Compositions to Treat HSF1-Related Diseases
CTGTTGCTGGGC
>HW247251.1 JP 2013514321-A/2894: Organic Compositions to Treat HSF1-Related Diseases
TGTTGCTGGGCA
>HW247250.1 JP 2013514321-A/2893: Organic Compositions to Treat HSF1-Related Diseases
GTTGCTGGGCAT
>HW247249.1 JP 2013514321-A/2892: Organic Compositions to Treat HSF1-Related Diseases
TTGCTGGGCATG
>HW247248.1 JP 2013514321-A/2891: Organic Compositions to Treat HSF1-Related Diseases
TGCTGGGCATGC
>HW247247.1 JP 2013514321-A/2890: Organic Compositions to Treat HSF1-Related Diseases
GCTGGGCATGCT
>HW247246.1 JP 2013514321-A/2889: Organic Compositions to Treat HSF1-Related Diseases
CTGGGCATGCTT
>HW247245.1 JP 2013514321-A/2888: Organic Compositions to Treat HSF1-Related Diseases
TGGGCATGCTTC
>HW247244.1 JP 2013514321-A/2887: Organic Compositions to Treat HSF1-Related Diseases
GGGCATGCTTCT
>HW247243.1 JP 2013514321-A/2886: Organic Compositions to Treat HSF1-Related Diseases
GGCATGCTTCTG
>HW247242.1 JP 2013514321-A/2885: Organic Compositions to Treat HSF1-Related Diseases
GCATGCTTCTGC
>HW247241.1 JP 2013514321-A/2884: Organic Compositions to Treat HSF1-Related Diseases
CATGCTTCTGCC
>HW247240.1 JP 2013514321-A/2883: Organic Compositions to Treat HSF1-Related Diseases
ATGCTTCTGCCG
>HW247239.1 JP 2013514321-A/2882: Organic Compositions to Treat HSF1-Related Diseases
TGCTTCTGCCGA
>HW247238.1 JP 2013514321-A/2881: Organic Compositions to Treat HSF1-Related Diseases
GCTTCTGCCGAA
>HW247237.1 JP 2013514321-A/2880: Organic Compositions to Treat HSF1-Related Diseases
CTTCTGCCGAAG
>HW247236.1 JP 2013514321-A/2879: Organic Compositions to Treat HSF1-Related Diseases
TTCTGCCGAAGG
>HW247235.1 JP 2013514321-A/2878: Organic Compositions to Treat HSF1-Related Diseases
TCTGCCGAAGGC
>HW247234.1 JP 2013514321-A/2877: Organic Compositions to Treat HSF1-Related Diseases
CTGCCGAAGGCT
>HW247233.1 JP 2013514321-A/2876: Organic Compositions to Treat HSF1-Related Diseases
TGCCGAAGGCTG
>HW247232.1 JP 2013514321-A/2875: Organic Compositions to Treat HSF1-Related Diseases
GCCGAAGGCTGG
>HW247231.1 JP 2013514321-A/2874: Organic Compositions to Treat HSF1-Related Diseases
CCGAAGGCTGGC
>HW247230.1 JP 2013514321-A/2873: Organic Compositions to Treat HSF1-Related Diseases
CGAAGGCTGGCC
>HW247229.1 JP 2013514321-A/2872: Organic Compositions to Treat HSF1-Related Diseases
GAAGGCTGGCCA
>HW247228.1 JP 2013514321-A/2871: Organic Compositions to Treat HSF1-Related Diseases
AAGGCTGGCCAC
>HW247227.1 JP 2013514321-A/2870: Organic Compositions to Treat HSF1-Related Diseases
AGGCTGGCCACC
>HW247226.1 JP 2013514321-A/2869: Organic Compositions to Treat HSF1-Related Diseases
GGCTGGCCACCT
>HW247225.1 JP 2013514321-A/2868: Organic Compositions to Treat HSF1-Related Diseases
GCTGGCCACCTC
>HW247224.1 JP 2013514321-A/2867: Organic Compositions to Treat HSF1-Related Diseases
CTGGCCACCTCC
>HW247223.1 JP 2013514321-A/2866: Organic Compositions to Treat HSF1-Related Diseases
TGGCCACCTCCC
>HW247222.1 JP 2013514321-A/2865: Organic Compositions to Treat HSF1-Related Diseases
GGCCACCTCCCG
>HW247221.1 JP 2013514321-A/2864: Organic Compositions to Treat HSF1-Related Diseases
GCCACCTCCCGC
>HW247220.1 JP 2013514321-A/2863: Organic Compositions to Treat HSF1-Related Diseases
CCACCTCCCGCC
>HW247219.1 JP 2013514321-A/2862: Organic Compositions to Treat HSF1-Related Diseases
CACCTCCCGCCA
>HW247218.1 JP 2013514321-A/2861: Organic Compositions to Treat HSF1-Related Diseases
ACCTCCCGCCAC
>HW247217.1 JP 2013514321-A/2860: Organic Compositions to Treat HSF1-Related Diseases
CCTCCCGCCACA
>HW247216.1 JP 2013514321-A/2859: Organic Compositions to Treat HSF1-Related Diseases
CTCCCGCCACAG
>HW247215.1 JP 2013514321-A/2858: Organic Compositions to Treat HSF1-Related Diseases
TCCCGCCACAGA
>HW247214.1 JP 2013514321-A/2857: Organic Compositions to Treat HSF1-Related Diseases
CCCGCCACAGAG
>HW247213.1 JP 2013514321-A/2856: Organic Compositions to Treat HSF1-Related Diseases
CCGCCACAGAGC
>HW247212.1 JP 2013514321-A/2855: Organic Compositions to Treat HSF1-Related Diseases
CGCCACAGAGCC
>HW247211.1 JP 2013514321-A/2854: Organic Compositions to Treat HSF1-Related Diseases
GCCACAGAGCCT
>HW247210.1 JP 2013514321-A/2853: Organic Compositions to Treat HSF1-Related Diseases
CCACAGAGCCTC
>HW247209.1 JP 2013514321-A/2852: Organic Compositions to Treat HSF1-Related Diseases
CACAGAGCCTCA
>HW247208.1 JP 2013514321-A/2851: Organic Compositions to Treat HSF1-Related Diseases
ACAGAGCCTCAT
>HW247207.1 JP 2013514321-A/2850: Organic Compositions to Treat HSF1-Related Diseases
CAGAGCCTCATT
>HW247206.1 JP 2013514321-A/2849: Organic Compositions to Treat HSF1-Related Diseases
AGAGCCTCATTC
>HW247205.1 JP 2013514321-A/2848: Organic Compositions to Treat HSF1-Related Diseases
GAGCCTCATTCT
>HW247204.1 JP 2013514321-A/2847: Organic Compositions to Treat HSF1-Related Diseases
CCTTCATCAGCT
>HW247203.1 JP 2013514321-A/2846: Organic Compositions to Treat HSF1-Related Diseases
CTTCATCAGCTG
>HW247202.1 JP 2013514321-A/2845: Organic Compositions to Treat HSF1-Related Diseases
TTCATCAGCTGC
>HW247201.1 JP 2013514321-A/2844: Organic Compositions to Treat HSF1-Related Diseases
TCATCAGCTGCA
>HW247200.1 JP 2013514321-A/2843: Organic Compositions to Treat HSF1-Related Diseases
CATCAGCTGCAC
>HW247199.1 JP 2013514321-A/2842: Organic Compositions to Treat HSF1-Related Diseases
ATCAGCTGCACG
>HW247198.1 JP 2013514321-A/2841: Organic Compositions to Treat HSF1-Related Diseases
TCAGCTGCACGT
>HW247197.1 JP 2013514321-A/2840: Organic Compositions to Treat HSF1-Related Diseases
CAGCTGCACGTC
>HW247196.1 JP 2013514321-A/2839: Organic Compositions to Treat HSF1-Related Diseases
AGCTGCACGTCC
>HW247195.1 JP 2013514321-A/2838: Organic Compositions to Treat HSF1-Related Diseases
GCTGCACGTCCG
>HW247194.1 JP 2013514321-A/2837: Organic Compositions to Treat HSF1-Related Diseases
CTGCACGTCCGT
>HW247193.1 JP 2013514321-A/2836: Organic Compositions to Treat HSF1-Related Diseases
TGCACGTCCGTC
>HW247192.1 JP 2013514321-A/2835: Organic Compositions to Treat HSF1-Related Diseases
GCACGTCCGTCA
>HW247191.1 JP 2013514321-A/2834: Organic Compositions to Treat HSF1-Related Diseases
CACGTCCGTCAG
>HW247190.1 JP 2013514321-A/2833: Organic Compositions to Treat HSF1-Related Diseases
ACGTCCGTCAGC
>HW247189.1 JP 2013514321-A/2832: Organic Compositions to Treat HSF1-Related Diseases
CGTCCGTCAGCA
>HW247188.1 JP 2013514321-A/2831: Organic Compositions to Treat HSF1-Related Diseases
GTCCGTCAGCAG
>HW247187.1 JP 2013514321-A/2830: Organic Compositions to Treat HSF1-Related Diseases
TCCGTCAGCAGC
>HW247186.1 JP 2013514321-A/2829: Organic Compositions to Treat HSF1-Related Diseases
CCGTCAGCAGCT
>HW247185.1 JP 2013514321-A/2828: Organic Compositions to Treat HSF1-Related Diseases
CGTCAGCAGCTT
>HW247184.1 JP 2013514321-A/2827: Organic Compositions to Treat HSF1-Related Diseases
GTCAGCAGCTTG
>HW247183.1 JP 2013514321-A/2826: Organic Compositions to Treat HSF1-Related Diseases
TCAGCAGCTTGG
>HW247182.1 JP 2013514321-A/2825: Organic Compositions to Treat HSF1-Related Diseases
CAGCAGCTTGGT
>HW247181.1 JP 2013514321-A/2824: Organic Compositions to Treat HSF1-Related Diseases
AGCAGCTTGGTG
>HW247180.1 JP 2013514321-A/2823: Organic Compositions to Treat HSF1-Related Diseases
GCAGCTTGGTGA
>HW247179.1 JP 2013514321-A/2822: Organic Compositions to Treat HSF1-Related Diseases
GGATCTTTATGT
>HW247178.1 JP 2013514321-A/2821: Organic Compositions to Treat HSF1-Related Diseases
GATCTTTATGTC
>HW247177.1 JP 2013514321-A/2820: Organic Compositions to Treat HSF1-Related Diseases
ATCTTTATGTCT
>HW247176.1 JP 2013514321-A/2819: Organic Compositions to Treat HSF1-Related Diseases
TCTTTATGTCTT
>HW247175.1 JP 2013514321-A/2818: Organic Compositions to Treat HSF1-Related Diseases
CTTTATGTCTTC
>HW247174.1 JP 2013514321-A/2817: Organic Compositions to Treat HSF1-Related Diseases
TTTATGTCTTCA
>HW247173.1 JP 2013514321-A/2816: Organic Compositions to Treat HSF1-Related Diseases
TTATGTCTTCAC
>HW247172.1 JP 2013514321-A/2815: Organic Compositions to Treat HSF1-Related Diseases
TATGTCTTCACT
>HW247171.1 JP 2013514321-A/2814: Organic Compositions to Treat HSF1-Related Diseases
ATGTCTTCACTC
>HW247170.1 JP 2013514321-A/2813: Organic Compositions to Treat HSF1-Related Diseases
TGTCTTCACTCT
>HW247169.1 JP 2013514321-A/2812: Organic Compositions to Treat HSF1-Related Diseases
GTCTTCACTCTT
>HW247168.1 JP 2013514321-A/2811: Organic Compositions to Treat HSF1-Related Diseases
TCTTCACTCTTC
>HW247167.1 JP 2013514321-A/2810: Organic Compositions to Treat HSF1-Related Diseases
CTTCACTCTTCA
>HW247166.1 JP 2013514321-A/2809: Organic Compositions to Treat HSF1-Related Diseases
TTCACTCTTCAG
>HW247165.1 JP 2013514321-A/2808: Organic Compositions to Treat HSF1-Related Diseases
TCACTCTTCAGG
>HW247164.1 JP 2013514321-A/2807: Organic Compositions to Treat HSF1-Related Diseases
CACTCTTCAGGG
>HW247163.1 JP 2013514321-A/2806: Organic Compositions to Treat HSF1-Related Diseases
ACTCTTCAGGGT
>HW247162.1 JP 2013514321-A/2805: Organic Compositions to Treat HSF1-Related Diseases
CTCTTCAGGGTG
>HW247161.1 JP 2013514321-A/2804: Organic Compositions to Treat HSF1-Related Diseases
TCTTCAGGGTGG
>HW247160.1 JP 2013514321-A/2803: Organic Compositions to Treat HSF1-Related Diseases
CTTCAGGGTGGA
>HW247159.1 JP 2013514321-A/2802: Organic Compositions to Treat HSF1-Related Diseases
TTCAGGGTGGAC
>HW247158.1 JP 2013514321-A/2801: Organic Compositions to Treat HSF1-Related Diseases
TCAGGGTGGACA
>HW247157.1 JP 2013514321-A/2800: Organic Compositions to Treat HSF1-Related Diseases
CAGGGTGGACAC
>HW247156.1 JP 2013514321-A/2799: Organic Compositions to Treat HSF1-Related Diseases
AGGGTGGACACA
>HW247155.1 JP 2013514321-A/2798: Organic Compositions to Treat HSF1-Related Diseases
GGGTGGACACAC
>HW247154.1 JP 2013514321-A/2797: Organic Compositions to Treat HSF1-Related Diseases
GGTGGACACACT
>HW247153.1 JP 2013514321-A/2796: Organic Compositions to Treat HSF1-Related Diseases
GTGGACACACTG
>HW247152.1 JP 2013514321-A/2795: Organic Compositions to Treat HSF1-Related Diseases
TGGACACACTGG
>HW247151.1 JP 2013514321-A/2794: Organic Compositions to Treat HSF1-Related Diseases
GGACACACTGGT
>HW247150.1 JP 2013514321-A/2793: Organic Compositions to Treat HSF1-Related Diseases
GACACACTGGTC
>HW247149.1 JP 2013514321-A/2792: Organic Compositions to Treat HSF1-Related Diseases
ACACACTGGTCA
>HW247148.1 JP 2013514321-A/2791: Organic Compositions to Treat HSF1-Related Diseases
CACACTGGTCAC
>HW247147.1 JP 2013514321-A/2790: Organic Compositions to Treat HSF1-Related Diseases
ACACTGGTCACT
>HW247146.1 JP 2013514321-A/2789: Organic Compositions to Treat HSF1-Related Diseases
CACTGGTCACTT
>HW247145.1 JP 2013514321-A/2788: Organic Compositions to Treat HSF1-Related Diseases
ACTGGTCACTTT
>HW247144.1 JP 2013514321-A/2787: Organic Compositions to Treat HSF1-Related Diseases
CTGGTCACTTTC
>HW247143.1 JP 2013514321-A/2786: Organic Compositions to Treat HSF1-Related Diseases
TGGTCACTTTCC
>HW247142.1 JP 2013514321-A/2785: Organic Compositions to Treat HSF1-Related Diseases
GGTCACTTTCCT
>HW247141.1 JP 2013514321-A/2784: Organic Compositions to Treat HSF1-Related Diseases
GTCACTTTCCTC
>HW247140.1 JP 2013514321-A/2783: Organic Compositions to Treat HSF1-Related Diseases
TCACTTTCCTCT
>HW247139.1 JP 2013514321-A/2782: Organic Compositions to Treat HSF1-Related Diseases
CACTTTCCTCTT
>HW247138.1 JP 2013514321-A/2781: Organic Compositions to Treat HSF1-Related Diseases
ACTTTCCTCTTG
>HW247137.1 JP 2013514321-A/2780: Organic Compositions to Treat HSF1-Related Diseases
CTTTCCTCTTGA
>HW247136.1 JP 2013514321-A/2779: Organic Compositions to Treat HSF1-Related Diseases
TTTCCTCTTGAT
>HW247135.1 JP 2013514321-A/2778: Organic Compositions to Treat HSF1-Related Diseases
TTCCTCTTGATG
>HW247134.1 JP 2013514321-A/2777: Organic Compositions to Treat HSF1-Related Diseases
TCCTCTTGATGT
>HW247133.1 JP 2013514321-A/2776: Organic Compositions to Treat HSF1-Related Diseases
CCTCTTGATGTT
>HW247132.1 JP 2013514321-A/2775: Organic Compositions to Treat HSF1-Related Diseases
CTCTTGATGTTC
>HW247131.1 JP 2013514321-A/2774: Organic Compositions to Treat HSF1-Related Diseases
TCTTGATGTTCT
>HW247130.1 JP 2013514321-A/2773: Organic Compositions to Treat HSF1-Related Diseases
CTTGATGTTCTC
>HW247129.1 JP 2013514321-A/2772: Organic Compositions to Treat HSF1-Related Diseases
TTGATGTTCTCA
>HW247128.1 JP 2013514321-A/2771: Organic Compositions to Treat HSF1-Related Diseases
TGATGTTCTCAA
>HW247127.1 JP 2013514321-A/2770: Organic Compositions to Treat HSF1-Related Diseases
GATGTTCTCAAG
>HW247126.1 JP 2013514321-A/2769: Organic Compositions to Treat HSF1-Related Diseases
ATGTTCTCAAGG
>HW247125.1 JP 2013514321-A/2768: Organic Compositions to Treat HSF1-Related Diseases
TGTTCTCAAGGA
>HW247124.1 JP 2013514321-A/2767: Organic Compositions to Treat HSF1-Related Diseases
GTTCTCAAGGAG
